Dexamethasone

Identification

Summary

Dexamethasone is a glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.

Brand Names

Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper

Generic Name

Dexamethasone

DrugBank Accession Number

DB01234

Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.¹³ Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.⁹

Dexamethasone was granted FDA approval on 30 October 1958.¹¹ In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.²²

Type

Small Molecule

Groups

Approved, Investigational, Vet approved

Structure

Similar Structures

Weight: Average: 392.4611
Monoisotopic: 392.199902243
Chemical Formula: C₂₂H₂₉FO₅

Synonyms

1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16α-Methyl-9α-fluoro-1-dehydrocortisol
9alpha-Fluoro-16alpha-methylprednisolone
9α-Fluoro-16α-methylprednisolone
Dexametasona
Dexamethasone
Dexaméthasone
Dexamethasonum

External IDs

ISV-305
NSC-34521
OTO-104

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.¹² Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.¹³ Oral tablets are indicated for the treatment of multiple myeloma.¹⁶ An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.¹⁹ Various ophthalmic formulations are indicated for inflammatory conditions of the eye.^{14,15,17,18,20,21}

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

Indication Type	Indication	Combined Product Details	Approval Level	Age Group	Patient Characteristics	Dose Form
Management of	Acne rosacea		••••••••••••
Management of	Acquired hemolytic anemia		••••••••••••
Management of	Acute gouty arthritis		••••••••••••
Management of	Acute leukemia		••••••••••••
Used in combination to treat	Acute otitis externa	Combination Product in combination with: Ciprofloxacin (DB00537)	••••••••••••	•••••• •••••••••• •••••••		••••••••••
Used in combination to treat	Acute otitis media	Combination Product in combination with: Ciprofloxacin (DB00537)	••••••••••••		•••••••••••• •••••	••••••••••
Diagnostic agent	Adrenocortical hyperfunction		••••••••••••
Management of	Adrenocortical insufficiency		••••••••••••
Management of	Allergic conjunctivitis		••••••••••••
Management of	Alopecia areata		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Ankylosing spondylitis		••••••••••••
Management of	Anterior segment inflammation		••••••••••••
Management of	Aspiration pneumonitis		••••••••••••
Management of	Asthma		••••••••••••
Management of	Atopic dermatitis		••••••••••••
Management of	Berylliosis		••••••••••••
Management of	Bullous dermatitis herpetiformis		••••••••••••
Management of	Bursitis		••••••••••••
Management of	Cerebral edema		••••••••••••
Management of	Chorioretinitis		••••••••••••
Management of	Choroiditis		••••••••••••
Management of	Congenital adrenal hyperplasia		••••••••••••
Management of	Congenital hypoplastic anemia		••••••••••••
Used in combination to treat	Conjunctivitis	Combination Product in combination with: Tetryzoline (DB06764), Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Used in combination to treat	Conjunctivitis allergic	Combination Product in combination with: Chlorpheniramine (DB01114)	••• •••			•••••••• • •••••
Management of	Contact dermatitis		••••••••••••
Used in combination to treat	Corneal inflammation	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Diagnostic agent	Cushing syndrome		••••••••••••
Treatment of	Diabetic macular edema		••••••••••••			•••••••
Management of	Discoid lupus erythematosus		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Drug hypersensitivity		••••••••••••
Management of	Epicondylitis		••••••••••••
Used in combination to treat	Episcleritis	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Management of	Erythroblastopenia		••••••••••••
Management of	Exfoliative dermatitis		••••••••••••
Used in combination to treat	Eye infections	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Used in combination to treat	Eye allergy	Combination Product in combination with: Chloramphenicol (DB00446), Tetryzoline (DB06764)	••••••••••••			•••••••• • •••••
Used in combination to treat	Eye inflammation	Combination Product in combination with: Tetryzoline (DB06764), Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Used in combination to treat	Eye swelling	Combination Product in combination with: Chloramphenicol (DB00446), Tetryzoline (DB06764)	••••••••••••			•••••••• • •••••
Used in combination to treat	Glaucoma	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Management of	Granuloma annulare		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Herpes zoster ophthalmicus		••••••••••••
Management of	Hypercalcemia		••••••••••••
Management of	Idiopathic thrombocytopenic purpura		••••••••••••
Used in combination to prevent	Infection	Combination Product in combination with: Levofloxacin (DB01137)	••••••••••••	•••••		••••••••
Treatment of	Inflammation		••••••••••••
Used in combination to treat	Inflammation of the external auditory canal	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••			•••••••••• • •••••
Used in combination to treat	Inflammatory reaction	Combination Product in combination with: Levofloxacin (DB01137)	••••••••••••	•••••		••••••••
Used in combination to prevent	Inflammatory reaction	Combination Product in combination with: Levofloxacin (DB01137)	••••••••••••	•••••		••••••••
Used in combination to treat	Intraocular inflammation	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••	•••••• ••••••••		•••••••••• • •••••
Management of	Iridocyclitis		••••••••••••
Management of	Iritis		••••••••••••
Management of	Juvenile rheumatoid arthritis		••••••••••••
Management of	Keloids		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Keratitis		••••••••••••
Management of	Lichen planus		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Lichen simplex chronicus		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Management of	Loeffler's syndrome		••••••••••••
Management of	Lymphomas		••••••••••••
Treatment of	Macular edema		••••••••••••			•••••••
Treatment of	Macular edema		••••••••••••			•••••••
Used in combination to treat	Middle ear inflammation	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••			•••••••••• • •••••
Used in combination to treat	Mucosal inflammation of the eye	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Used in combination to treat	Multiple myeloma (mm)	Regimen in combination with: Pomalidomide (DB08910), Isatuximab (DB14811)	••••••••••••	•••••	•••••••• •• ••••• ••• ••••• ••••••••• ••••••••• •••••••••••• ••• • •••••••••• •••••••••	•••••••••• ••••••••• ••••••••
Used in combination to treat	Muscle inflammation caused by cataract surgery of the eye	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Management of	Mycosis fungoides		••••••••••••
Management of	Necrobiosis lipoidica diabeticorum		••••••••••••			•••••••••• •••••••••• ••••••••• •••••••••• ••••••••••
Treatment of	Noninfectious posterior uveitis		••••••••••••			•••••••
Used in combination to treat	Ocular infections, irritations and inflammations	Combination Product in combination with: Gatifloxacin (DB01044)	••••••••••••			••••••
Treatment of	Ocular inflammation and pain		••••••••••••		•••••••••• •••••••	••••••
Used in combination to treat	Ocular irritation	Combination Product in combination with: Tetryzoline (DB06764), Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Treatment of	Ocular itching		••••••••••••			••••••
Management of	Optic neuritis		••••••••••••
Used in combination to treat	Otitis externa	Combination Product in combination with: Neomycin (DB00994), Lidocaine (DB00281), Polymyxin B (DB00781)	••••••••••••			••••••••
Management of	Pemphigus		••••••••••••
Management of	Perennial allergic rhinitis		••••••••••••
Used in combination to treat	Phlyctenular keratoconjunctivitis	Combination Product in combination with: Chlorpheniramine (DB01114)	••• •••			•••••••• • •••••
Management of	Post-traumatic osteoarthritis		••••••••••••
Used in combination to prevent	Postoperative infections caused by susceptible bacteria of the eyes	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••	•••••• ••••••••		•••••••••• • •••••
Management of	Regional enteritis		••••••••••••
Management of	Rheumatoid arthritis		••••••••••••
Management of	Sarcoidosis		••••••••••••
Used in combination to treat	Scleritis	Combination Product in combination with: Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••
Management of	Seasonal allergic rhinitis		••••••••••••
Management of	Secondary thrombocytopenia		••••••••••••
Management of	Serum sickness		••••••••••••
Management of	Severe seborrheic dermatitis		••••••••••••
Used in combination to treat	Skin inflammation	Combination Product in combination with: Clotrimazole (DB00257), Neomycin (DB00994)	••••••••••••			•••••
Management of	Stevens-johnson syndrome		••••••••••••
Management of	Sympathetic ophthalmia		••••••••••••
Management of	Synovitis		••••••••••••
Management of	Systemic lupus erythematosus		••••••••••••
Management of	Tenosynovitis		••••••••••••
Management of	Trichinosis		••••••••••••
Management of	Tuberculosis		••••••••••••
Management of	Tuberculosis meningitis		••••••••••••
Management of	Ulcerative colitis		••••••••••••
Management of	Uveitis		••••••••••••
Used in combination to treat	Vernal keratoconjunctivitis	Combination Product in combination with: Chlorpheniramine (DB01114)	••• •••			•••••••• • •••••
Management of	Acute rheumatic carditis		••••••••••••
Used in combination to treat	Corticosteroid-responsive dermatosis	Combination Product in combination with: Diphenhydramine (DB01075)	••••••••••••			••••••••
Used in combination to prevent	Ear infection-not otherwise specified caused by susceptible bacteria	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••			•••••••••• • •••••
Used in combination to treat	Ear infection-not otherwise specified caused by susceptible bacteria	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••			•••••••••• • •••••
Management of	Non-suppurative thyroiditis		••••••••••••
Used in combination to treat	Ocular bacterial infections	Combination Product in combination with: Ciprofloxacin (DB00537)	••••••••••••			••••••••• •••••••• • •••••• ••••••••••
Used in combination to treat	Ocular bacterial infections	Combination Product in combination with: Toremifene (DB00539)	••••••••••••	•••••••••		••••••••••
Used in combination to treat	Ocular bacterial infections	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••			••••••••
Treatment of	Ocular inflammatory conditions		••••••••••••		•••••••••• •••••••	••••••••••
Management of	Severe psoriasis		••••••••••••
Used in combination to treat	Steroid-responsive inflammation of the eye	Combination Product in combination with: Polymyxin B (DB00781), Neomycin (DB00994)	••••••••••••		•••••• ••••••••• ••••••••••	••••••••
Used in combination to treat	Steroid-responsive inflammation of the eye	Combination Product in combination with: Tobramycin (DB00684)	••••••••••••		•••••• ••••••••• ••••••••••	••••••••••
Used in combination to treat	Watery itchy eyes	Combination Product in combination with: Tetryzoline (DB06764), Chloramphenicol (DB00446)	••••••••••••			•••••••• • •••••

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.³ Dexamethasone's duration of action varies depending on the route.^{12,13,14,15,16,17,18,19,20,21} Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.³ Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.³

Mechanism of action

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.³ Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.³

Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.³

Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.³ High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.³

Target	Actions	Organism
AGlucocorticoid receptor	agonist	Humans
UNuclear receptor subfamily 0 group B member 1	stimulator	Humans
UAnnexin A1	agonist	Humans
UNitric oxide synthase, inducible	negative modulator	Humans
UNuclear receptor subfamily 1 group I member 2	agonist	Humans

Absorption

Absorption via the intramuscular route is slower than via the intravenous route.¹³ A 3mg intramuscular dose reaches a C_max of 34.6±6.0ng/mL with a T_max of 2.0±1.2h and an AUC of 113±38ng*h/mL.⁵ A 1.5mg oral dose reaches a C_max of 13.9±6.8ng/mL with a T_max of 2.0±0.5h and an AUC of 331±50ng*h/mL.⁵ Oral dexamethasone is approximately 70-78% bioavailable in healthy subjects.⁶

Volume of distribution

A 1.5mg oral dose of dexamethasone has a volume of distribution of 51.0L, while a 3mg intramuscular dose has a volume of distribution of 96.0L.⁵

Protein binding

Dexamethasone is approximately 77% protein bound in plasma.¹⁶ The majority of protein binding is with serum albumin.¹⁰ Dexamethasone does not significantly bind to corticosteroid binding protein.¹⁰

Metabolism

Dexamethasone is 6-hydroxylated by CYP3A4 to 6α- and 6β-hydroxydexamethasone.¹ Dexamethasone is reversibly metabolized to 11-dehydrodexamethasone by corticosteroid 11-beta-dehydrogenase isozyme 2 and can also be converted back to dexamethasone by Corticosteroid 11-beta-dehydrogenase isozyme 1.^7,8

Hover over products below to view reaction partners

Dexamethasone

Route of elimination

Corticosteroids are generally eliminated predominantly in the urine.⁴ However, dexamethasone is <10% elminated in urine.¹⁶

Half-life

The mean terminal half life of a 20mg oral tablet is 4 hours.¹⁶ A 1.5mg oral dose of dexamethasone has a half life of 6.6±4.3h, while a 3mg intramuscular dose has a half life of 4.2±1.2h.⁵

Clearance

A 20mg oral tablet has a clearance of 15.7L/h.¹⁶ A 1.5mg oral dose of dexamethasone has a clearance of 15.6±4.9L/h while a 3.0mg intramuscular dose has a clearance of 9.9±1.4L/h.⁵

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

The oral LD₅₀ in female mice was 6.5g/kg and 794mg/kg via the intravenous route.¹³

Overdoses are not expected with otic formulations.¹² Chronic high doses of glucocorticoids can lead to the development of cataract, glaucoma, hypertension, water retention, hyperlipidemia, peptic ulcer, pancreatitis, myopathy, osteoporosis, mood changes, psychosis, dermal atrophy, allergy, acne, hypertrichosis, immune suppression, decreased resistance to infection, moon face, hyperglycemia, hypocalcemia, hypophosphatemia, metabolic acidosis, growth suppression, and secondary adrenal insufficiency.² Overdose may be treated by adjusting the dose or stopping the corticosteroid as well as initiating symptomatic and supportive treatment.²

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Drug	Interaction
Integrate drug-drug interactions in your software
1,2-Benzodiazepine	The metabolism of 1,2-Benzodiazepine can be increased when combined with Dexamethasone.
Abametapir	The serum concentration of Dexamethasone can be increased when it is combined with Abametapir.
Abatacept	The metabolism of Dexamethasone can be increased when combined with Abatacept.
Abemaciclib	The metabolism of Abemaciclib can be increased when combined with Dexamethasone.
Abiraterone	The metabolism of Abiraterone can be increased when combined with Dexamethasone.
Acalabrutinib	The metabolism of Acalabrutinib can be increased when combined with Dexamethasone.
Acarbose	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Acarbose.
Aceclofenac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Aceclofenac.
Acemetacin	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Acemetacin.
Acenocoumarol	Dexamethasone may increase the anticoagulant activities of Acenocoumarol.
Acetaminophen	Dexamethasone may increase the hepatotoxic activities of Acetaminophen.
Acetohexamide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Acetohexamide.
Acetyldigitoxin	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Acetyldigitoxin.
Acetylsalicylic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Acetylsalicylic acid.
Acipimox	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Acipimox.
Acyclovir	The excretion of Dexamethasone can be decreased when combined with Acyclovir.
Adagrasib	The serum concentration of Adagrasib can be decreased when it is combined with Dexamethasone.
Adalimumab	The metabolism of Dexamethasone can be increased when combined with Adalimumab.
Adenovirus type 7 vaccine live	The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Dexamethasone.
Afatinib	Dexamethasone may decrease the excretion rate of Afatinib which could result in a higher serum level.
Albendazole	The metabolism of Albendazole can be increased when combined with Dexamethasone.
Albiglutide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Albiglutide.
Albuterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Salbutamol.
Alclofenac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Alclofenac.
Aldesleukin	The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexamethasone.
Alectinib	The metabolism of Alectinib can be increased when combined with Dexamethasone.
Alefacept	The risk or severity of adverse effects can be increased when Alefacept is combined with Dexamethasone.
Alemtuzumab	The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Dexamethasone.
Alendronic acid	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Dexamethasone.
Alfacalcidol	The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Dexamethasone.
Alfentanil	The metabolism of Alfentanil can be increased when combined with Dexamethasone.
Alfuzosin	The metabolism of Alfuzosin can be decreased when combined with Dexamethasone.
Aliskiren	The metabolism of Aliskiren can be increased when combined with Dexamethasone.
Allogeneic processed thymus tissue	The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Dexamethasone.
Allopurinol	Dexamethasone may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Almasilate	The bioavailability of Dexamethasone can be decreased when combined with Almasilate.
Almotriptan	The metabolism of Almotriptan can be increased when combined with Dexamethasone.
Alogliptin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Alogliptin.
Alosetron	The metabolism of Alosetron can be increased when combined with Dexamethasone.
Alpelisib	The serum concentration of Alpelisib can be decreased when it is combined with Dexamethasone.
Alprazolam	The metabolism of Alprazolam can be decreased when combined with Dexamethasone.
Altretamine	The risk or severity of adverse effects can be increased when Altretamine is combined with Dexamethasone.
Aluminium phosphate	The bioavailability of Dexamethasone can be decreased when combined with Aluminium phosphate.
Aluminum hydroxide	The bioavailability of Dexamethasone can be decreased when combined with Aluminum hydroxide.
Ambenonium	The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dexamethasone.
Ambrisentan	The metabolism of Ambrisentan can be increased when combined with Dexamethasone.
Ambroxol	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Ambroxol.
Aminoglutethimide	The therapeutic efficacy of Dexamethasone can be decreased when used in combination with Aminoglutethimide.
Aminohippuric acid	The excretion of Dexamethasone can be decreased when combined with Aminohippuric acid.
Aminophenazone	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Aminophenazone.
Aminophylline	The metabolism of Aminophylline can be increased when combined with Dexamethasone.
Aminosalicylic acid	The serum concentration of Aminosalicylic acid can be decreased when it is combined with Dexamethasone.
Amiodarone	The metabolism of Dexamethasone can be decreased when combined with Amiodarone.
Amitriptyline	The metabolism of Amitriptyline can be increased when combined with Dexamethasone.
Amlodipine	The metabolism of Amlodipine can be increased when combined with Dexamethasone.
Amodiaquine	The metabolism of Amodiaquine can be increased when combined with Dexamethasone.
Amphotericin B	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Amphotericin B.
Amprenavir	The metabolism of Dexamethasone can be decreased when combined with Amprenavir.
Amsacrine	The risk or severity of adverse effects can be increased when Amsacrine is combined with Dexamethasone.
Anakinra	The metabolism of Dexamethasone can be increased when combined with Anakinra.
Anastrozole	The metabolism of Anastrozole can be increased when combined with Dexamethasone.
Anifrolumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Anifrolumab.
Anthrax immune globulin human	The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Dexamethasone.
Anthrax vaccine	The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Dexamethasone.
Antilymphocyte immunoglobulin (horse)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Antilymphocyte immunoglobulin (horse).
Antipyrine	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Antipyrine.
Antithymocyte immunoglobulin (rabbit)	The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Dexamethasone.
Antrafenine	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Antrafenine.
Apalutamide	The serum concentration of Dexamethasone can be decreased when it is combined with Apalutamide.
Apixaban	The metabolism of Apixaban can be increased when combined with Dexamethasone.
Apomorphine	The metabolism of Apomorphine can be increased when combined with Dexamethasone.
Apremilast	The metabolism of Dexamethasone can be increased when combined with Apremilast.
Aprepitant	The metabolism of Aprepitant can be increased when combined with Dexamethasone.
Aprotinin	The therapeutic efficacy of Aprotinin can be decreased when used in combination with Dexamethasone.
Arbutamine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Arbutamine.
Arformoterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Arformoterol.
Aripiprazole	The metabolism of Aripiprazole can be increased when combined with Dexamethasone.
Aripiprazole lauroxil	The serum concentration of aripiprazole, an active metabolite of Dexamethasone, can be decreased when used in combination with Aripiprazole lauroxil.
Armodafinil	The metabolism of Dexamethasone can be increased when combined with Armodafinil.
Arsenic trioxide	The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dexamethasone.
Artemether	The metabolism of Artemether can be increased when combined with Dexamethasone.
Articaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Articaine.
Asciminib	The metabolism of Asciminib can be increased when combined with Dexamethasone.
Asenapine	The metabolism of Asenapine can be increased when combined with Dexamethasone.
Asparaginase Erwinia chrysanthemi	The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Erwinia chrysanthemi.
Asparaginase Escherichia coli	The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.
Astemizole	The metabolism of Astemizole can be increased when combined with Dexamethasone.
AstraZeneca COVID-19 Vaccine	The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Dexamethasone.
Asunaprevir	The metabolism of Asunaprevir can be increased when combined with Dexamethasone.
Ataluren	The excretion of Dexamethasone can be decreased when combined with Ataluren.
Atazanavir	The metabolism of Dexamethasone can be decreased when combined with Atazanavir.
Atenolol	Dexamethasone may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.
Atogepant	The serum concentration of Atogepant can be decreased when it is combined with Dexamethasone.
Atorvastatin	The metabolism of Atorvastatin can be decreased when combined with Dexamethasone.
Atovaquone	The metabolism of Atovaquone can be increased when combined with Dexamethasone.
Atracurium	The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone.
Atracurium besylate	The risk or severity of myopathy and weakness can be increased when Atracurium besylate is combined with Dexamethasone.
Atropine	Dexamethasone may increase the excretion rate of Atropine which could result in a lower serum level and potentially a reduction in efficacy.
Avacopan	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Avacopan.
Avanafil	The serum concentration of Avanafil can be increased when it is combined with Dexamethasone.
Avapritinib	The metabolism of Avapritinib can be increased when combined with Dexamethasone.
Avatrombopag	The metabolism of Avatrombopag can be increased when combined with Dexamethasone.
Axitinib	The metabolism of Axitinib can be increased when combined with Dexamethasone.
Azacitidine	The risk or severity of adverse effects can be increased when Azacitidine is combined with Dexamethasone.
Azathioprine	The risk or severity of adverse effects can be increased when Azathioprine is combined with Dexamethasone.
Azelastine	The metabolism of Azelastine can be increased when combined with Dexamethasone.
Azithromycin	The serum concentration of Dexamethasone can be increased when it is combined with Azithromycin.
Bacillus calmette-guerin substrain connaught live antigen	The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Dexamethasone.
Bacillus calmette-guerin substrain russian BCG-I live antigen	The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Dexamethasone.
Bacillus calmette-guerin substrain tice live antigen	The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Dexamethasone.
Baclofen	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Dexamethasone.
Balsalazide	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Balsalazide.
Baricitinib	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Baricitinib.
Basiliximab	The risk or severity of adverse effects can be increased when Basiliximab is combined with Dexamethasone.
BCG vaccine	The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dexamethasone.
Beclomethasone dipropionate	The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Dexamethasone.
Bedaquiline	The serum concentration of Bedaquiline can be decreased when it is combined with Dexamethasone.
Belantamab mafodotin	Dexamethasone may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.
Belatacept	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belatacept.
Belimumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belimumab.
Belinostat	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belinostat.
Belumosudil	The serum concentration of Belumosudil can be decreased when it is combined with Dexamethasone.
Bendamustine	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Bendamustine.
Bendroflumethiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Bendroflumethiazide.
Benorilate	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benorilate.
Benoxaprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benoxaprofen.
Benzocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzocaine.
Benzoic acid	The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Dexamethasone.
Benzphetamine	The metabolism of Benzphetamine can be increased when combined with Dexamethasone.
Benzthiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Benzthiazide.
Benzydamine	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benzydamine.
Benzyl alcohol	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzyl alcohol.
Benzylpenicillin	The excretion of Dexamethasone can be decreased when combined with Benzylpenicillin.
Bepridil	The metabolism of Bepridil can be increased when combined with Dexamethasone.
Berotralstat	The serum concentration of Berotralstat can be increased when it is combined with Dexamethasone.
Betaine	The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone.
Betamethasone phosphate	The metabolism of Betamethasone phosphate can be increased when combined with Dexamethasone.
Bexagliflozin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Bexagliflozin.
Bexarotene	The risk or severity of adverse effects can be increased when Bexarotene is combined with Dexamethasone.
Bezafibrate	The metabolism of Bezafibrate can be increased when combined with Dexamethasone.
Bicalutamide	The metabolism of Bicalutamide can be increased when combined with Dexamethasone.
Bictegravir	The metabolism of Bictegravir can be increased when combined with Dexamethasone.
Bimekizumab	The metabolism of Dexamethasone can be increased when combined with Bimekizumab.
Binimetinib	The metabolism of Binimetinib can be increased when combined with Dexamethasone.
Bismuth subsalicylate	The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Dexamethasone.
Bisoprolol	The metabolism of Bisoprolol can be increased when combined with Dexamethasone.
Bleomycin	The risk or severity of adverse effects can be increased when Bleomycin is combined with Dexamethasone.
Blinatumomab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Blinatumomab.
Boceprevir	The metabolism of Dexamethasone can be decreased when combined with Boceprevir.
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)	The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Bortezomib	The serum concentration of Bortezomib can be decreased when it is combined with Dexamethasone.
Bosentan	The metabolism of Bosentan can be increased when combined with Dexamethasone.
Bosutinib	The serum concentration of Bosutinib can be decreased when it is combined with Dexamethasone.
Botulinum toxin type A	The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Dexamethasone.
Brentuximab vedotin	The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone.
Brexpiprazole	The metabolism of Brexpiprazole can be increased when combined with Dexamethasone.
Brigatinib	The metabolism of Brigatinib can be increased when combined with Dexamethasone.
Brivaracetam	The metabolism of Brivaracetam can be increased when combined with Dexamethasone.
Brodalumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Brodalumab.
Bromocriptine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Bromocriptine.
Brompheniramine	The metabolism of Brompheniramine can be increased when combined with Dexamethasone.
Budesonide	The risk or severity of adverse effects can be increased when Budesonide is combined with Dexamethasone.
Bumadizone	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Bumadizone.
Bumetanide	The excretion of Dexamethasone can be decreased when combined with Bumetanide.
Bupivacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Bupivacaine.
Buprenorphine	The metabolism of Buprenorphine can be increased when combined with Dexamethasone.
Bupropion	The metabolism of Bupropion can be increased when combined with Dexamethasone.
Buspirone	The metabolism of Buspirone can be increased when combined with Dexamethasone.
Busulfan	The metabolism of Busulfan can be increased when combined with Dexamethasone.
Butacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Butacaine.
Butamben	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Butamben.
Cabazitaxel	The metabolism of Cabazitaxel can be increased when combined with Dexamethasone.
Cabergoline	The metabolism of Cabergoline can be increased when combined with Dexamethasone.
Cabotegravir	The excretion of Dexamethasone can be decreased when combined with Cabotegravir.
Cabozantinib	The metabolism of Cabozantinib can be increased when combined with Dexamethasone.
Calcifediol	The therapeutic efficacy of Calcifediol can be decreased when used in combination with Dexamethasone.
Calcitriol	The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone.
Calcium carbonate	The bioavailability of Dexamethasone can be decreased when combined with Calcium carbonate.
Canagliflozin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Canagliflozin.
Canakinumab	The metabolism of Dexamethasone can be increased when combined with Canakinumab.
Candicidin	The serum concentration of Dexamethasone can be increased when it is combined with Candicidin.
Cannabidiol	The metabolism of Cannabidiol can be increased when combined with Dexamethasone.
Capecitabine	The risk or severity of adverse effects can be increased when Capecitabine is combined with Dexamethasone.
Capivasertib	The serum concentration of Capivasertib can be decreased when it is combined with Dexamethasone.
Capmatinib	The serum concentration of Capmatinib can be decreased when it is combined with Dexamethasone.
Capsaicin	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Capsaicin.
Captopril	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Dexamethasone.
Carbamazepine	The metabolism of Carbamazepine can be increased when combined with Dexamethasone.
Carbimazole	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Dexamethasone.
Carboplatin	The risk or severity of adverse effects can be increased when Carboplatin is combined with Dexamethasone.
Carfilzomib	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Carfilzomib.
Cariprazine	The metabolism of Cariprazine can be increased when combined with Dexamethasone.
Carmustine	The risk or severity of adverse effects can be increased when Carmustine is combined with Dexamethasone.
Carprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Carprofen.
Carvedilol	The metabolism of Carvedilol can be increased when combined with Dexamethasone.
Cefaclor	The excretion of Dexamethasone can be decreased when combined with Cefaclor.
Cefadroxil	The excretion of Dexamethasone can be decreased when combined with Cefadroxil.
Cefalotin	The excretion of Dexamethasone can be decreased when combined with Cefalotin.
Cefamandole	The excretion of Dexamethasone can be decreased when combined with Cefamandole.
Cefazolin	The excretion of Dexamethasone can be decreased when combined with Cefazolin.
Cefoperazone	The excretion of Dexamethasone can be decreased when combined with Cefoperazone.
Cefotaxime	The excretion of Dexamethasone can be decreased when combined with Cefotaxime.
Cefotiam	The excretion of Dexamethasone can be decreased when combined with Cefotiam.
Ceftibuten	The excretion of Dexamethasone can be decreased when combined with Ceftibuten.
Ceftizoxime	The excretion of Dexamethasone can be decreased when combined with Ceftizoxime.
Ceftriaxone	The excretion of Dexamethasone can be decreased when combined with Ceftriaxone.
Celecoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Celecoxib.
Celiprolol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Celiprolol.
Cenobamate	The serum concentration of Dexamethasone can be decreased when it is combined with Cenobamate.
Cephalexin	The metabolism of Cephalexin can be increased when combined with Dexamethasone.
Ceritinib	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ceritinib.
Cerivastatin	The metabolism of Cerivastatin can be increased when combined with Dexamethasone.
Certolizumab pegol	The metabolism of Dexamethasone can be increased when combined with Certolizumab pegol.
Cevimeline	The metabolism of Cevimeline can be increased when combined with Dexamethasone.
Chenodeoxycholic acid	The metabolism of Chenodeoxycholic acid can be increased when combined with Dexamethasone.
Chikungunya vaccine (live, attenuated)	The risk or severity of infection can be increased when Chikungunya vaccine (live, attenuated) is combined with Dexamethasone.
Chlorambucil	The risk or severity of adverse effects can be increased when Chlorambucil is combined with Dexamethasone.
Chloramphenicol	The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dexamethasone.
Chloroprocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Chloroprocaine.
Chloroquine	The metabolism of Chloroquine can be increased when combined with Dexamethasone.
Chlorothiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Chlorothiazide.
Chlorpheniramine	The metabolism of Chlorpheniramine can be increased when combined with Dexamethasone.
Chlorpromazine	The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Dexamethasone.
Chlorpropamide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Chlorpropamide.
Chlorthalidone	Dexamethasone may increase the hypokalemic activities of Chlorthalidone.
Chlorzoxazone	The metabolism of Chlorzoxazone can be increased when combined with Dexamethasone.
Cholecalciferol	The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Dexamethasone.
Cholestyramine	Cholestyramine may increase the excretion rate of Dexamethasone which could result in a lower serum level and potentially a reduction in efficacy.
Cholic Acid	The excretion of Dexamethasone can be decreased when combined with Cholic Acid.
Choline magnesium trisalicylate	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Choline magnesium trisalicylate.
Choline salicylate	The serum concentration of Choline salicylate can be decreased when it is combined with Dexamethasone.
Ciclesonide	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ciclesonide.
Cilastatin	The excretion of Dexamethasone can be decreased when combined with Cilastatin.
Cilostazol	The metabolism of Cilostazol can be decreased when combined with Dexamethasone.
Cimetidine	The excretion of Dexamethasone can be decreased when combined with Cimetidine.
Cinacalcet	The metabolism of Cinacalcet can be increased when combined with Dexamethasone.
Cinchocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Cinchocaine.
Cinnarizine	The metabolism of Cinnarizine can be increased when combined with Dexamethasone.
Cinoxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Cinoxacin.
Ciprofibrate	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ciprofibrate.
Ciprofloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ciprofloxacin.
Cisapride	The metabolism of Cisapride can be increased when combined with Dexamethasone.
Cisatracurium	The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Dexamethasone.
Cisplatin	The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dexamethasone.
Citalopram	The metabolism of Citalopram can be increased when combined with Dexamethasone.
Cladribine	The risk or severity of adverse effects can be increased when Cladribine is combined with Dexamethasone.
Clarithromycin	The metabolism of Dexamethasone can be decreased when combined with Clarithromycin.
Clenbuterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Clenbuterol.
Clevidipine	The metabolism of Clevidipine can be increased when combined with Dexamethasone.
Clindamycin	The metabolism of Clindamycin can be increased when combined with Dexamethasone.
Clobazam	The metabolism of Clobazam can be increased when combined with Dexamethasone.
Clobetasol propionate	The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Dexamethasone.
Clofarabine	The risk or severity of adverse effects can be increased when Clofarabine is combined with Dexamethasone.
Clofazimine	The metabolism of Dexamethasone can be decreased when combined with Clofazimine.
Clofibrate	The metabolism of Clofibrate can be increased when combined with Dexamethasone.
Clomipramine	The metabolism of Clomipramine can be increased when combined with Dexamethasone.
Clonazepam	The metabolism of Clonazepam can be increased when combined with Dexamethasone.
Clonidine	The metabolism of Clonidine can be increased when combined with Dexamethasone.
Clopidogrel	The metabolism of Clopidogrel can be increased when combined with Dexamethasone.
Clorazepic acid	The metabolism of Clorazepic acid can be increased when combined with Dexamethasone.
Clostridium tetani toxoid antigen (formaldehyde inactivated)	The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Clotiazepam	The metabolism of Clotiazepam can be increased when combined with Dexamethasone.
Clozapine	The serum concentration of Clozapine can be increased when it is combined with Dexamethasone.
Cobicistat	The serum concentration of Cobicistat can be decreased when it is combined with Dexamethasone.
Cobimetinib	The serum concentration of Cobimetinib can be decreased when it is combined with Dexamethasone.
Cocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Cocaine.
Codeine	The metabolism of Codeine can be increased when combined with Dexamethasone.
Colchicine	The metabolism of Colchicine can be decreased when combined with Dexamethasone.
Conivaptan	The metabolism of Dexamethasone can be decreased when combined with Conivaptan.
Conjugated estrogens	The serum concentration of Dexamethasone can be increased when it is combined with Conjugated estrogens.
Copanlisib	The metabolism of Copanlisib can be increased when combined with Dexamethasone.
Corticorelin ovine triflutate	The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Dexamethasone.
Corticotropin	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Corticotropin.
Cortisone acetate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Cortisone acetate.
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)	The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Crizotinib	The metabolism of Crizotinib can be increased when combined with Dexamethasone.
Curcumin	The metabolism of Dexamethasone can be decreased when combined with Curcumin.
Cyclandelate	The metabolism of Cyclandelate can be increased when combined with Dexamethasone.
Cyclobenzaprine	The metabolism of Cyclobenzaprine can be increased when combined with Dexamethasone.
Cyclopenthiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Cyclopenthiazide.
Cyclophosphamide	The metabolism of Cyclophosphamide can be increased when combined with Dexamethasone.
Cyclosporine	Dexamethasone may increase the immunosuppressive activities of Cyclosporine.
Cyclothiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Cyclothiazide.
Cyproterone acetate	The serum concentration of Dexamethasone can be increased when it is combined with Cyproterone acetate.
Cytarabine	The risk or severity of adverse effects can be increased when Cytarabine is combined with Dexamethasone.
Dabrafenib	The serum concentration of Dexamethasone can be decreased when it is combined with Dabrafenib.
Dacarbazine	The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dexamethasone.
Daclatasvir	The metabolism of Daclatasvir can be increased when combined with Dexamethasone.
Dacomitinib	The metabolism of Dacomitinib can be increased when combined with Dexamethasone.
Dactinomycin	The risk or severity of adverse effects can be increased when Dactinomycin is combined with Dexamethasone.
Danazol	The metabolism of Dexamethasone can be decreased when combined with Danazol.
Dapagliflozin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dapagliflozin.
Daprodustat	The metabolism of Daprodustat can be increased when combined with Dexamethasone.
Dapsone	The metabolism of Dapsone can be increased when combined with Dexamethasone.
Daptomycin	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Dexamethasone.
Darbepoetin alfa	The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexamethasone.
Daridorexant	The metabolism of Daridorexant can be increased when combined with Dexamethasone.
Darifenacin	The metabolism of Darifenacin can be increased when combined with Dexamethasone.
Darolutamide	The serum concentration of Darolutamide can be decreased when it is combined with Dexamethasone.
Darunavir	The metabolism of Dexamethasone can be decreased when combined with Darunavir.
Dasabuvir	The metabolism of Dasabuvir can be increased when combined with Dexamethasone.
Dasatinib	The therapeutic efficacy of Dasatinib can be decreased when used in combination with Dexamethasone.
Daunorubicin	The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dexamethasone.
DaxibotulinumtoxinA	The risk or severity of myopathy and weakness can be increased when DaxibotulinumtoxinA is combined with Dexamethasone.
Decamethonium	The therapeutic efficacy of Decamethonium can be decreased when used in combination with Dexamethasone.
Decitabine	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Decitabine.
Deferasirox	The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Dexamethasone is combined with Deferasirox.
Deflazacort	The serum concentration of Deflazacort can be decreased when it is combined with Dexamethasone.
Delafloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Delafloxacin.
Delamanid	The metabolism of Delamanid can be increased when combined with Dexamethasone.
Delavirdine	The metabolism of Dexamethasone can be decreased when combined with Delavirdine.
Demecarium	The therapeutic efficacy of Demecarium can be decreased when used in combination with Dexamethasone.
Denosumab	The risk or severity of adverse effects can be increased when Denosumab is combined with Dexamethasone.
Deslanoside	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Deslanoside.
Desogestrel	The serum concentration of Dexamethasone can be increased when it is combined with Desogestrel.
Desoximetasone	The risk or severity of adverse effects can be increased when Desoximetasone is combined with Dexamethasone.
Desoxycorticosterone acetate	The metabolism of Desoxycorticosterone acetate can be increased when combined with Dexamethasone.
Desvenlafaxine	The metabolism of Desvenlafaxine can be increased when combined with Dexamethasone.
Deucravacitinib	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Deucravacitinib.
Deutetrabenazine	The metabolism of Deutetrabenazine can be increased when combined with Dexamethasone.
Dexibuprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Dexibuprofen.
Dexketoprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Dexketoprofen.
Dexlansoprazole	The metabolism of Dexlansoprazole can be increased when combined with Dexamethasone.
Dexpanthenol	The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Dexamethasone.
Dexrazoxane	The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Dexamethasone.
Dextromethorphan	The metabolism of Dextromethorphan can be increased when combined with Dexamethasone.
Dextropropoxyphene	The metabolism of Dextropropoxyphene can be increased when combined with Dexamethasone.
Diazepam	The metabolism of Diazepam can be increased when combined with Dexamethasone.
Diclofenac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Diclofenac.
Dicoumarol	Dexamethasone may increase the anticoagulant activities of Dicoumarol.
Dienestrol	The serum concentration of Dexamethasone can be increased when it is combined with Dienestrol.
Dienogest	The metabolism of Dienogest can be increased when combined with Dexamethasone.
Diethylcarbamazine	The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Dexamethasone.
Diethylstilbestrol	The serum concentration of Dexamethasone can be increased when it is combined with Diethylstilbestrol.
Diflunisal	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Diflunisal.
Difluocortolone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Difluocortolone.
Digitoxin	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digitoxin.
Digoxin	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digoxin.
Dihydro-alpha-ergocryptine	The metabolism of Dihydro-alpha-ergocryptine can be increased when combined with Dexamethasone.
Dihydrocodeine	The metabolism of Dihydrocodeine can be increased when combined with Dexamethasone.
Dihydroergocornine	The metabolism of Dihydroergocornine can be increased when combined with Dexamethasone.
Dihydroergocristine	The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone.
Dihydroergotamine	The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone.
Dihydrotachysterol	The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Dexamethasone.
Diltiazem	The metabolism of Diltiazem can be increased when combined with Dexamethasone.
Dimethyl fumarate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Dimethyl fumarate.
Dinoprostone	The excretion of Dexamethasone can be decreased when combined with Dinoprostone.
Dinutuximab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Dinutuximab.
Diphenhydramine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Diphenhydramine.
Dipyridamole	Dexamethasone may increase the excretion rate of Dipyridamole which could result in a lower serum level and potentially a reduction in efficacy.
Diroximel fumarate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Diroximel fumarate.
Disopyramide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Disopyramide.
Disulfiram	The metabolism of Disulfiram can be increased when combined with Dexamethasone.
Dobutamine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Dobutamine.
Docetaxel	The metabolism of Docetaxel can be increased when combined with Dexamethasone.
Dofetilide	The metabolism of Dofetilide can be increased when combined with Dexamethasone.
Dolasetron	The metabolism of Dolasetron can be increased when combined with Dexamethasone.
Dolutegravir	The excretion of Dexamethasone can be decreased when combined with Dolutegravir.
Domperidone	The metabolism of Domperidone can be increased when combined with Dexamethasone.
Donepezil	The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone.
Doravirine	The metabolism of Doravirine can be increased when combined with Dexamethasone.
Dosulepin	The metabolism of Dosulepin can be increased when combined with Dexamethasone.
Doxacurium	The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Dexamethasone.
Doxazosin	The metabolism of Doxazosin can be increased when combined with Dexamethasone.
Doxepin	The metabolism of Doxepin can be increased when combined with Dexamethasone.
Doxercalciferol	The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Dexamethasone.
Doxorubicin	The serum concentration of Doxorubicin can be increased when it is combined with Dexamethasone.
Dronabinol	The serum concentration of Dronabinol can be increased when it is combined with Dexamethasone.
Dronedarone	The metabolism of Dronedarone can be increased when combined with Dexamethasone.
Drospirenone	The serum concentration of Dexamethasone can be increased when it is combined with Drospirenone.
Droxidopa	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Droxidopa.
Dulaglutide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dulaglutide.
Durvalumab	The therapeutic efficacy of Durvalumab can be decreased when used in combination with Dexamethasone.
Dutasteride	The metabolism of Dutasteride can be increased when combined with Dexamethasone.
Duvelisib	The metabolism of Duvelisib can be increased when combined with Dexamethasone.
Dyclonine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Dyclonine.
Dydrogesterone	The metabolism of Dydrogesterone can be increased when combined with Dexamethasone.
Ebastine	The metabolism of Ebastine can be increased when combined with Dexamethasone.
Ebola Zaire vaccine (live, attenuated)	The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Dexamethasone.
Eculizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Eculizumab.
Edrophonium	The therapeutic efficacy of Edrophonium can be decreased when used in combination with Dexamethasone.
Efalizumab	The risk or severity of adverse effects can be increased when Efalizumab is combined with Dexamethasone.
Efavirenz	The metabolism of Dexamethasone can be decreased when combined with Efavirenz.
Efgartigimod alfa	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Efgartigimod alfa.
Elacestrant	The serum concentration of Elacestrant can be decreased when it is combined with Dexamethasone.
Elagolix	The metabolism of Elagolix can be increased when combined with Dexamethasone.
Elbasvir	The metabolism of Elbasvir can be increased when combined with Dexamethasone.
Eletriptan	The metabolism of Eletriptan can be increased when combined with Dexamethasone.
Elexacaftor	The serum concentration of Elexacaftor can be decreased when it is combined with Dexamethasone.
Eliglustat	The metabolism of Eliglustat can be decreased when combined with Dexamethasone.
Eltrombopag	The metabolism of Eltrombopag can be increased when combined with Dexamethasone.
Elvitegravir	The serum concentration of Elvitegravir can be decreased when it is combined with Dexamethasone.
Emapalumab	The metabolism of Dexamethasone can be increased when combined with Emapalumab.
Empagliflozin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Empagliflozin.
Enalapril	The excretion of Dexamethasone can be decreased when combined with Enalapril.
Enasidenib	The metabolism of Enasidenib can be increased when combined with Dexamethasone.
Encorafenib	The serum concentration of Encorafenib can be decreased when it is combined with Dexamethasone.
Enflurane	The metabolism of Enflurane can be increased when combined with Dexamethasone.
Enfortumab vedotin	The metabolism of Enfortumab vedotin can be increased when combined with Dexamethasone.
Enoxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Enoxacin.
Entrectinib	The metabolism of Entrectinib can be increased when combined with Dexamethasone.
Enzalutamide	The serum concentration of Dexamethasone can be decreased when it is combined with Enzalutamide.
Epcoritamab	The serum concentration of Dexamethasone can be increased when it is combined with Epcoritamab.
Ephedrine	Ephedrine may increase the excretion rate of Dexamethasone which could result in a lower serum level and potentially a reduction in efficacy.
Epinastine	The metabolism of Epinastine can be increased when combined with Dexamethasone.
Epinephrine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Epinephrine.
Epirubicin	The risk or severity of adverse effects can be increased when Epirubicin is combined with Dexamethasone.
Eplerenone	The metabolism of Eplerenone can be increased when combined with Dexamethasone.
Eprosartan	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Dexamethasone.
Eravacycline	The metabolism of Eravacycline can be increased when combined with Dexamethasone.
Erdafitinib	The metabolism of Erdafitinib can be increased when combined with Dexamethasone.
Ergocalciferol	The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Dexamethasone.
Ergoloid mesylate	The metabolism of Ergoloid mesylate can be increased when combined with Dexamethasone.
Ergometrine	The metabolism of Ergometrine can be increased when combined with Dexamethasone.
Ergotamine	The metabolism of Dexamethasone can be decreased when combined with Ergotamine.
Eribulin	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Eribulin.
Erlotinib	The metabolism of Erlotinib can be increased when combined with Dexamethasone.
Ertugliflozin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ertugliflozin.
Erythromycin	The serum concentration of Dexamethasone can be increased when it is combined with Erythromycin.
Erythropoietin	The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexamethasone.
Escitalopram	The metabolism of Escitalopram can be increased when combined with Dexamethasone.
Esketamine	The metabolism of Esketamine can be increased when combined with Dexamethasone.
Esomeprazole	The metabolism of Esomeprazole can be increased when combined with Dexamethasone.
Estazolam	The metabolism of Estazolam can be increased when combined with Dexamethasone.
Esterified estrogens	The serum concentration of Dexamethasone can be increased when it is combined with Esterified estrogens.
Estetrol	The risk or severity of adverse effects can be increased when Estetrol is combined with Dexamethasone.
Estradiol	The serum concentration of Dexamethasone can be increased when it is combined with Estradiol.
Estradiol acetate	The serum concentration of Dexamethasone can be increased when it is combined with Estradiol acetate.
Estradiol benzoate	The serum concentration of Dexamethasone can be increased when it is combined with Estradiol benzoate.
Estradiol cypionate	The serum concentration of Dexamethasone can be increased when it is combined with Estradiol cypionate.
Estradiol dienanthate	The metabolism of Estradiol dienanthate can be increased when combined with Dexamethasone.
Estradiol valerate	The serum concentration of Dexamethasone can be increased when it is combined with Estradiol valerate.
Estramustine	The risk or severity of adverse effects can be increased when Estramustine is combined with Dexamethasone.
Estriol	The serum concentration of Dexamethasone can be increased when it is combined with Estriol.
Estrone	The serum concentration of Dexamethasone can be increased when it is combined with Estrone.
Estrone sulfate	The serum concentration of Dexamethasone can be increased when it is combined with Estrone sulfate.
Eszopiclone	The serum concentration of Eszopiclone can be decreased when it is combined with Dexamethasone.
Etacrynic acid	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Etacrynic acid.
Etafedrine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Etafedrine.
Etanercept	The metabolism of Dexamethasone can be increased when combined with Etanercept.
Ethanol	The metabolism of Ethanol can be increased when combined with Dexamethasone.
Ethinylestradiol	The serum concentration of Dexamethasone can be increased when it is combined with Ethinylestradiol.
Ethosuximide	The metabolism of Ethosuximide can be increased when combined with Dexamethasone.
Ethyl chloride	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Ethyl chloride.
Ethynodiol diacetate	The serum concentration of Dexamethasone can be increased when it is combined with Ethynodiol diacetate.
Etidocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Etidocaine.
Etodolac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etodolac.
Etonogestrel	The serum concentration of Dexamethasone can be increased when it is combined with Etonogestrel.
Etoposide	The metabolism of Etoposide can be increased when combined with Dexamethasone.
Etoricoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etoricoxib.
Etrasimod	The risk or severity of immunosuppression can be increased when Dexamethasone is combined with Etrasimod.
Etravirine	The metabolism of Etravirine can be increased when combined with Dexamethasone.
Everolimus	The metabolism of Everolimus can be increased when combined with Dexamethasone.
Exemestane	The metabolism of Exemestane can be increased when combined with Dexamethasone.
Exenatide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Exenatide.
Ezetimibe	Dexamethasone may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Famotidine	The excretion of Dexamethasone can be decreased when combined with Famotidine.
Famtozinameran	The therapeutic efficacy of Famtozinameran can be decreased when used in combination with Dexamethasone.
Favipiravir	The excretion of Dexamethasone can be decreased when combined with Favipiravir.
Fedratinib	The serum concentration of Fedratinib can be decreased when it is combined with Dexamethasone.
Felbamate	The metabolism of Felbamate can be increased when combined with Dexamethasone.
Felodipine	The metabolism of Felodipine can be increased when combined with Dexamethasone.
Fenbufen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Fenbufen.
Fenfluramine	The metabolism of Fenfluramine can be increased when combined with Dexamethasone.
Fenofibrate	The metabolism of Fenofibrate can be increased when combined with Dexamethasone.
Fenofibric acid	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Fenofibric acid.
Fenoprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Fenoprofen.
Fenoterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Fenoterol.
Fentanyl	The metabolism of Fentanyl can be increased when combined with Dexamethasone.
Fesoterodine	The metabolism of Fesoterodine can be increased when combined with Dexamethasone.
Fexinidazole	The metabolism of Fexinidazole can be increased when combined with Dexamethasone.
Filgotinib	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Filgotinib.
Finasteride	The metabolism of Finasteride can be increased when combined with Dexamethasone.
Finerenone	The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone.
Fingolimod	Dexamethasone may increase the immunosuppressive activities of Fingolimod.
Fish oil	The metabolism of Fish oil can be increased when combined with Dexamethasone.
Flibanserin	The metabolism of Flibanserin can be increased when combined with Dexamethasone.
Floctafenine	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Floctafenine.
Floxuridine	The risk or severity of adverse effects can be increased when Floxuridine is combined with Dexamethasone.
Flucloxacillin	Dexamethasone may increase the excretion rate of Flucloxacillin which could result in a lower serum level and potentially a reduction in efficacy.
Fluconazole	The metabolism of Dexamethasone can be decreased when combined with Fluconazole.
Flucytosine	The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone.
Fludarabine	The risk or severity of adverse effects can be increased when Fludarabine is combined with Dexamethasone.
Fludrocortisone	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Dexamethasone.
Fluindione	Dexamethasone may increase the anticoagulant activities of Fluindione.
Flumethasone	The metabolism of Flumethasone can be increased when combined with Dexamethasone.
Flunarizine	The metabolism of Flunarizine can be increased when combined with Dexamethasone.
Flunisolide	The risk or severity of adverse effects can be increased when Flunisolide is combined with Dexamethasone.
Flunitrazepam	The metabolism of Flunitrazepam can be increased when combined with Dexamethasone.
Fluocinolone acetonide	The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Dexamethasone.
Fluocinonide	The risk or severity of adverse effects can be increased when Fluocinonide is combined with Dexamethasone.
Fluocortolone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluocortolone.
Fluorescein	Dexamethasone may increase the excretion rate of Fluorescein which could result in a lower serum level and potentially a reduction in efficacy.
Fluorometholone	The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dexamethasone.
Fluorouracil	The metabolism of Fluorouracil can be increased when combined with Dexamethasone.
Fluoxetine	The metabolism of Fluoxetine can be increased when combined with Dexamethasone.
Fluoxymesterone	The risk or severity of fluid retention can be increased when Dexamethasone is combined with Fluoxymesterone.
Fluprednisolone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluprednisolone.
Flurazepam	The metabolism of Flurazepam can be increased when combined with Dexamethasone.
Flurbiprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Flurbiprofen.
Fluspirilene	The metabolism of Fluspirilene can be increased when combined with Dexamethasone.
Flutamide	The metabolism of Flutamide can be increased when combined with Dexamethasone.
Fluticasone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluticasone.
Fluticasone furoate	The serum concentration of Fluticasone furoate can be increased when it is combined with Dexamethasone.
Fluticasone propionate	The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Dexamethasone.
Fluvastatin	The metabolism of Fluvastatin can be increased when combined with Dexamethasone.
Fluvoxamine	The metabolism of Fluvoxamine can be increased when combined with Dexamethasone.
Folic acid	Dexamethasone may decrease the excretion rate of Folic acid which could result in a higher serum level.
Formestane	The risk or severity of edema formation can be increased when Formestane is combined with Dexamethasone.
Formoterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Formoterol.
Fosamprenavir	The metabolism of Fosamprenavir can be increased when combined with Dexamethasone.
Fosaprepitant	The metabolism of Fosaprepitant can be increased when combined with Dexamethasone.
Fosnetupitant	The metabolism of Dexamethasone can be decreased when combined with Fosnetupitant.
Fosphenytoin	The serum concentration of Dexamethasone can be decreased when it is combined with Fosphenytoin.
Fostamatinib	The metabolism of Fostamatinib can be increased when combined with Dexamethasone.
Fostemsavir	The serum concentration of Fostemsavir can be decreased when it is combined with Dexamethasone.
Fruquintinib	The serum concentration of Fruquintinib can be decreased when it is combined with Dexamethasone.
Furosemide	The excretion of Dexamethasone can be decreased when combined with Furosemide.
Fusidic acid	The metabolism of Fusidic acid can be increased when combined with Dexamethasone.
Futibatinib	The metabolism of Futibatinib can be increased when combined with Dexamethasone.
Galantamine	The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone.
Gallamine triethiodide	The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Dexamethasone.
Ganaxolone	The metabolism of Ganaxolone can be increased when combined with Dexamethasone.
Ganciclovir	The excretion of Dexamethasone can be decreased when combined with Ganciclovir.
Gatifloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gatifloxacin.
Gefitinib	The metabolism of Gefitinib can be increased when combined with Dexamethasone.
Gemcitabine	The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dexamethasone.
Gemfibrozil	The metabolism of Gemfibrozil can be increased when combined with Dexamethasone.
Gemifloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gemifloxacin.
Gemtuzumab ozogamicin	The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexamethasone.
Gepirone	The serum concentration of Gepirone can be increased when it is combined with Dexamethasone.
Gestrinone	The serum concentration of Dexamethasone can be increased when it is combined with Gestrinone.
Gilteritinib	The metabolism of Gilteritinib can be increased when combined with Dexamethasone.
Ginkgo biloba	The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Dexamethasone.
Glasdegib	The serum concentration of Glasdegib can be decreased when it is combined with Dexamethasone.
Glatiramer	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Glatiramer.
Glecaprevir	Dexamethasone may decrease the excretion rate of Glecaprevir which could result in a higher serum level.
Gliclazide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliclazide.
Glimepiride	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glimepiride.
Glipizide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glipizide.
Gliquidone	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliquidone.
Glofitamab	The serum concentration of Dexamethasone can be increased when it is combined with Glofitamab.
Glyburide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glyburide.
Glycerol phenylbutyrate	The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone.
Glycol salicylate	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Glycol salicylate.
Glycyrrhizic acid	Dexamethasone may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.
Glymidine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glymidine.
Golimumab	The metabolism of Dexamethasone can be increased when combined with Golimumab.
Granisetron	The metabolism of Granisetron can be increased when combined with Dexamethasone.
Grazoprevir	The metabolism of Grazoprevir can be increased when combined with Dexamethasone.
Grepafloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Grepafloxacin.
Guanfacine	The metabolism of Guanfacine can be increased when combined with Dexamethasone.
Guanidine	The excretion of Dexamethasone can be decreased when combined with Guanidine.
Guselkumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Guselkumab.
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dexamethasone.
Halofantrine	The metabolism of Halofantrine can be increased when combined with Dexamethasone.
Haloperidol	The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone.
Halothane	The metabolism of Halothane can be increased when combined with Dexamethasone.
Hepatitis A Vaccine	The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dexamethasone.
Hepatitis B Vaccine (Recombinant)	The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dexamethasone.
Hexafluronium	The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone.
Human adenovirus e serotype 4 strain cl-68578 antigen	The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Dexamethasone.
Huperzine A	The therapeutic efficacy of Huperzine A can be decreased when used in combination with Dexamethasone.
Hyaluronidase	The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexamethasone.
Hyaluronidase (human recombinant)	The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dexamethasone.
Hyaluronidase (ovine)	The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dexamethasone.
Hydrochlorothiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydrochlorothiazide.
Hydrocodone	The metabolism of Hydrocodone can be increased when combined with Dexamethasone.
Hydrocortisone	The metabolism of Hydrocortisone can be increased when combined with Dexamethasone.
Hydrocortisone acetate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone acetate.
Hydrocortisone butyrate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone butyrate.
Hydrocortisone cypionate	The metabolism of Hydrocortisone cypionate can be increased when combined with Dexamethasone.
Hydrocortisone phosphate	The metabolism of Hydrocortisone phosphate can be increased when combined with Dexamethasone.
Hydrocortisone succinate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone succinate.
Hydroflumethiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydroflumethiazide.
Hydrotalcite	The bioavailability of Dexamethasone can be decreased when combined with Hydrotalcite.
Hydroxychloroquine	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydroxychloroquine.
Hydroxyprogesterone caproate	The serum concentration of Dexamethasone can be increased when it is combined with Hydroxyprogesterone caproate.
Hydroxyurea	The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dexamethasone.
Hydroxyzine	The metabolism of Hydroxyzine can be increased when combined with Dexamethasone.
Ibandronate	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Dexamethasone.
Ibrexafungerp	The serum concentration of Ibrexafungerp can be decreased when it is combined with Dexamethasone.
Ibritumomab tiuxetan	The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Dexamethasone.
Ibrutinib	The metabolism of Ibrutinib can be decreased when combined with Dexamethasone.
Ibuprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ibuprofen.
Icosapent	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Icosapent.
Idarubicin	The risk or severity of adverse effects can be increased when Idarubicin is combined with Dexamethasone.
Idelalisib	The metabolism of Idelalisib can be increased when combined with Dexamethasone.
Ifosfamide	The metabolism of Ifosfamide can be increased when combined with Dexamethasone.
Iloperidone	The metabolism of Iloperidone can be decreased when combined with Dexamethasone.
Imatinib	The metabolism of Imatinib can be increased when combined with Dexamethasone.
Imipramine	The metabolism of Imipramine can be increased when combined with Dexamethasone.
Indacaterol	The metabolism of Indacaterol can be increased when combined with Dexamethasone.
Indapamide	The metabolism of Indapamide can be increased when combined with Dexamethasone.
Indinavir	The metabolism of Dexamethasone can be decreased when combined with Indinavir.
Indocyanine green acid form	Dexamethasone may increase the excretion rate of Indocyanine green acid form which could result in a lower serum level and potentially a reduction in efficacy.
Indomethacin	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Indomethacin.
Inebilizumab	The risk or severity of infection can be increased when Dexamethasone is combined with Inebilizumab.
Infigratinib	The metabolism of Infigratinib can be increased when combined with Dexamethasone.
Infliximab	The metabolism of Dexamethasone can be increased when combined with Infliximab.
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen	The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Dexamethasone.
Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen	The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Dexamethasone.
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)	The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)	The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)	The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)	The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)	The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Dexamethasone.
Insulin aspart	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin aspart.
Insulin beef	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin beef.
Insulin degludec	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin degludec.
Insulin detemir	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin detemir.
Insulin glargine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glargine.
Insulin glulisine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glulisine.
Insulin human	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin human.
Insulin lispro	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin lispro.
Insulin pork	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin pork.
Interferon alfa-2a	The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Dexamethasone.
Interferon alfa-2b	The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Dexamethasone.
Interferon alfa-n1	The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone.
Interferon alfa-n3	The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone.
Interferon alfacon-1	The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Dexamethasone.
Interferon beta-1b	The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Dexamethasone.
Interferon gamma-1b	The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone.
Ipecac	The metabolism of Ipecac can be increased when combined with Dexamethasone.
Iptacopan	The serum concentration of Iptacopan can be decreased when it is combined with Dexamethasone.
Irbesartan	The metabolism of Irbesartan can be increased when combined with Dexamethasone.
Irinotecan	The metabolism of Irinotecan can be increased when combined with Dexamethasone.
Isavuconazole	The metabolism of Isavuconazole can be increased when combined with Dexamethasone.
Isavuconazonium	The metabolism of Isavuconazonium can be increased when combined with Dexamethasone.
Isoetharine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Isoetharine.
Isoflurane	The metabolism of Isoflurane can be increased when combined with Dexamethasone.
Isoflurophate	The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Dexamethasone.
Isoniazid	The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone.
Isoprenaline	The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Dexamethasone.
Isotretinoin	The metabolism of Isotretinoin can be increased when combined with Dexamethasone.
Isoxicam	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Isoxicam.
Isradipine	The metabolism of Isradipine can be increased when combined with Dexamethasone.
Istradefylline	The metabolism of Istradefylline can be increased when combined with Dexamethasone.
Itraconazole	The metabolism of Dexamethasone can be decreased when combined with Itraconazole.
Ivabradine	The metabolism of Ivabradine can be increased when combined with Dexamethasone.
Ivacaftor	The serum concentration of Ivacaftor can be decreased when it is combined with Dexamethasone.
Ivermectin	The metabolism of Ivermectin can be increased when combined with Dexamethasone.
Ivosidenib	The metabolism of Ivosidenib can be increased when combined with Dexamethasone.
Ixabepilone	The metabolism of Ixabepilone can be increased when combined with Dexamethasone.
Ixazomib	The metabolism of Ixazomib can be increased when combined with Dexamethasone.
Ixekizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ixekizumab.
Janssen COVID-19 Vaccine	The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dexamethasone.
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)	The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.
Ketamine	The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone.
Ketazolam	The metabolism of Ketazolam can be increased when combined with Dexamethasone.
Ketoconazole	The metabolism of Dexamethasone can be decreased when combined with Ketoconazole.
Ketoprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketoprofen.
Ketorolac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketorolac.
Lacidipine	The metabolism of Lacidipine can be increased when combined with Dexamethasone.
Lacosamide	The metabolism of Lacosamide can be increased when combined with Dexamethasone.
Lamivudine	Dexamethasone may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Lansoprazole	The metabolism of Lansoprazole can be increased when combined with Dexamethasone.
Lapatinib	The metabolism of Lapatinib can be increased when combined with Dexamethasone.
Larotrectinib	The metabolism of Larotrectinib can be increased when combined with Dexamethasone.
Lefamulin	The metabolism of Lefamulin can be increased when combined with Dexamethasone.
Leflunomide	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Leflunomide.
Lemborexant	The serum concentration of Lemborexant can be decreased when it is combined with Dexamethasone.
Lenacapavir	The metabolism of Lenacapavir can be increased when combined with Dexamethasone.
Lenalidomide	Dexamethasone may increase the thrombogenic activities of Lenalidomide.
Lenvatinib	The excretion of Dexamethasone can be decreased when combined with Lenvatinib.
Lercanidipine	The metabolism of Lercanidipine can be increased when combined with Dexamethasone.
Letermovir	The metabolism of Dexamethasone can be decreased when combined with Letermovir.
LetibotulinumtoxinA	The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Dexamethasone.
Letrozole	The metabolism of Letrozole can be increased when combined with Dexamethasone.
Leucovorin	The excretion of Dexamethasone can be decreased when combined with Leucovorin.
Leuprolide	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Dexamethasone.
Levacetylmethadol	The metabolism of Levacetylmethadol can be increased when combined with Dexamethasone.
Levamlodipine	The serum concentration of Levamlodipine can be increased when it is combined with Dexamethasone.
Levobupivacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Levobupivacaine.
Levocetirizine	The metabolism of Levocetirizine can be increased when combined with Dexamethasone.
Levofloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Levofloxacin.
Levoketoconazole	The metabolism of Dexamethasone can be decreased when combined with Levoketoconazole.
Levomenthol	The metabolism of Levomenthol can be increased when combined with Dexamethasone.
Levomilnacipran	The metabolism of Levomilnacipran can be increased when combined with Dexamethasone.
Levonorgestrel	The serum concentration of Dexamethasone can be increased when it is combined with Levonorgestrel.
Levosalbutamol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Levosalbutamol.
Lidoflazine	The metabolism of Lidoflazine can be increased when combined with Dexamethasone.
Linagliptin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Linagliptin.
Linezolid	The risk or severity of adverse effects can be increased when Linezolid is combined with Dexamethasone.
Liothyronine	The excretion of Dexamethasone can be decreased when combined with Liothyronine.
Liotrix	The metabolism of Liotrix can be increased when combined with Dexamethasone.
Liraglutide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Liraglutide.
Lisuride	The metabolism of Lisuride can be increased when combined with Dexamethasone.
Lixisenatide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Lixisenatide.
Lomefloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Lomefloxacin.
Lomitapide	The metabolism of Lomitapide can be decreased when combined with Dexamethasone.
Lomustine	The risk or severity of adverse effects can be increased when Lomustine is combined with Dexamethasone.
Lonafarnib	The metabolism of Dexamethasone can be decreased when combined with Lonafarnib.
Loperamide	The metabolism of Loperamide can be increased when combined with Dexamethasone.
Lopinavir	The serum concentration of Dexamethasone can be increased when it is combined with Lopinavir.
Loratadine	The metabolism of Loratadine can be increased when combined with Dexamethasone.
Lorazepam	The metabolism of Lorazepam can be increased when combined with Dexamethasone.
Lorcaserin	The metabolism of Lorcaserin can be increased when combined with Dexamethasone.
Lorlatinib	The metabolism of Lorlatinib can be increased when combined with Dexamethasone.
Lornoxicam	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Lornoxicam.
Lorpiprazole	The metabolism of Lorpiprazole can be increased when combined with Dexamethasone.
Losartan	The metabolism of Losartan can be increased when combined with Dexamethasone.
Lovastatin	The metabolism of Lovastatin can be decreased when combined with Dexamethasone.
Loxoprofen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Loxoprofen.
Lumacaftor	The metabolism of Dexamethasone can be increased when combined with Lumacaftor.
Lumateperone	The serum concentration of Lumateperone can be decreased when it is combined with Dexamethasone.
Lumefantrine	The metabolism of Lumefantrine can be increased when combined with Dexamethasone.
Lumiracoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Lumiracoxib.
Lurasidone	The metabolism of Lurasidone can be increased when combined with Dexamethasone.
Lurbinectedin	The serum concentration of Lurbinectedin can be decreased when it is combined with Dexamethasone.
Lusutrombopag	Dexamethasone may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Lynestrenol	The serum concentration of Dexamethasone can be increased when it is combined with Lynestrenol.
Macimorelin	The metabolism of Macimorelin can be increased when combined with Dexamethasone.
Macitentan	The metabolism of Macitentan can be increased when combined with Dexamethasone.
Magaldrate	The bioavailability of Dexamethasone can be decreased when combined with Magaldrate.
Magnesium	The serum concentration of Magnesium can be decreased when it is combined with Dexamethasone.
Magnesium carbonate	The bioavailability of Dexamethasone can be decreased when combined with Magnesium carbonate.
Magnesium hydroxide	The bioavailability of Dexamethasone can be decreased when combined with Magnesium hydroxide.
Magnesium oxide	The bioavailability of Dexamethasone can be decreased when combined with Magnesium oxide.
Magnesium silicate	The bioavailability of Dexamethasone can be decreased when combined with Magnesium silicate.
Magnesium trisilicate	The bioavailability of Dexamethasone can be decreased when combined with Magnesium trisilicate.
Manidipine	The metabolism of Manidipine can be increased when combined with Dexamethasone.
Maraviroc	The metabolism of Maraviroc can be increased when combined with Dexamethasone.
Maribavir	The serum concentration of Maribavir can be decreased when it is combined with Dexamethasone.
Mavacamten	The serum concentration of Mavacamten can be decreased when it is combined with Dexamethasone.
Measles virus vaccine live attenuated	The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Dexamethasone.
Mebeverine	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Mebeverine.
Mecasermin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Mecasermin.
Mechlorethamine	The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Dexamethasone.
Meclofenamic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Meclofenamic acid.
Medrogestone	The metabolism of Medrogestone can be increased when combined with Dexamethasone.
Medroxyprogesterone acetate	The serum concentration of Dexamethasone can be increased when it is combined with Medroxyprogesterone acetate.
Mefenamic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Mefenamic acid.
Mefloquine	The therapeutic efficacy of Mefloquine can be decreased when used in combination with Dexamethasone.
Megestrol acetate	The serum concentration of Dexamethasone can be increased when it is combined with Megestrol acetate.
Melatonin	The excretion of Dexamethasone can be decreased when combined with Melatonin.
Meloxicam	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Meloxicam.
Melphalan	The risk or severity of adverse effects can be increased when Melphalan is combined with Dexamethasone.
Memantine	The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone.
Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine	The therapeutic efficacy of Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine can be decreased when used in combination with Dexamethasone.
Menthyl salicylate	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Menthyl salicylate.
Meperidine	The metabolism of Meperidine can be increased when combined with Dexamethasone.
Mephenytoin	The metabolism of Mephenytoin can be increased when combined with Dexamethasone.
Mepivacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Mepivacaine.
Mepolizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Mepolizumab.
Meprednisone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Meprednisone.
Mercaptopurine	The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Dexamethasone.
Mesalazine	The serum concentration of Mesalazine can be decreased when it is combined with Dexamethasone.
Mestranol	The serum concentration of Dexamethasone can be increased when it is combined with Mestranol.
Metformin	The therapeutic efficacy of Metformin can be decreased when used in combination with Dexamethasone.
Methacholine	Dexamethasone may decrease effectiveness of Methacholine as a diagnostic agent.
Methadone	The metabolism of Methadone can be increased when combined with Dexamethasone.
Methimazole	The metabolism of Dexamethasone can be decreased when combined with Methimazole.
Methotrexate	The metabolism of Methotrexate can be increased when combined with Dexamethasone.
Methoxy polyethylene glycol-epoetin beta	The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dexamethasone.
Methoxyflurane	The metabolism of Methoxyflurane can be increased when combined with Dexamethasone.
Methyl salicylate	The serum concentration of Methyl salicylate can be decreased when it is combined with Dexamethasone.
Methyldopa	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Dexamethasone.
Methylene blue	The metabolism of Dexamethasone can be decreased when combined with Methylene blue.
Methylergometrine	The metabolism of Methylergometrine can be increased when combined with Dexamethasone.
Methylphenobarbital	The metabolism of Methylphenobarbital can be increased when combined with Dexamethasone.
Methylprednisolone	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Dexamethasone.
Methylprednisone	The metabolism of Methylprednisone can be increased when combined with Dexamethasone.
Methyltestosterone	The risk or severity of edema formation can be increased when Methyltestosterone is combined with Dexamethasone.
Methysergide	The metabolism of Methysergide can be increased when combined with Dexamethasone.
Metoclopramide	The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Dexamethasone.
Metocurine	The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Dexamethasone.
Metocurine iodide	The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Dexamethasone.
Metolazone	Dexamethasone may increase the hypokalemic activities of Metolazone.
Metreleptin	The metabolism of Dexamethasone can be increased when combined with Metreleptin.
Metronidazole	The metabolism of Metronidazole can be increased when combined with Dexamethasone.
Mexiletine	The metabolism of Mexiletine can be increased when combined with Dexamethasone.
Mianserin	The metabolism of Mianserin can be increased when combined with Dexamethasone.
Miconazole	The metabolism of Dexamethasone can be decreased when combined with Miconazole.
Midazolam	The serum concentration of Midazolam can be increased when it is combined with Dexamethasone.
Midostaurin	The metabolism of Dexamethasone can be decreased when combined with Midostaurin.
Mifamurtide	The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Dexamethasone.
Mifepristone	The serum concentration of Dexamethasone can be increased when it is combined with Mifepristone.
Miglitol	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Miglitol.
Milnacipran	The metabolism of Milnacipran can be increased when combined with Dexamethasone.
Minaprine	The therapeutic efficacy of Minaprine can be decreased when used in combination with Dexamethasone.
Minocycline	The excretion of Dexamethasone can be decreased when combined with Minocycline.
Miocamycin	The serum concentration of Dexamethasone can be increased when it is combined with Miocamycin.
Mirabegron	The metabolism of Mirabegron can be increased when combined with Dexamethasone.
Mirtazapine	The metabolism of Mirtazapine can be increased when combined with Dexamethasone.
Mitapivat	The metabolism of Mitapivat can be increased when combined with Dexamethasone.
Mitomycin	The risk or severity of adverse effects can be increased when Mitomycin is combined with Dexamethasone.
Mitotane	The serum concentration of Dexamethasone can be decreased when it is combined with Mitotane.
Mitoxantrone	The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone.
Mivacurium	The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Dexamethasone.
Mobocertinib	The serum concentration of Mobocertinib can be decreased when it is combined with Dexamethasone.
Modafinil	The metabolism of Modafinil can be increased when combined with Dexamethasone.
Moderna COVID-19 Vaccine	The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Dexamethasone.
Modified vaccinia ankara	The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Dexamethasone.
Mometasone furoate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Mometasone furoate.
Monomethyl fumarate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Monomethyl fumarate.
Montelukast	The metabolism of Montelukast can be increased when combined with Dexamethasone.
Morphine	The metabolism of Morphine can be increased when combined with Dexamethasone.
Mosunetuzumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Mosunetuzumab.
Moxifloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Moxifloxacin.
Mumps virus strain B level jeryl lynn live antigen	The therapeutic efficacy of Mumps virus strain B level jeryl lynn live antigen can be decreased when used in combination with Dexamethasone.
Muromonab	The risk or severity of adverse effects can be increased when Muromonab is combined with Dexamethasone.
Mycophenolate mofetil	The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Dexamethasone.
Mycophenolic acid	The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Dexamethasone.
Nabilone	The metabolism of Nabilone can be increased when combined with Dexamethasone.
Nabumetone	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Nabumetone.
Nafarelin	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Dexamethasone.
Nalidixic acid	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Nalidixic acid.
Naloxegol	The metabolism of Naloxegol can be increased when combined with Dexamethasone.
Nandrolone decanoate	The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Dexamethasone.
Nandrolone phenpropionate	The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone.
Naproxen	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Naproxen.
Natalizumab	The risk or severity of immunosuppression can be increased when Dexamethasone is combined with Natalizumab.
Nateglinide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Nateglinide.
Nebivolol	The metabolism of Nebivolol can be increased when combined with Dexamethasone.
Nefazodone	The metabolism of Dexamethasone can be decreased when combined with Nefazodone.
Nelarabine	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Nelarabine.
Nelfinavir	The metabolism of Dexamethasone can be decreased when combined with Nelfinavir.
Neostigmine	The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dexamethasone.
Neratinib	The metabolism of Neratinib can be increased when combined with Dexamethasone.
Netupitant	The metabolism of Dexamethasone can be decreased when combined with Netupitant.
Nevirapine	The metabolism of Nevirapine can be increased when combined with Dexamethasone.
Niacin	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Dexamethasone.
Nicardipine	The metabolism of Nicardipine can be increased when combined with Dexamethasone.
Nicorandil	The risk or severity of ulceration can be increased when Dexamethasone is combined with Nicorandil.
Nicotine	The metabolism of Nicotine can be increased when combined with Dexamethasone.
Nifedipine	The metabolism of Nifedipine can be increased when combined with Dexamethasone.
Nilotinib	The metabolism of Dexamethasone can be decreased when combined with Nilotinib.
Nilvadipine	The metabolism of Nilvadipine can be increased when combined with Dexamethasone.
Nimesulide	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Nimesulide.
Nimodipine	The metabolism of Nimodipine can be increased when combined with Dexamethasone.
Nintedanib	The metabolism of Nintedanib can be increased when combined with Dexamethasone.
Nirmatrelvir	The metabolism of Nirmatrelvir can be increased when combined with Dexamethasone.
Nirogacestat	The serum concentration of Nirogacestat can be decreased when it is combined with Dexamethasone.
Nisoldipine	The metabolism of Nisoldipine can be increased when combined with Dexamethasone.
Nitrazepam	The metabolism of Nitrazepam can be increased when combined with Dexamethasone.
Nitrendipine	The metabolism of Nitrendipine can be increased when combined with Dexamethasone.
Nitrofurantoin	Dexamethasone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Nizatidine	The therapeutic efficacy of Nizatidine can be decreased when used in combination with Dexamethasone.
Nomegestrol	The serum concentration of Dexamethasone can be increased when it is combined with Nomegestrol.
Nomegestrol acetate	The serum concentration of Dexamethasone can be increased when it is combined with Nomegestrol acetate.
Norelgestromin	The serum concentration of Dexamethasone can be increased when it is combined with Norelgestromin.
Norepinephrine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Norepinephrine.
Norethisterone	The serum concentration of Dexamethasone can be increased when it is combined with Norethisterone.
Norethynodrel	The serum concentration of Dexamethasone can be increased when it is combined with Norethynodrel.
Norfloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Norfloxacin.
Norgestimate	The serum concentration of Dexamethasone can be increased when it is combined with Norgestimate.
Norgestrel	The serum concentration of Dexamethasone can be increased when it is combined with Norgestrel.
Nortriptyline	The metabolism of Nortriptyline can be increased when combined with Dexamethasone.
Novobiocin	The excretion of Dexamethasone can be decreased when combined with Novobiocin.
Nuvaxovid	The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Dexamethasone.
Nylidrin	The metabolism of Nylidrin can be increased when combined with Dexamethasone.
Obinutuzumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Obinutuzumab.
Ocrelizumab	Ocrelizumab may increase the immunosuppressive activities of Dexamethasone.
Ofatumumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ofatumumab.
Ofloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ofloxacin.
Olaparib	The metabolism of Olaparib can be increased when combined with Dexamethasone.
Oliceridine	The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone.
Olodaterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Olodaterol.
Olsalazine	The serum concentration of Olsalazine can be decreased when it is combined with Dexamethasone.
Olutasidenib	The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Dexamethasone.
Omaveloxolone	The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Dexamethasone.
Ombitasvir	Dexamethasone may decrease the excretion rate of Ombitasvir which could result in a higher serum level.
Ondansetron	The metabolism of Ondansetron can be increased when combined with Dexamethasone.
Opium	The metabolism of Opium can be increased when combined with Dexamethasone.
Orciprenaline	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Orciprenaline.
Orphenadrine	The metabolism of Orphenadrine can be increased when combined with Dexamethasone.
Osilodrostat	The serum concentration of Osilodrostat can be decreased when it is combined with Dexamethasone.
Osimertinib	The metabolism of Osimertinib can be increased when combined with Dexamethasone.
Ospemifene	The metabolism of Ospemifene can be increased when combined with Dexamethasone.
Ouabain	The excretion of Dexamethasone can be decreased when combined with Ouabain.
Oxaliplatin	The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dexamethasone.
Oxandrolone	The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxandrolone.
Oxaprozin	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxaprozin.
Oxcarbazepine	The metabolism of Dexamethasone can be increased when combined with Oxcarbazepine.
Oxetacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Oxetacaine.
Oxybuprocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Oxybuprocaine.
Oxybutynin	The metabolism of Oxybutynin can be increased when combined with Dexamethasone.
Oxycodone	The metabolism of Oxycodone can be increased when combined with Dexamethasone.
Oxymetazoline	The absorption of Dexamethasone can be decreased when combined with Oxymetazoline.
Oxymetholone	The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxymetholone.
Oxymorphone	The metabolism of Oxymorphone can be increased when combined with Dexamethasone.
Oxyphenbutazone	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxyphenbutazone.
Oxytetracycline	The excretion of Dexamethasone can be decreased when combined with Oxytetracycline.
Ozanimod	Dexamethasone may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Paclitaxel	The metabolism of Paclitaxel can be increased when combined with Dexamethasone.
Pacritinib	The serum concentration of Pacritinib can be decreased when it is combined with Dexamethasone.
Palbociclib	The metabolism of Palbociclib can be increased when combined with Dexamethasone.
Paliperidone	The metabolism of Paliperidone can be increased when combined with Dexamethasone.
Palonosetron	The metabolism of Palonosetron can be increased when combined with Dexamethasone.
Palovarotene	The serum concentration of Palovarotene can be decreased when it is combined with Dexamethasone.
Pamidronic acid	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Dexamethasone.
Pancuronium	The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dexamethasone.
Panobinostat	The metabolism of Panobinostat can be increased when combined with Dexamethasone.
Pantoprazole	The metabolism of Pantoprazole can be increased when combined with Dexamethasone.
Paramethadione	The metabolism of Paramethadione can be increased when combined with Dexamethasone.
Parecoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Parecoxib.
Paricalcitol	The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone.
Paritaprevir	The metabolism of Paritaprevir can be increased when combined with Dexamethasone.
Paroxetine	The metabolism of Paroxetine can be increased when combined with Dexamethasone.
Pazopanib	The metabolism of Pazopanib can be increased when combined with Dexamethasone.
Pefloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Pefloxacin.
Pegaspargase	The serum concentration of Dexamethasone can be increased when it is combined with Pegaspargase.
Pegcetacoplan	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pegcetacoplan.
Peginesatide	The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dexamethasone.
Peginterferon alfa-2a	The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone.
Peginterferon alfa-2b	The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone.
Peginterferon beta-1a	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Peginterferon beta-1a.
Pegvisomant	The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dexamethasone.
Pemetrexed	The risk or severity of adverse effects can be increased when Pemetrexed is combined with Dexamethasone.
Pemigatinib	The metabolism of Pemigatinib can be increased when combined with Dexamethasone.
Penicillamine	The risk or severity of adverse effects can be increased when Penicillamine is combined with Dexamethasone.
Pentamidine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Pentamidine.
Pentobarbital	The metabolism of Dexamethasone can be increased when combined with Pentobarbital.
Pentostatin	The risk or severity of adverse effects can be increased when Pentostatin is combined with Dexamethasone.
Perampanel	The metabolism of Perampanel can be increased when combined with Dexamethasone.
Perhexiline	The metabolism of Perhexiline can be increased when combined with Dexamethasone.
Pertussis vaccine	The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Dexamethasone.
Pexidartinib	The metabolism of Pexidartinib can be increased when combined with Dexamethasone.
Phenformin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Phenformin.
Phenindione	Dexamethasone may increase the anticoagulant activities of Phenindione.
Phenobarbital	The metabolism of Phenobarbital can be increased when combined with Dexamethasone.
Phenol	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Phenol.
Phenprocoumon	Dexamethasone may increase the anticoagulant activities of Phenprocoumon.
Phentermine	The metabolism of Phentermine can be increased when combined with Dexamethasone.
Phenyl aminosalicylate	The serum concentration of Phenyl aminosalicylate can be decreased when it is combined with Dexamethasone.
Phenylacetic acid	The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Dexamethasone.
Phenylalanine	The risk or severity of adverse effects can be increased when Phenylalanine is combined with Dexamethasone.
Phenylbutazone	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Phenylbutazone.
Phenylbutyric acid	The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Dexamethasone.
Phenylpropanolamine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Phenylpropanolamine.
Phenytoin	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.
Physostigmine	The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dexamethasone.
Pibrentasvir	Dexamethasone may decrease the excretion rate of Pibrentasvir which could result in a higher serum level.
Pimavanserin	The metabolism of Pimavanserin can be increased when combined with Dexamethasone.
Pimecrolimus	The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexamethasone.
Pimozide	The metabolism of Pimozide can be increased when combined with Dexamethasone.
Pinacidil	The metabolism of Pinacidil can be increased when combined with Dexamethasone.
Pinaverium	The metabolism of Pinaverium can be increased when combined with Dexamethasone.
Pioglitazone	The metabolism of Pioglitazone can be increased when combined with Dexamethasone.
Pipecuronium	The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Dexamethasone.
Piperaquine	The metabolism of Piperaquine can be increased when combined with Dexamethasone.
Pipotiazine	The metabolism of Pipotiazine can be increased when combined with Dexamethasone.
Pirbuterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Pirbuterol.
Piretanide	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Piretanide.
Pirfenidone	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pirfenidone.
Piroxicam	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Piroxicam.
Pirtobrutinib	The serum concentration of Pirtobrutinib can be decreased when it is combined with Dexamethasone.
Pitavastatin	Dexamethasone may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Pitolisant	The metabolism of Pitolisant can be increased when combined with Dexamethasone.
Polatuzumab vedotin	The risk or severity of adverse effects can be decreased when Dexamethasone is combined with Polatuzumab vedotin.
Polyestradiol phosphate	The serum concentration of Dexamethasone can be increased when it is combined with Polyestradiol phosphate.
Polythiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Polythiazide.
Pomalidomide	The metabolism of Pomalidomide can be increased when combined with Dexamethasone.
Ponatinib	The metabolism of Ponatinib can be increased when combined with Dexamethasone.
Ponesimod	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ponesimod.
Posaconazole	The metabolism of Dexamethasone can be decreased when combined with Posaconazole.
Pralatrexate	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pralatrexate.
Pralsetinib	The serum concentration of Pralsetinib can be decreased when it is combined with Dexamethasone.
Pramlintide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Pramlintide.
Pramocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Pramocaine.
Prasterone enantate	The risk or severity of edema formation can be increased when Prasterone enantate is combined with Dexamethasone.
Prasugrel	The metabolism of Prasugrel can be increased when combined with Dexamethasone.
Pravastatin	The excretion of Dexamethasone can be decreased when combined with Pravastatin.
Prazepam	The metabolism of Prazepam can be increased when combined with Dexamethasone.
Praziquantel	The metabolism of Praziquantel can be increased when combined with Dexamethasone.
Prazosin	Dexamethasone may decrease the excretion rate of Prazosin which could result in a higher serum level.
Prednisolone	The risk or severity of adverse effects can be increased when Prednisolone is combined with Dexamethasone.
Prednisolone acetate	The metabolism of Prednisolone acetate can be increased when combined with Dexamethasone.
Prednisolone phosphate	The metabolism of Prednisolone phosphate can be increased when combined with Dexamethasone.
Prednisone	The risk or severity of adverse effects can be increased when Prednisone is combined with Dexamethasone.
Prednisone acetate	The metabolism of Dexamethasone can be increased when combined with Prednisone acetate.
Pregnenolone	The metabolism of Pregnenolone can be increased when combined with Dexamethasone.
Prenylamine	The metabolism of Prenylamine can be increased when combined with Dexamethasone.
Pretomanid	The serum concentration of Pretomanid can be decreased when it is combined with Dexamethasone.
Prilocaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Prilocaine.
Primaquine	The metabolism of Primaquine can be increased when combined with Dexamethasone.
Primidone	The metabolism of Dexamethasone can be increased when combined with Primidone.
Probenecid	The excretion of Dexamethasone can be decreased when combined with Probenecid.
Procainamide	The therapeutic efficacy of Procainamide can be decreased when used in combination with Dexamethasone.
Procaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Procaine.
Procarbazine	The risk or severity of adverse effects can be increased when Procarbazine is combined with Dexamethasone.
Procaterol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Procaterol.
Prochlorperazine	The metabolism of Prochlorperazine can be increased when combined with Dexamethasone.
Profenamine	The therapeutic efficacy of Profenamine can be decreased when used in combination with Dexamethasone.
Progesterone	The serum concentration of Dexamethasone can be increased when it is combined with Progesterone.
Promazine	The metabolism of Promazine can be increased when combined with Dexamethasone.
Promethazine	The metabolism of Promethazine can be increased when combined with Dexamethasone.
Propafenone	The metabolism of Propafenone can be increased when combined with Dexamethasone.
Proparacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Proparacaine.
Propiverine	The metabolism of Propiverine can be increased when combined with Dexamethasone.
Propofol	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Dexamethasone.
Propoxycaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Propoxycaine.
Propranolol	The serum concentration of Propranolol can be decreased when it is combined with Dexamethasone.
Propylthiouracil	The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Dexamethasone.
Protokylol	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Protokylol.
Prucalopride	The metabolism of Prucalopride can be decreased when combined with Dexamethasone.
Pyrantel	The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone.
Pyridostigmine	The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dexamethasone.
Quazepam	The metabolism of Quazepam can be increased when combined with Dexamethasone.
Quetiapine	The metabolism of Quetiapine can be increased when combined with Dexamethasone.
Quinestrol	The serum concentration of Dexamethasone can be increased when it is combined with Quinestrol.
Quinethazone	Dexamethasone may increase the hypokalemic activities of Quinethazone.
Quinidine	The metabolism of Quinidine can be increased when combined with Dexamethasone.
Quinine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Quinine.
Quizartinib	The serum concentration of Quizartinib can be decreased when it is combined with Dexamethasone.
Rabies immune globulin, human	The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Dexamethasone.
Rabies virus inactivated antigen, A	The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Dexamethasone.
Rabies virus inactivated antigen, B	The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Dexamethasone.
Racepinephrine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Racepinephrine.
Raloxifene	Dexamethasone may decrease the excretion rate of Raloxifene which could result in a higher serum level.
Raltegravir	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Raltegravir.
Raltitrexed	The risk or severity of adverse effects can be increased when Raltitrexed is combined with Dexamethasone.
Ramelteon	The metabolism of Ramelteon can be increased when combined with Dexamethasone.
Ranitidine	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Dexamethasone.
Ranolazine	The metabolism of Ranolazine can be increased when combined with Dexamethasone.
Rapacuronium	The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Dexamethasone.
Ravulizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ravulizumab.
Reboxetine	The metabolism of Reboxetine can be increased when combined with Dexamethasone.
Regorafenib	The metabolism of Regorafenib can be increased when combined with Dexamethasone.
Relugolix	The serum concentration of Relugolix can be decreased when it is combined with Dexamethasone.
Repaglinide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Repaglinide.
Repotrectinib	The serum concentration of Repotrectinib can be decreased when it is combined with Dexamethasone.
Reserpine	The metabolism of Dexamethasone can be increased when combined with Reserpine.
Resmetirom	The metabolism of Resmetirom can be increased when combined with Dexamethasone.
Respiratory syncytial virus vaccine, adjuvanted	The therapeutic efficacy of GSK-3844766A can be decreased when used in combination with Dexamethasone.
Retapamulin	The metabolism of Retapamulin can be decreased when combined with Dexamethasone.
Revefenacin	Dexamethasone may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Ribociclib	The metabolism of Dexamethasone can be decreased when combined with Ribociclib.
Rifabutin	The metabolism of Rifabutin can be increased when combined with Dexamethasone.
Rifampicin	The metabolism of Dexamethasone can be increased when combined with Rifampicin.
Rifamycin	The metabolism of Dexamethasone can be increased when combined with Rifamycin.
Rifapentine	The metabolism of Dexamethasone can be increased when combined with Rifapentine.
Rilonacept	The metabolism of Dexamethasone can be increased when combined with Rilonacept.
Rilpivirine	The serum concentration of Rilpivirine can be decreased when it is combined with Dexamethasone.
Riluzole	Dexamethasone may decrease the excretion rate of Riluzole which could result in a higher serum level.
Rimegepant	The metabolism of Rimegepant can be increased when combined with Dexamethasone.
Rimonabant	The metabolism of Rimonabant can be increased when combined with Dexamethasone.
Riociguat	The metabolism of Riociguat can be increased when combined with Dexamethasone.
Ripretinib	The serum concentration of Ripretinib can be decreased when it is combined with Dexamethasone.
Risankizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Risankizumab.
Risedronic acid	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Dexamethasone.
Risperidone	The metabolism of Risperidone can be increased when combined with Dexamethasone.
Ritlecitinib	The serum concentration of Ritlecitinib can be decreased when it is combined with Dexamethasone.
Ritodrine	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Ritodrine.
Ritonavir	The serum concentration of Dexamethasone can be increased when it is combined with Ritonavir.
Rituximab	The risk or severity of adverse effects can be increased when Rituximab is combined with Dexamethasone.
Rivaroxaban	The metabolism of Rivaroxaban can be increased when combined with Dexamethasone.
Rivastigmine	The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Dexamethasone.
Rocuronium	The risk or severity of myopathy and weakness can be increased when Rocuronium is combined with Dexamethasone.
Rofecoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Rofecoxib.
Roflumilast	The serum concentration of Roflumilast can be increased when it is combined with Dexamethasone.
Rolapitant	The metabolism of Rolapitant can be increased when combined with Dexamethasone.
Romidepsin	The metabolism of Romidepsin can be increased when combined with Dexamethasone.
Ropeginterferon alfa-2b	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ropeginterferon alfa-2b.
Ropivacaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Ropivacaine.
Rosiglitazone	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Rosiglitazone.
Rosoxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Rosoxacin.
Rosuvastatin	The metabolism of Rosuvastatin can be increased when combined with Dexamethasone.
Rotavirus vaccine	The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Dexamethasone.
Rotigotine	The metabolism of Rotigotine can be increased when combined with Dexamethasone.
Roxadustat	The metabolism of Roxadustat can be increased when combined with Dexamethasone.
Roxithromycin	The serum concentration of Dexamethasone can be increased when it is combined with Roxithromycin.
Rozanolixizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Rozanolixizumab.
Rubella virus vaccine	The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Dexamethasone.
Rucaparib	The metabolism of Rucaparib can be increased when combined with Dexamethasone.
Rupatadine	The metabolism of Rupatadine can be increased when combined with Dexamethasone.
Ruxolitinib	The metabolism of Ruxolitinib can be increased when combined with Dexamethasone.
Safinamide	The metabolism of Safinamide can be increased when combined with Dexamethasone.
Salicylamide	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salicylamide.
Salicylic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salicylic acid.
Salmeterol	The metabolism of Salmeterol can be increased when combined with Dexamethasone.
Salsalate	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salsalate.
Samidorphan	The metabolism of Samidorphan can be increased when combined with Dexamethasone.
Saquinavir	The metabolism of Dexamethasone can be decreased when combined with Saquinavir.
Sarilumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Sarilumab.
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)	The therapeutic efficacy of SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains) can be decreased when used in combination with Dexamethasone.
Satralizumab	The serum concentration of Dexamethasone can be decreased when it is combined with Satralizumab.
Saxagliptin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Saxagliptin.
Scopolamine	The metabolism of Scopolamine can be increased when combined with Dexamethasone.
Secukinumab	The metabolism of Dexamethasone can be increased when combined with Secukinumab.
Segesterone acetate	The metabolism of Segesterone acetate can be increased when combined with Dexamethasone.
Selegiline	The metabolism of Selegiline can be increased when combined with Dexamethasone.
Selexipag	The metabolism of Selexipag can be increased when combined with Dexamethasone.
Selinexor	The metabolism of Selinexor can be increased when combined with Dexamethasone.
Selpercatinib	The serum concentration of Selpercatinib can be decreased when it is combined with Dexamethasone.
Selumetinib	The serum concentration of Selumetinib can be decreased when it is combined with Dexamethasone.
Semaglutide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Semaglutide.
Sertindole	The metabolism of Sertindole can be increased when combined with Dexamethasone.
Sertraline	The metabolism of Sertraline can be increased when combined with Dexamethasone.
Sevoflurane	The metabolism of Sevoflurane can be increased when combined with Dexamethasone.
Sibutramine	The metabolism of Sibutramine can be increased when combined with Dexamethasone.
Sildenafil	The therapeutic efficacy of Sildenafil can be decreased when used in combination with Dexamethasone.
Silodosin	The metabolism of Silodosin can be increased when combined with Dexamethasone.
Siltuximab	The metabolism of Dexamethasone can be increased when combined with Siltuximab.
Simeprevir	The metabolism of Simeprevir can be increased when combined with Dexamethasone.
Simvastatin	The metabolism of Simvastatin can be increased when combined with Dexamethasone.
Siponimod	The therapeutic efficacy of Siponimod can be decreased when used in combination with Dexamethasone.
Sipuleucel-T	The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Dexamethasone.
Sirolimus	The serum concentration of Dexamethasone can be increased when it is combined with Sirolimus.
Sitagliptin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sitagliptin.
Smallpox (Vaccinia) Vaccine, Live	The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Dexamethasone.
Sodium bicarbonate	The bioavailability of Dexamethasone can be decreased when combined with Sodium bicarbonate.
Sofosbuvir	Dexamethasone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Solifenacin	The metabolism of Solifenacin can be increased when combined with Dexamethasone.
Somatotropin	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.
Somatrogon	The metabolism of Dexamethasone can be increased when combined with Somatrogon.
Sonidegib	The metabolism of Sonidegib can be increased when combined with Dexamethasone.
Sorafenib	The metabolism of Sorafenib can be increased when combined with Dexamethasone.
Sotagliflozin	The serum concentration of Sotagliflozin can be decreased when it is combined with Dexamethasone.
Sotorasib	The serum concentration of Sotorasib can be decreased when it is combined with Dexamethasone.
Sparfloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Sparfloxacin.
Sparsentan	The serum concentration of Sparsentan can be decreased when it is combined with Dexamethasone.
Spesolimab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Spesolimab.
Spiramycin	The serum concentration of Dexamethasone can be increased when it is combined with Spiramycin.
St. John's Wort	The metabolism of St. John's Wort can be increased when combined with Dexamethasone.
Stanozolol	The risk or severity of fluid retention can be increased when Dexamethasone is combined with Stanozolol.
Stavudine	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Dexamethasone.
Stiripentol	The metabolism of Dexamethasone can be decreased when combined with Stiripentol.
Streptozocin	The risk or severity of adverse effects can be increased when Streptozocin is combined with Dexamethasone.
Succinylcholine	The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Dexamethasone.
Sufentanil	The metabolism of Sufentanil can be increased when combined with Dexamethasone.
Sulfadiazine	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sulfadiazine.
Sulfamethoxazole	The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Dexamethasone.
Sulfasalazine	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Sulfasalazine.
Sulfinpyrazone	The metabolism of Sulfinpyrazone can be increased when combined with Dexamethasone.
Sulfisoxazole	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sulfisoxazole.
Sulindac	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Sulindac.
Sulpiride	The therapeutic efficacy of Sulpiride can be decreased when used in combination with Dexamethasone.
Sumatriptan	Dexamethasone may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Sunitinib	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sunitinib.
Sutimlimab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Sutimlimab.
Suvorexant	The metabolism of Suvorexant can be increased when combined with Dexamethasone.
Synthetic Conjugated Estrogens, A	The serum concentration of Dexamethasone can be increased when it is combined with Synthetic Conjugated Estrogens, A.
Synthetic Conjugated Estrogens, B	The serum concentration of Dexamethasone can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine	The therapeutic efficacy of Tacrine can be decreased when used in combination with Dexamethasone.
Tacrolimus	The serum concentration of Tacrolimus can be increased when it is combined with Dexamethasone.
Tadalafil	The metabolism of Tadalafil can be increased when combined with Dexamethasone.
Tafamidis	The excretion of Dexamethasone can be decreased when combined with Tafamidis.
Talazoparib	The serum concentration of Talazoparib can be increased when it is combined with Dexamethasone.
Tamoxifen	The metabolism of Tamoxifen can be increased when combined with Dexamethasone.
Tamsulosin	The metabolism of Tamsulosin can be increased when combined with Dexamethasone.
Tasimelteon	The metabolism of Tasimelteon can be increased when combined with Dexamethasone.
Taurocholic acid	The excretion of Dexamethasone can be decreased when combined with Taurocholic acid.
Tazarotene	The metabolism of Tazarotene can be increased when combined with Dexamethasone.
Tazemetostat	The metabolism of Tazemetostat can be increased when combined with Dexamethasone.
Tazobactam	The excretion of Dexamethasone can be decreased when combined with Tazobactam.
Tegafur	The metabolism of Tegafur can be increased when combined with Dexamethasone.
Tegaserod	Dexamethasone may decrease the excretion rate of Tegaserod which could result in a higher serum level.
Telaprevir	The metabolism of Dexamethasone can be decreased when combined with Telaprevir.
Telithromycin	The metabolism of Dexamethasone can be decreased when combined with Telithromycin.
Telmisartan	Dexamethasone may increase the excretion rate of Telmisartan which could result in a lower serum level and potentially a reduction in efficacy.
Telotristat ethyl	The serum concentration of Dexamethasone can be decreased when it is combined with Telotristat ethyl.
Temozolomide	The risk or severity of adverse effects can be increased when Temozolomide is combined with Dexamethasone.
Temsirolimus	The serum concentration of Dexamethasone can be increased when it is combined with Temsirolimus.
Teniposide	The metabolism of Teniposide can be increased when combined with Dexamethasone.
Tenofovir alafenamide	The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dexamethasone.
Tenoxicam	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tenoxicam.
Tepotinib	The serum concentration of Tepotinib can be decreased when it is combined with Dexamethasone.
Teprotumumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Teprotumumab.
Terbinafine	The metabolism of Terbinafine can be increased when combined with Dexamethasone.
Terbutaline	The therapeutic efficacy of Terbutaline can be decreased when used in combination with Dexamethasone.
Terfenadine	The metabolism of Dexamethasone can be decreased when combined with Terfenadine.
Teriflunomide	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Teriflunomide.
Testosterone	The risk or severity of edema formation can be increased when Testosterone is combined with Dexamethasone.
Testosterone cypionate	The risk or severity of edema formation can be increased when Testosterone cypionate is combined with Dexamethasone.
Testosterone enantate benzilic acid hydrazone	The risk or severity of edema formation can be increased when Testosterone enantate benzilic acid hydrazone is combined with Dexamethasone.
Testosterone enanthate	The serum concentration of Dexamethasone can be increased when it is combined with Testosterone enanthate.
Testosterone propionate	The risk or severity of edema formation can be increased when Testosterone propionate is combined with Dexamethasone.
Testosterone undecanoate	The risk or severity of edema formation can be increased when Testosterone undecanoate is combined with Dexamethasone.
Tetracaine	The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Tetracaine.
Tetracycline	The metabolism of Tetracycline can be increased when combined with Dexamethasone.
Tezacaftor	The serum concentration of Tezacaftor can be decreased when it is combined with Dexamethasone.
Thalidomide	The risk or severity of thromboembolism can be increased when Dexamethasone is combined with Thalidomide.
Theophylline	The metabolism of Theophylline can be increased when combined with Dexamethasone.
Thiamylal	The metabolism of Thiamylal can be increased when combined with Dexamethasone.
Thiopental	The metabolism of Thiopental can be increased when combined with Dexamethasone.
Thiotepa	The therapeutic efficacy of Thiotepa can be decreased when used in combination with Dexamethasone.
Tiagabine	The metabolism of Tiagabine can be increased when combined with Dexamethasone.
Tiaprofenic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tiaprofenic acid.
Tibolone	The serum concentration of Dexamethasone can be increased when it is combined with Tibolone.
Ticagrelor	The metabolism of Ticagrelor can be increased when combined with Dexamethasone.
Tick-borne encephalitis vaccine (whole virus, inactivated)	The therapeutic efficacy of Tick-borne encephalitis vaccine (whole virus, inactivated) can be decreased when used in combination with Dexamethasone.
Tinidazole	The metabolism of Tinidazole can be increased when combined with Dexamethasone.
Tioguanine	The risk or severity of adverse effects can be increased when Tioguanine is combined with Dexamethasone.
Tiotropium	The metabolism of Tiotropium can be increased when combined with Dexamethasone.
Tipranavir	The metabolism of Dexamethasone can be decreased when combined with Tipranavir.
Tirzepatide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tirzepatide.
Tisotumab vedotin	The metabolism of Tisotumab vedotin can be increased when combined with Dexamethasone.
Tivozanib	The metabolism of Tivozanib can be increased when combined with Dexamethasone.
Tixocortol	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Tixocortol.
Tocilizumab	The metabolism of Dexamethasone can be increased when combined with Tocilizumab.
Tocofersolan	The metabolism of Tocofersolan can be increased when combined with Dexamethasone.
Tocopherol	The metabolism of Tocopherol can be increased when combined with Dexamethasone.
Tofacitinib	The metabolism of Tofacitinib can be decreased when combined with Dexamethasone.
Tolazamide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tolazamide.
Tolbutamide	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tolbutamide.
Tolfenamic acid	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tolfenamic acid.
Tolmetin	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tolmetin.
Tolterodine	The metabolism of Tolterodine can be increased when combined with Dexamethasone.
Tolvaptan	The metabolism of Tolvaptan can be increased when combined with Dexamethasone.
Topotecan	The risk or severity of adverse effects can be increased when Topotecan is combined with Dexamethasone.
Torasemide	The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Torasemide.
Toremifene	The metabolism of Toremifene can be increased when combined with Dexamethasone.
Tositumomab	The risk or severity of adverse effects can be increased when Tositumomab is combined with Dexamethasone.
Trabectedin	The metabolism of Trabectedin can be increased when combined with Dexamethasone.
Tramadol	The metabolism of Tramadol can be decreased when combined with Dexamethasone.
Trastuzumab	The risk or severity of neutropenia can be increased when Trastuzumab is combined with Dexamethasone.
Trastuzumab emtansine	The metabolism of Trastuzumab emtansine can be increased when combined with Dexamethasone.
Trazodone	The serum concentration of Trazodone can be decreased when it is combined with Dexamethasone.
Treprostinil	The metabolism of Treprostinil can be increased when combined with Dexamethasone.
Tretinoin	The metabolism of Tretinoin can be increased when combined with Dexamethasone.
Triamcinolone	The risk or severity of adverse effects can be increased when Triamcinolone is combined with Dexamethasone.
Triazolam	The metabolism of Triazolam can be increased when combined with Dexamethasone.
Trichlormethiazide	The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Trichlormethiazide.
Triclabendazole	The metabolism of Triclabendazole can be increased when combined with Dexamethasone.
Triflupromazine	The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Dexamethasone.
Trifluridine	The risk or severity of adverse effects can be increased when Trifluridine is combined with Dexamethasone.
Trilaciclib	Dexamethasone may decrease the excretion rate of Trilaciclib which could result in a higher serum level.
Trilostane	The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone.
Trimebutine	The metabolism of Trimebutine can be increased when combined with Dexamethasone.
Trimethadione	The metabolism of Trimethadione can be increased when combined with Dexamethasone.
Trimethoprim	The metabolism of Trimethoprim can be increased when combined with Dexamethasone.
Trimipramine	The metabolism of Trimipramine can be increased when combined with Dexamethasone.
Troglitazone	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Troglitazone.
Troleandomycin	The metabolism of Dexamethasone can be decreased when combined with Troleandomycin.
Trovafloxacin	The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Trovafloxacin.
Tubocurarine	The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Dexamethasone.
Tucatinib	The metabolism of Tucatinib can be increased when combined with Dexamethasone.
Typhoid vaccine	The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Dexamethasone.
Typhoid Vaccine Live	The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Dexamethasone.
Typhoid Vi polysaccharide vaccine	The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Dexamethasone.
Tyrothricin	The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Dexamethasone.
Ubidecarenone	The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ubidecarenone.
Ublituximab	The risk or severity of infection can be increased when Ublituximab is combined with Dexamethasone.
Ubrogepant	The serum concentration of Ubrogepant can be decreased when it is combined with Dexamethasone.
Udenafil	The metabolism of Udenafil can be increased when combined with Dexamethasone.
Ulipristal	The metabolism of Ulipristal can be increased when combined with Dexamethasone.
Upadacitinib	The metabolism of Upadacitinib can be increased when combined with Dexamethasone.
Ursodeoxycholic acid	Dexamethasone may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.
Vadadustat	The serum concentration of Dexamethasone can be increased when it is combined with Vadadustat.
Valbenazine	The serum concentration of Valbenazine can be decreased when it is combined with Dexamethasone.
Valdecoxib	The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Valdecoxib.
Valproic acid	The excretion of Dexamethasone can be decreased when combined with Valproic acid.
Vamorolone	The metabolism of Vamorolone can be increased when combined with Dexamethasone.
Vandetanib	The metabolism of Vandetanib can be increased when combined with Dexamethasone.
Vardenafil	The metabolism of Vardenafil can be decreased when combined with Dexamethasone.
Varicella zoster vaccine (live/attenuated)	The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Dexamethasone.
Varicella zoster vaccine (recombinant)	The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dexamethasone.
Vecuronium	The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone.
Vedolizumab	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vedolizumab.
Velpatasvir	The metabolism of Velpatasvir can be increased when combined with Dexamethasone.
Vemurafenib	The metabolism of Vemurafenib can be increased when combined with Dexamethasone.
Venetoclax	The metabolism of Venetoclax can be increased when combined with Dexamethasone.
Venlafaxine	The metabolism of Venlafaxine can be increased when combined with Dexamethasone.
Verapamil	The metabolism of Verapamil can be increased when combined with Dexamethasone.
Vibrio cholerae CVD 103-HgR strain live antigen	The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dexamethasone.
Vilanterol	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vilanterol.
Vilazodone	The metabolism of Vilazodone can be increased when combined with Dexamethasone.
Vildagliptin	The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Vildagliptin.
Viloxazine	The metabolism of Dexamethasone can be decreased when combined with Viloxazine.
Vinblastine	The metabolism of Vinblastine can be increased when combined with Dexamethasone.
Vincristine	The metabolism of Vincristine can be increased when combined with Dexamethasone.
Vindesine	The metabolism of Vindesine can be increased when combined with Dexamethasone.
Vinflunine	The metabolism of Vinflunine can be increased when combined with Dexamethasone.
Vinorelbine	The metabolism of Vinorelbine can be increased when combined with Dexamethasone.
Vitamin D	The therapeutic efficacy of Vitamin D can be decreased when used in combination with Dexamethasone.
Vitamin E	The metabolism of Vitamin E can be increased when combined with Dexamethasone.
Voclosporin	The metabolism of Voclosporin can be increased when combined with Dexamethasone.
Vonoprazan	The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Dexamethasone.
Vorapaxar	The metabolism of Vorapaxar can be increased when combined with Dexamethasone.
Voriconazole	The serum concentration of Dexamethasone can be increased when it is combined with Voriconazole.
Vorinostat	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vorinostat.
Vortioxetine	The metabolism of Vortioxetine can be increased when combined with Dexamethasone.
Voxelotor	The serum concentration of Voxelotor can be increased when it is combined with Dexamethasone.
Voxilaprevir	The metabolism of Voxilaprevir can be increased when combined with Dexamethasone.
Warfarin	Dexamethasone may increase the anticoagulant activities of Warfarin.
Yellow fever vaccine	The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Dexamethasone.
Yohimbine	The metabolism of Yohimbine can be increased when combined with Dexamethasone.
Zaleplon	The metabolism of Zaleplon can be increased when combined with Dexamethasone.
Zanubrutinib	The metabolism of Zanubrutinib can be increased when combined with Dexamethasone.
Zidovudine	The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone.
Zileuton	The metabolism of Zileuton can be increased when combined with Dexamethasone.
Zimelidine	The metabolism of Dexamethasone can be decreased when combined with Zimelidine.
Ziprasidone	The metabolism of Ziprasidone can be increased when combined with Dexamethasone.
Zolpidem	The metabolism of Zolpidem can be increased when combined with Dexamethasone.
Zonisamide	The metabolism of Zonisamide can be increased when combined with Dexamethasone.
Zopiclone	The metabolism of Zopiclone can be decreased when combined with Dexamethasone.
Zotepine	The metabolism of Zotepine can be increased when combined with Dexamethasone.
Zuclopenthixol	The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone.
Zuranolone	The serum concentration of Zuranolone can be decreased when it is combined with Dexamethasone.

Food Interactions

Avoid alcohol.
Take with food. Food reduces irritation.

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Product Ingredients

Ingredient	UNII	CAS	InChI Key
Dexamethasone phosphate	2BP70L44PR	312-93-6	VQODGRNSFPNSQE-CXSFZGCWSA-N
Dexamethasone sodium phosphate	AI9376Y64P	2392-39-4	PLCQGRYPOISRTQ-FCJDYXGNSA-L

Product Images

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End
Accufix II Dec Model 033-212	Implant	0.7 mg / imp	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1999-08-27
Decadron	Tablet	0.5 mg/1	Oral	Merck Sharp & Dohme Corp.	1958-10-30	2007-11-30
Decadron	Tablet	0.75 mg/1	Oral	Merck Sharp & Dohme Corp.	1958-10-30	2007-11-30
Decadron Phosphate Eye Ear Sol 0.1%	Liquid	1 mg / mL	Auricular (otic); Ophthalmic	Merck Frosst Canada & Cie, Merck Frosst Canada & Co.	1960-12-31	1998-04-21
Decadron Phosphate Inj 4mg/ml	Liquid	4 mg / mL	Intramuscular; Intravenous	Merck Frosst Canada & Cie, Merck Frosst Canada & Co.	1959-12-31	2001-08-01
Decadron Tab 0.5mg	Tablet	.5 mg	Oral	Merck Frosst Canada & Cie, Merck Frosst Canada & Co.	1958-12-31	2002-07-29
Decadron Tab 4mg	Tablet	4 mg	Oral	Merck Frosst Canada & Cie, Merck Frosst Canada & Co.	1976-12-31	2003-08-08
Dexamethasone	Solution	0.1 %	Auricular (otic); Ophthalmic	Pharma Stulln Inc.	1994-12-31	Not applicable
Dexamethasone Omega Unidose	Solution	10 mg / 1 mL	Intramuscular; Intrasynovial; Intravenous	Omega Laboratories Limited	2013-05-08	Not applicable
Dexamethasone Sod Phos Inj 4mg/ml	Liquid	4 mg / mL	Intramuscular; Intravenous	Taro Pharmaceuticals, Inc.	1989-12-31	2001-08-21
Dexamethasone Sod Phosph Inj 10mg/ml USP	Liquid	10 mg / 1 mL	Intramuscular; Intrasynovial; Intravenous	Sandoz Canada Incorporated	1990-12-31	Not applicable
Dexamethasone Sodium Phosphate 0.1%	Solution / drops	.1 %	Auricular (otic); Ophthalmic	Rivex Ophthalmics Inc.	1997-05-07	2003-07-28
Dexamethasone Sodium Phosphate Inj USP 4mg/ml	Solution	4 mg / mL	Intramuscular; Intrasynovial; Intravenous	Sandoz Canada Incorporated	1986-12-31	Not applicable
Dexamethasone Sodium Phosphate Injection Sdz	Solution	10 mg / mL	Intramuscular; Intrasynovial; Intravenous	Sandoz Canada Incorporated	Not applicable	Not applicable
Dexamethasone Sodium Phosphate Injection Sdz	Solution	4 mg / mL	Intramuscular; Intrasynovial; Intravenous	Sandoz Canada Incorporated	Not applicable	Not applicable
Dexamethasone Sodium Phosphate Injection, USP	Solution	4 mg / mL	Intra-articular; Intramuscular; Intravenous	Sterimax Inc	1992-12-31	Not applicable
Dexamethasone Sodium Phosphate Injection, USP	Solution	10 mg / mL	Intramuscular; Intravenous	Strides Pharma Canada Inc	Not applicable	Not applicable
Dexamethasone Sodium Phosphate Injection, USP	Solution	4 mg / mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Strides Pharma Canada Inc	Not applicable	Not applicable
Dexamethasone Unidose	Solution	10 mg / mL	Intramuscular; Intrasynovial; Intravenous	Juno Pharmaceuticals Corp.	Not applicable	Not applicable
Dexamethasone-omega	Liquid	10 mg / mL	Intramuscular; Intravenous	Omega Laboratories Ltd	1999-06-30	Not applicable
Dexamethasone-omega	Liquid	4 mg / mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Omega Laboratories Ltd	1999-04-01	Not applicable
Dexasone 0.5mg	Tablet	0.5 mg	Oral	Valeant Canada Lp Valeant Canada S.E.C.	1974-12-31	2014-07-30
Dexasone 0.75mg	Tablet	0.75 mg	Oral	Valeant Canada Lp Valeant Canada S.E.C.	1974-12-31	2014-07-30
Dexasone 4mg	Tablet	4 mg	Oral	Valeant Canada Lp Valeant Canada S.E.C.	1979-12-31	2016-07-08
Dextenza	Insert	0.4 mg/1	Ophthalmic	Ocular Therapeutix, Inc.	2019-01-07	Not applicable
Dexycu	Injection, suspension	517 ug/0.005mL	Intraocular	EyePoint Pharmaceuticals US, Inc	2018-05-22	Not applicable
Dexycu	Injection, suspension	517 ug/0.005mL	Intraocular	Icon Bioscience, Inc.	2018-10-01	2018-10-01
Dmt Suik	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Asclemed Usa, Inc.	2003-05-29	Not applicable
Encor Dec Model 033-159 Imp 0.5mg/imp	Implant	.5 mg / unit	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1999-08-27
Encor Dec Model 033-443 Imp 0.5mg/imp	Implant	.5 mg / unit	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1999-08-27
Encor Dec Model 033-448 Imp 0.5mg/imp	Implant	.5 mg / unit	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1999-08-27
Encor Dec Model 033-757 Imp 0.5mg/imp	Implant	0.5 mg / unit	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1996-09-10
Encor Dec Model 033-856 Imp 0.5mg/imp	Implant	.5 mg / unit	Intravitreal	Telectronics Pacing Systems Inc.	1994-12-31	1996-09-10
Hemady	Tablet	20 mg/1	Oral	Edenbridge Pharmaceuticals LLC.	2019-10-03	Not applicable
Hemady	Tablet	20 mg/1	Oral	Acrotech Biopharma Llc	2020-06-11	Not applicable
Hemady	Tablet	20 mg/1	Oral	Dexcel Pharma Technologies Ltd.	2020-03-31	2020-03-31
Hexadrol Phosphate	Injection, solution	10 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Organon	1964-12-04	1998-12-31
Hexadrol Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Organon	1964-12-04	1998-12-31
Hexadrol Phosphate Inj 10mg/ml	Liquid	10 mg / mL	Intramuscular; Intravenous	Organon Teknika Canada Inc.	1987-12-31	2001-09-18
Hexadrol Phosphate Inj 4mg/ml	Liquid	4 mg / mL	Intramuscular; Intravenous	Organon Teknika Canada Inc.	1987-12-31	2001-09-18
Maxidex	Ointment	0.5 mg/1g	Ophthalmic	Alcon	2006-12-26	Not applicable
Maxidex	Ointment	0.1 % w/w	Ophthalmic	Novartis	1966-12-31	Not applicable
Maxidex	Suspension	0.1 % w/v	Ophthalmic	Novartis	1977-12-31	Not applicable
Maxidex	Suspension / drops	1 mg/1mL	Ophthalmic	Novartis Pharmaceuticals Corporation	1966-05-15	Not applicable
Maxidex	Suspension	1 mg/1mL	Ophthalmic	ALCON LABORATORIES, INC.	1966-05-15	2023-08-31
Neofordex	Tablet	40 mg	Oral	Theravia	2016-09-08	Not applicable
Ocudex Liq 0.1%	Liquid	.1 %	Ophthalmic; Topical	Herdt Et Charton Inc.	1994-12-31	1999-09-17
Ozurdex	Implant	0.7 mg	Intravitreal	Abbvie	2011-06-02	Not applicable
Ozurdex	Implant	700 mcg	Intravitreal	Abb Vie Deutschland Gmb H & Co. Kg	2016-09-20	Not applicable
Ozurdex	Implant	0.7 mg/1	Intravitreal	Allergan, Inc.	2009-09-01	Not applicable
R.O.-dexsone	Solution / drops	.1 %	Auricular (otic); Ophthalmic	Richmond Pharmaceuticals Inc.	1992-12-31	1997-08-11

Generic Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End
Apo-dexamethasone	Tablet	0.5 mg	Oral	Apotex Corporation	2004-11-17	Not applicable
Apo-dexamethasone	Tablet	4 mg	Oral	Apotex Corporation	2004-03-08	Not applicable
Baycadron	Elixir	0.5 mg/5mL	Oral	Wockhardt	1983-07-27	Not applicable
Decadron	Tablet	0.75 mg/1	Oral	Pragma Pharmaceuticals, LLC	2018-02-28	2022-03-31
Decadron	Tablet	6 mg/1	Oral	Pragma Pharmaceuticals, LLC	2018-02-28	2022-03-31
Decadron	Tablet	0.5 mg/1	Oral	Pragma Pharmaceuticals, LLC	2018-02-28	2022-03-31
Decadron	Tablet	4 mg/1	Oral	Pragma Pharmaceuticals, LLC	2018-02-28	2022-03-31
Decadron	Tablet	1.5 mg/1	Oral	Wraser Llc	2017-09-11	2017-09-25
Decadron	Elixir	0.5 mg/5mL	Oral	Pragma Pharmaceuticals, LLC	2018-03-15	Not applicable
Decadron DP	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2017-09-11	2017-09-25
Dexabliss	Tablet	1.5 mg/1	Oral	Levins Pharmaceuticals, LLC	2020-04-09	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Key Therapeutics	2023-07-17	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Fera Pharmaceuticals, LLC	2018-06-01	2020-12-31
Dexamethasone	Tablet	2 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Prasco Laboratories	2022-04-30	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Aidarex Pharmaceuticals LLC	1975-06-03	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Apotex Corp.	2023-12-05	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Preferred Pharmaceuticals Inc.	2022-09-12	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2019-01-04	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	RedPharm Drug, Inc.	2021-01-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Lake Erie Medical DBA Quality Care Products LLC	1978-07-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	ANI Pharmaceuticals, Inc.	2023-05-09	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Fera Pharmaceuticals, LLC	2018-06-01	2020-09-30
Dexamethasone	Tablet	0.5 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Stat Rx USA	1978-07-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1982-08-26	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Fera Pharmaceuticals, LLC	2021-06-01	2021-06-01
Dexamethasone	Tablet	6 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-15	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	ANI Pharmaceuticals, Inc.	2022-08-08	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Morton Grove Pharmaceuticals, Inc.	1983-07-27	Not applicable
Dexamethasone	Tablet	0.75 mg/0.75mg	Oral	NorthStar Rx LLC	2023-11-13	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	2022-04-30	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Avera McKennan Hospital	2016-06-22	2017-05-24
Dexamethasone	Tablet	1 mg/1	Oral	bryant ranch prepack	1983-09-15	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Rebel Distributors	1982-08-26	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	RedPharm Drug	2018-01-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	A-S Medication Solutions	1983-04-28	2017-11-30
Dexamethasone	Solution	0.5 mg/5mL	Oral	Pharmaceutical Associates, Inc.	1975-07-25	2022-12-01
Dexamethasone	Tablet	1.5 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-05-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	NorthStar Rx LLC	2023-08-07	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Doc Rx	1982-08-26	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Apotex Corp.	2023-11-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-06-03	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Proficient Rx LP	1978-07-19	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Rebel Distributors	1975-06-03	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-07-25	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	NorthStar Rx LLC	2023-08-07	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Nucare Pharmaceuticals,inc.	2021-09-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Cardinal Health 107, LLC	1978-07-19	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Direct Rx	2020-06-15	Not applicable
Dexamethasone	Tablet	1 mg/1	Oral	Apotex Corp.	2023-11-01	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Par Pharmaceutical Inc.	1983-11-28	2019-12-31
Dexamethasone	Tablet	1.5 mg/1	Oral	ECR Pharmaceuticals Co., Inc.	2009-04-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Preferred Pharmaceuticals, Inc.	2012-01-17	2019-08-14
Dexamethasone	Tablet	4 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Chartwell Rx, Llc	2011-05-11	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Blenheim Pharmacal, Inc.	2013-11-15	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	REMEDYREPACK INC.	2023-08-18	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Physicians Total Care, Inc.	2005-06-21	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	bryant ranch prepack	1978-07-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	American Health Packaging	2023-11-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Par Pharmaceutical Inc.	1983-04-28	2019-08-31
Dexamethasone	Tablet	4 mg/1	Oral	Golden State Medical Supply, Inc.	1982-01-01	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Direct Rx	2021-09-20	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Preferred Pharmaceuticals Inc.	2022-11-29	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-05-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Bionpharma Inc.,	2023-08-01	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Qualitest	2011-05-11	2017-07-31
Dexamethasone	Solution	0.5 mg/5mL	Oral	bryant ranch prepack	1983-09-01	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Physicians Total Care, Inc.	2009-01-28	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	ANI Pharmaceuticals, Inc.	2023-10-09	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	A S Medication Solutions	1975-06-03	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	STI Pharma LLC	1976-09-21	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Preferred Pharmaceuticals Inc.	2018-09-25	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	medsource pharmaceuticals	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Proficient Rx LP	2021-06-28	Not applicable
Dexamethasone	Tablet	1 mg/1	Oral	Doc Rx	1983-09-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Aidarex Pharmaceuticals LLC	1983-04-28	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-07-25	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Preferred Pharmaceuticals, Inc.	2023-06-26	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Fera Pharmaceuticals, LLC	2018-06-01	2023-06-30
Dexamethasone	Tablet	4 mg/1	Oral	Amerincan Health Packaging	2017-07-01	2017-11-02
Dexamethasone	Tablet	1.5 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	NorthStar Rx LLC	2023-08-07	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Rising Pharma Holdings, Inc.	2011-08-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Nucare Pharmaceuticals,inc.	1983-04-28	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	REMEDYREPACK INC.	2018-10-15	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Fera Pharmaceuticals, LLC	2021-06-01	2021-06-01
Dexamethasone	Tablet	2 mg/1	Oral	Amneal Pharmaceuticals NY LLC	2022-09-12	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Physicians Total Care, Inc.	2008-05-30	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	bryant ranch prepack	1983-04-28	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Par Pharmaceutical Inc.	1983-04-28	2020-05-31
Dexamethasone	Tablet	1.5 mg/1	Oral	Direct_Rx	2023-05-04	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	PD-Rx Pharmaceuticals, Inc.	1982-08-26	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Direct_Rx	2023-09-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Dispensing Solutions, Inc.	1978-07-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Cardinal Health 107, LLC	1982-08-26	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Direct_Rx	2023-11-13	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Fera Pharmaceuticals, LLC	2021-06-01	2021-06-01
Dexamethasone	Tablet	4 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	ANI Pharmaceuticals, Inc.	2022-08-08	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Physicians Total Care, Inc.	1996-06-21	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	RedPharm Drug, Inc.	1983-04-28	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Par Pharmaceutical Inc.	1983-04-28	2019-12-31
Dexamethasone	Tablet	4 mg/1	Oral	A S Medication Solutions	1978-07-19	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Blenheim Pharmacal, Inc.	2013-12-10	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Nucare Pharmaceuticals,inc.	2023-08-07	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Bionpharma Inc.,	2023-08-01	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	bryant ranch prepack	1983-09-15	Not applicable
Dexamethasone	Tablet	1 mg/1	Oral	Rebel Distributors	1983-09-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	H.J. Harkins Company, Inc.	1983-04-28	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Aidarex Pharmaceuticals LLC	2017-05-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Apotex Corp.	2023-11-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	1983-04-28	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	REMEDYREPACK INC.	2021-03-17	Not applicable
Dexamethasone	Tablet	1 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A S Medication Solutions	1978-07-19	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	RedPharm Drug, Inc	2021-09-01	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	ECR Pharmaceuticals Co., Inc.	2000-04-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	PD-Rx Pharmaceuticals, Inc.	1978-07-19	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Advanced Rx Pharmacy of Tennessee, LLC	2023-07-31	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Aidarex Pharmaceuticals LLC	2018-04-17	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	REMEDYREPACK INC.	2017-11-10	2020-05-06
Dexamethasone	Elixir	0.5 mg/5mL	Oral	STI Pharma	1976-09-21	2013-09-30
Dexamethasone	Tablet	0.75 mg/1	Oral	Apotex Corp.	2023-12-05	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	REMEDYREPACK INC.	2021-01-25	Not applicable
Dexamethasone	Solution	0.5 mg/5mL	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	REMEDYREPACK INC.	2007-09-21	2018-08-21
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	1978-07-19	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Fera Pharmaceuticals, LLC	2018-06-01	2020-12-31
Dexamethasone	Tablet	6 mg/1	Oral	Amneal Pharmaceuticals NY LLC	2021-09-01	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2017-09-11	2018-12-21
Dexamethasone	Tablet	4 mg/1	Oral	Cardinal Health 107, LLC	2021-09-01	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Proficient Rx LP	1982-08-26	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Nucare Pharmaceuticals,inc.	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Quality Care Products, LLC	2022-01-31	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Viona Pharmaceuticals Inc	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Rebel Distributors	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	American Health Packaging	2022-11-17	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	bryant ranch prepack	1983-04-28	2021-04-23
Dexamethasone	Tablet	0.75 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Advanced Rx Pharmacy of Tennessee, LLC	2023-04-24	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Alvogen Inc.	2021-06-28	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	ANI Pharmaceuticals, Inc.	2023-10-09	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Doc Rx	1978-07-19	Not applicable
Dexamethasone	Tablet	1 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-15	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	bryant ranch prepack	1975-06-03	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Direct_Rx	2022-09-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	1978-07-19	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	American Health Packaging	2023-04-27	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	NorthStar Rx LLC	2023-08-07	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Direct Rx	2015-01-01	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Physicians Total Care, Inc.	2005-06-13	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	AvKARE	2022-08-31	Not applicable
Dexamethasone	Elixir	0.5 mg/5mL	Oral	Cardinal Health	1983-07-27	2013-07-31
Dexamethasone	Tablet	0.5 mg/0.5mg	Oral	NorthStar Rx LLC	2023-11-13	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	RedPharm Drug, Inc.	2021-06-28	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Fera Pharmaceuticals, LLC	2021-06-01	2023-12-31
Dexamethasone	Tablet	1.5 mg/1	Oral	ECR Pharmaceuticals Co., Inc.	2006-09-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Preferred Pharmaceuticals, Inc.	2012-01-17	2019-08-14
Dexamethasone	Tablet	4 mg/1	Oral	bryant ranch prepack	2022-08-08	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Physicians Total Care, Inc.	1994-01-19	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Par Pharmaceutical Inc.	1983-04-28	2020-02-29
Dexamethasone	Tablet	0.75 mg/1	Oral	PD-Rx Pharmaceuticals, Inc.	1975-06-03	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1982-08-26	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	ANI Pharmaceuticals, Inc.	2022-08-08	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Amneal Pharmaceuticals NY LLC	2021-09-01	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	bryant ranch prepack	1975-05-19	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Apotex Corp.	2023-12-05	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Major Pharmaceuticals	2021-09-01	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	1983-04-28	Not applicable
Dexamethasone	Solution	1 mg/10mL	Oral	Pharmaceutical Associates, Inc.	1975-07-25	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	Zydus Pharmaceuticals USA Inc.	2024-03-18	Not applicable
Dexamethasone	Tablet	6 mg/1	Oral	Bionpharma Inc.,	2023-08-01	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	H.J. Harkins Company, Inc.	1983-04-28	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Lake Erie Medical Dba Quality Care Produts Llc	2015-07-10	2017-12-31
Dexamethasone	Tablet	4 mg/1	Oral	Nucare Pharmaceuticals, Inc.	1983-04-28	2018-12-31
Dexamethasone	Tablet	0.75 mg/1	Oral	Physicians Total Care, Inc.	1996-05-10	Not applicable
Dexamethasone	Tablet	2 mg/1	Oral	A S Medication Solutions	1982-08-26	Not applicable
Dexamethasone	Tablet	0.75 mg/1	Oral	Hikma Pharmaceuticals USA, Inc.	1975-06-03	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	bryant ranch prepack	2021-06-28	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	Alvogen Inc.	2021-06-28	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	Apotex Corp.	2023-12-05	Not applicable
Dexamethasone	Tablet	4 mg/1	Oral	A-S Medication Solutions	2022-04-30	Not applicable
Dexamethasone	Tablet	1.5 mg/1	Oral	ECR Pharmaceuticals Co., Inc.	2009-04-01	2017-07-10
Dexamethasone	Tablet	4 mg/1	Oral	Preferred Pharmaceuticals Inc.	2018-04-19	Not applicable
Dexamethasone	Tablet	0.5 mg/1	Oral	Zydus Lifesciences Limited	2024-04-15	Not applicable
Dexamethasone 1.5 mg	Tablet	1.5 mg/1	Oral	Proficient Rx LP	2017-09-01	Not applicable
Dexamethasone 1.5 mg	Tablet	1.5 mg/1	Oral	Larken Laboratories, Inc.	2017-09-01	Not applicable
DEXAMETHASONE 6-Day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2020-05-07	Not applicable
Dexamethasone Intensol	Solution, concentrate	1 mg/1mL	Oral	Hikma Pharmaceuticals USA, Inc.	1983-09-01	Not applicable
Dexamethasone Intensol	Solution, concentrate	1 mg/1mL	Oral	Carilion Materials Management	1983-09-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2015-03-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	REMEDYREPACK INC.	2017-11-28	2020-05-07
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Civica, Inc.	2019-11-13	Not applicable
Dexamethasone Sodium Phosphate	Injection, suspension	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables & Vaccines	2010-07-01	2011-12-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	A S Medication Solutions	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Solution	1 mg/1mL	Ophthalmic	Rebel Distributors	1985-01-16	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	1975-07-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2021-06-14	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Somerset Therapeutics, Llc	2018-06-08	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	General Injectables & Vaccines	2010-08-01	2017-02-01
Dexamethasone Sodium Phosphate	Injection, emulsion	10 mg/1mL	Intramuscular; Intravenous	Fresenius Kabi USA, LLC	2024-02-21	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2017-12-31
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Cardinal Health	2003-05-29	2017-10-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Fresenius Kabi USA, LLC	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	General Injectables and Vaccines, Inc.	2014-05-26	2024-01-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Henry Schein, Inc.	2022-01-10	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	A-S Medication Solutions	2011-05-11	2014-12-16
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Cardinal Health	2011-05-11	2015-02-28
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	HF Acquisition Co LLC, DBA HealthFirst	2019-12-21	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Gland Pharma Limited	2023-09-25	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Asclemed Usa, Inc.	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular	Remedy Repack	2015-01-23	2016-09-29
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Hikma Pharmaceuticals USA Inc.	1975-07-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Mylan Institutional LLC	2020-04-15	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Hikma Pharmaceuticals USA Inc.	2018-12-16	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2020-11-09	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	American Regent	1990-09-30	2016-11-08
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	HF Acquisition Co LLC, DBA HealthFirst	2019-07-21	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2022-07-22	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Remedy Repack	2017-07-17	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2020-04-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Nucare Pharmaceuticals,inc.	2015-12-01	2019-12-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	A-S Medication Solutions	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Advanced Rx Pharmacy of Tennessee, LLC	2023-02-16	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2021-02-08	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Asclemed Usa, Inc.	2020-02-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Eugia US LLC	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Solution	1 mg/1mL	Ophthalmic	Physicians Total Care, Inc.	2005-06-20	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Amneal Pharmaceuticals LLC	2018-08-27	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Fresenius Kabi USA, LLC	2020-11-30	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Medical Purchasing Solutions, Llc	1982-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2022-03-08	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Nucare Pharmaceuticals,inc.	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intravenous	Remedy Repack	2012-03-01	2013-04-04
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	REMEDYREPACK INC.	2016-11-08	2018-09-25
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Bausch & Lomb Incorporated	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	1982-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	2000-09-07	2017-07-31
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Amneal Pharmaceuticals LLC	2018-08-26	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Fresenius Kabi USA, LLC	2003-05-29	Not applicable
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	A S Medication Solutions	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Fresenius Kabi USA, LLC	2015-10-30	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Henry Schein, Inc.	2022-01-09	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2015-08-31
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	HF Acquisition Co LLC, DBA HealthFirst	2018-12-22	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Mylan Institutional LLC	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Butler Animal Health Supply	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Somerset Therapeutics, Llc	2019-06-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Gland Pharma Limited	2021-08-04	Not applicable
DEXAMETHASONE Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Teva Parenteral Medicines, Inc.	1990-08-31	2011-03-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Phlow Corporation	2021-12-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2015-01-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	American Regent	1990-09-30	2016-11-08
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	REMEDYREPACK INC.	2017-05-17	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables & Vaccines	2010-07-01	2012-01-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Hikma Pharmaceuticals USA Inc.	1982-09-07	Not applicable
DEXAMETHASONE Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Physicians Total Care, Inc.	2010-01-15	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Somerset Therapeutics, Llc	2018-06-08	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2015-07-17	2016-11-09
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2017-12-31
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Major Pharmaceuticals	1996-07-26	2011-11-21
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	2005-04-05	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Cardinal Health	2011-05-11	2018-02-28
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Asclemed Usa, Inc.	1975-07-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2020-04-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Medical Purchasing Solutions, Llc	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Eugia US LLC	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	HF Acquisition Co LLC, DBA HealthFirst	2019-10-08	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	A-S Medication Solutions	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Civica, Inc.	2019-11-13	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	A S Medication Solutions	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Solution	1 mg/1mL	Ophthalmic	Sandoz Inc	2004-07-01	2018-08-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables & Vaccines, Inc.	2019-09-06	Not applicable
Dexamethasone Sodium Phosphate	Solution	1 mg/1mL	Ophthalmic	Dispensing Solutions, Inc.	2004-07-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2015-04-30
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection	100 mg/10mL	Intramuscular; Intravenous	HF Acquisition Co LLC, DBA HealthFirst	2022-05-20	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Physicians Total Care, Inc.	1995-07-21	2012-06-30
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	REMEDYREPACK INC.	2019-02-28	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Cardinal Health	2000-09-07	2015-08-31
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	REMEDYREPACK INC.	2023-04-25	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Amneal Pharmaceuticals LLC	2018-08-27	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2017-12-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Cardinal Health	2011-05-11	2015-03-31
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Medical Purchasing Solutions, Llc	2019-06-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Fresenius Kabi USA, LLC	2005-04-05	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Cardinal Health 107, LLC	1982-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	1975-07-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Pfizer Laboratories Div Pfizer Inc.	2011-05-11	2017-12-31
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	2003-05-29	2019-02-28
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	HF Acquisition Co LLC, DBA HealthFirst	2019-10-13	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2011-05-11	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	10 mg/1mL	Intramuscular; Intravenous	Henry Schein, Inc.	2022-01-09	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular	Remedy Repack	2016-08-15	2016-08-15
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Somerset Therapeutics, Llc	2018-06-08	Not applicable
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Rebel Distributors	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	General Injectables & Vaccines	2011-07-18	2017-02-01
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	REMEDYREPACK INC.	2017-04-06	Not applicable
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Phoenix Pharmaceutical, Inc.	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Cardinal Health	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Gland Pharma Limited	2021-08-04	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Mylan Institutional LLC	2020-04-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	A-S Medication Solutions	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables and Vaccines, Inc	2015-08-21	2022-06-30
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	American Regent	1990-09-30	2016-11-08
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	A-S Medication Solutions	1996-07-26	2016-10-31
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Somerset Therapeutics, Llc	2018-04-19	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables & Vaccines, Inc.	2019-08-09	2023-08-31
Dexamethasone Sodium Phosphate	Injection	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Hikma Pharmaceuticals USA Inc.	1975-07-15	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	General Injectables and Vaccines, Inc	2016-02-18	2023-10-31
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	Cardinal Health 107, LLC	2000-09-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intramuscular; Intravenous	A-S Medication Solutions	2000-09-07	2018-02-28
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Amneal Pharmaceuticals LLC	2018-08-27	Not applicable
Dexamethasone Sodium Phosphate	Injection	10 mg/1mL	Intramuscular; Intravenous	Eugia US LLC	2020-06-05	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Medical Purchasing Solutions, Llc	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Solution / drops	1 mg/1mL	Ophthalmic	Stat Rx USA	1996-07-26	Not applicable
Dexamethasone Sodium Phosphate	Injection	100 mg/10mL	Intramuscular; Intravenous	Eugia US LLC	2019-06-07	Not applicable
Dexamethasone Sodium Phosphate	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Eugia US LLC	2015-12-01	Not applicable
Dexamethasone Sodium Phosphate	Injection, emulsion	10 mg/1mL	Intramuscular; Intravenous	Fresenius Kabi USA, LLC	2018-07-06	Not applicable
Dexamethasone Sodium Phosphate	Injection	100 mg/10mL	Intramuscular; Intravenous	Medical Purchasing Solutions, Llc	2019-06-07	Not applicable
Dexamethasone Sodium Phosphates	Injection, solution	4 mg/1mL	Intra-articular; Intralesional; Intramuscular; Intravenous; Soft tissue	Cardinal Health	1990-09-30	2011-10-31
Dexamethasone Tablets	Tablet	6 mg/1	Oral	Par Pharmaceutical Inc.	1983-11-28	2009-12-07
Dexamethsone	Tablet	4 mg/1	Oral	Northwind Pharmaceuticals	2014-08-11	Not applicable
Dom-dexamethasone Tablet 4mg	Tablet	4 mg	Oral	Dominion Pharmacal	1999-03-04	Not applicable
Dxevo	Tablet	1.5 mg/1	Oral	Skylar Laboratories, Llc	2019-03-25	2019-03-25
Dxevo	Tablet	1.5 mg/1	Oral	Phlight Pharma, Llc	2019-06-17	Not applicable
Dxevo	Tablet	1.5 mg/1	Oral	Skylar Laboratories, Llc	2019-03-25	Not applicable
HiDex 6-day	Tablet	1.5 mg/1	Oral	Gentex Pharma, Llc	2019-02-22	Not applicable
LoCort 11-Day	Tablet	1.5 mg/1	Oral	Allegis Pharmaceuticals, LLC	2017-02-06	2017-03-01
LoCort 11-Day	Tablet	1.5 mg/1	Oral	Allegis Holdings, Llc	2017-03-10	2017-12-22
LoCort 7-Day	Tablet	1.5 mg/1	Oral	Allegis Holdings, Llc	2017-03-10	2017-12-22
LoCort 7-Day	Tablet	1.5 mg/1	Oral	Allegis Pharmaceuticals, LLC	2017-02-06	2017-03-01
Odan-dexamethasone	Solution	0.1 %	Auricular (otic); Ophthalmic	Odan Laboratories Ltd	1985-12-31	Not applicable
Odan-dexamethasone Elixir	Elixir	0.5 mg / 5 mL	Oral	Odan Laboratories Ltd	2022-11-25	Not applicable
PHL-dexamethasone	Elixir	0.5 mg / 5 mL	Oral	Pharmel Inc	2004-12-06	2004-12-07
PHL-dexamethasone	Tablet	0.5 mg	Oral	Pharmel Inc	1998-02-17	2004-08-03
PHL-dexamethasone	Tablet	4 mg	Oral	Pharmel Inc	1998-02-17	2004-08-03
PHL-dexamethasone	Liquid	10 mg / mL	Intramuscular; Intravenous	Pharmel Inc	2004-12-06	2004-12-07
PHL-dexamethasone	Tablet	0.75 mg	Oral	Pharmel Inc	1998-02-17	2004-08-03
PMS-dexamethasone	Tablet	0.5 mg	Oral	Pharmascience Inc	1996-08-26	Not applicable
PMS-dexamethasone	Tablet	0.75 mg	Oral	Pharmascience Inc	1996-09-05	Not applicable
PMS-dexamethasone	Tablet	2 mg	Oral	Pharmascience Inc	2006-06-08	Not applicable
PMS-dexamethasone	Tablet	4 mg	Oral	Pharmascience Inc	1996-09-05	Not applicable
PMS-dexamethasone Elixir	Elixir	0.5 mg / 5 mL	Oral	Pharmascience Inc	1992-12-31	Not applicable
PMS-dexamethasone Sod Phosphate Dps 1mg/ml	Solution / drops	0.1 %	Auricular (otic); Ophthalmic	Pharmascience Inc	1989-12-31	Not applicable
PMS-dexamethasone Sod Phosphate Inj 10mg/ml	Liquid	10 mg / mL	Intramuscular; Intravenous	Pharmascience Inc	1990-12-31	2022-09-20
PMS-dexamethasone Sod Phosphate Inj 4mg/ml	Solution	4 mg / mL	Intra-articular; Intramuscular; Intravenous	Pharmascience Inc	1989-12-31	Not applicable
Pro-dexamethasone - 4	Tablet	4 mg	Oral	Pro Doc Limitee	2008-07-04	2019-04-10
Ratio-dexamethasone	Tablet	0.5 mg	Oral	TEVA Canada Limited	1999-10-29	2018-05-18
Ratio-dexamethasone	Tablet	4 mg	Oral	TEVA Canada Limited	1999-10-29	2018-05-18
Ratio-dexamethasone Tablets, USP	Tablet	0.75 mg	Oral	Ratiopharm Inc Division Of Teva Canada Limited	1999-10-29	2009-07-17
ReadySharp Dexamethasone	Injection	10 mg/1mL	Intramuscular; Intravenous	Preferred Pharmaceuticals, Inc.	1982-09-07	Not applicable
ReadySharp Dexamethasone	Injection	10 mg/1mL	Intramuscular; Intravenous	Terrain Pharmaceuticals	1982-09-07	Not applicable
Sandoz Dexamethasone	Solution / drops	0.1 %	Auricular (otic); Ophthalmic	Sandoz Canada Incorporated	1990-12-31	2017-08-01
TaperDex 12-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2018-01-19	Not applicable
TaperDex 12-day	Tablet	1.5 mg/1	Oral	Proficient Rx LP	2018-01-19	Not applicable
TaperDex 12-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2018-01-19	Not applicable
TaperDex 6-day	Tablet	1.5 mg/1	Oral	Proficient Rx LP	2018-01-19	Not applicable
TaperDex 6-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2018-01-19	Not applicable
TaperDex 6-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2018-01-19	Not applicable
TaperDex 6-day	Tablet	1.5 mg/1	Oral	Quality Care Products, LLC	2020-03-27	Not applicable
TaperDex 7-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2019-02-22	Not applicable
TaperDex 7-day	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2019-02-22	Not applicable
Viadox	Injection	10 mg/1mL	Intramuscular; Intravenous	It3 Medical Llc	2018-08-01	Not applicable
Zcort	Tablet	1.5 mg/1	Oral	Scite Pharma, LLC	2020-07-20	Not applicable
Zema Pak	Tablet	1.5 mg/1	Oral	Macoven Pharmaceuticals LLC	2006-07-07	2011-09-30
Zema Pak	Tablet	1.5 mg/1	Oral	Macoven Pharmaceuticals LLC	2006-07-07	2011-09-30
Zema Pak	Tablet	1.5 mg/1	Oral	Macoven Pharmaceuticals LLC	2006-07-07	2014-01-31
ZoDex	Tablet	1.5 mg/1	Oral	Xspire Pharma, Llc	2017-08-16	2018-06-20
ZonaCort 11-Day	Tablet	1.5 mg/1	Oral	Key Therapeutics, Llc	2017-02-01	2017-12-22
ZonaCort 7-Day	Tablet	1.5 mg/1	Oral	Key Therapeutics, Llc	2017-02-01	2017-12-22

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
999 Itch Relief	Dexamethasone (15 mg/20000mg) + Menthol (200 mg/20000mg) + Synthetic camphor (200 mg/20000mg)	Ointment	Topical	China Resources Sanjiu Medical & Pharmaceutical Co Ltd	2003-07-03	Not applicable
ACEFOS DUO® SUSPENSIÓN INYECTABLE	Dexamethasone (8 mg) + Dexamethasone (2 mg)	Suspension	Intra-articular; Intralesional; Intramuscular	ARBOFARMA S.A.S.	2018-06-20	Not applicable
ACEFOS DUO® SUSPENSIÓN INYECTABLE	Dexamethasone (8 mg) + Dexamethasone (2 mg)	Suspension	Intra-articular; Intralesional; Intramuscular	ARBOFARMA S.A.S.	2018-06-20	Not applicable
AK-Trol	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Physicians Total Care, Inc.	1996-01-05	2000-06-30
BIODERM® CREMA	Dexamethasone (0.04 g) + Gentamicin sulfate (0.1 g) + Ketoconazole (2 g)	Cream	Topical	LABORATORIOS SIEGFRIED S.A.S.	2006-11-10	Not applicable
CILODEX OTIC SUSPENSION	Dexamethasone (0.1 %) + Ciprofloxacin hydrochloride (0.3 %)	Solution	Auricular (otic)	NOVARTIS (SINGAPORE) PTE LTD	2006-04-18	Not applicable
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Nucare Pharmaceuticals,inc.	2003-08-04	Not applicable
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	ALCON LABORATORIES, INC.	2003-08-04	2021-11-30
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Proficient Rx LP	2003-08-04	Not applicable
Ciprodex	Dexamethasone (0.1 % w/v) + Ciprofloxacin hydrochloride (0.3 % w/v)	Suspension	Auricular (otic)	Novartis	2004-05-13	Not applicable
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension	Auricular (otic)	Rebel Distributors	2003-08-15	Not applicable
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Clinical Solutions Wholsesale	2003-08-15	2017-06-28
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Novartis Pharmaceuticals Corporation	2003-08-04	Not applicable
Ciprodex	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension	Auricular (otic)	Physicians Total Care, Inc.	2004-09-21	Not applicable
Ciprofloxacin and Dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	bryant ranch prepack	2020-08-10	Not applicable
Ciprofloxacin and Dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Sandoz Inc	2020-08-10	Not applicable
Ciprofloxacin and Dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Northstar RxLLC	2022-08-01	Not applicable
Ciprofloxacin and Dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Dr. Reddy's Laboratories, Inc.	2020-08-10	Not applicable
Ciprofloxacin and Dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Amneal Pharmaceuticals of New York Llc	2024-03-26	Not applicable
Ciprofloxacin and dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Sun Pharmaceutical Industries, Inc.	2022-09-01	Not applicable
Ciprofloxacin and dexamethasone	Dexamethasone (1 mg/1mL) + Ciprofloxacin hydrochloride (3 mg/1mL)	Suspension / drops	Auricular (otic)	Armas Pharmaceuticals Inc.	2023-11-01	Not applicable
CIPROFLOXACINA 0.3% + DEXAMETASONA 0.1% SUSPENSIÓN OFTÁLMICA	Dexamethasone (1 mg) + Propylthiouracil (3 mg)	Suspension	Ophthalmic	OPHARM LTDA.	2022-05-02	Not applicable
CLONODEX®	Dexamethasone (0.053 g) + Clotrimazole (1 g) + Neomycin (0.83 g)	Cream	Topical	COLOMPACK S.A.	2020-06-19	Not applicable
CLORADEX	Dexamethasone (0.2 %) + Chloramphenicol (0.5 %)	Suspension / drops	Ophthalmic	Bausch & Lomb Iom S.P.A.	2014-07-08	Not applicable
CLORADEX	Dexamethasone (0.2 %) + Chloramphenicol (0.5 %)	Suspension / drops	Ophthalmic	Bausch & Lomb Iom S.P.A.	2014-07-08	Not applicable
CLOTRISHER® CREMA TOPICA	Dexamethasone (0.04 g) + Clotrimazole (1 g) + Neomycin sulfate (0.5 g)	Cream	Topical	COASPHARMA S.A.S.	2018-04-30	Not applicable
COLDETOM	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Auricular (otic)	Scharper S.P.A.	2014-10-06	Not applicable
COLDETOM	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Auricular (otic)	Scharper S.P.A.	2014-10-06	Not applicable
COMBİDEX %0.3 + %0.1 GÖZ DAMLASI, ÇÖZELTİ, 5 ML	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Ophthalmic	BİLİM İLAÇ SAN. VE TİC. A.Ş.	2018-11-06	Not applicable
COMBIDEX OFTALMIK SÜSPANSIYON, 5 ML	Dexamethasone (1 mg/ml) + Tobramycin (3 mg/ml)	Suspension	Ophthalmic	BİLİM İLAÇ SAN. VE TİC. A.Ş.	2020-08-14	2018-08-16
COMBITIMOR	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Ophthalmic	Fidia Farmaceutici S.P.A.	2014-07-08	Not applicable
COMBITIMOR	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Auricular (otic)	Fidia Farmaceutici S.P.A.	2014-07-08	Not applicable
COMBITIMOR	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Auricular (otic)	Fidia Farmaceutici S.P.A.	2014-07-08	Not applicable
COMBITIMOR	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Auricular (otic)	Fidia Farmaceutici S.P.A.	2014-07-08	Not applicable
Cortaren Corticosteroid/Anti-Inflammatory System	Dexamethasone sodium phosphate (4 mg/1mL) + Bupivacaine hydrochloride (5 mg/1mL) + Isopropyl alcohol (0.7 mL/1mL) + Triamcinolone acetonide (40 mg/1mL)	Injection, solution; Injection, suspension; Kit	Epidural; Intra-articular; Intracaudal; Intramuscular; Intravenous; Perineural; Topical	It3 Medical Llc	2017-03-01	Not applicable
CORTICOL® SUSPENSION OFTALMICA	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6000 IU)	Suspension	Ophthalmic	COASPHARMA S.A.S.	2018-07-25	Not applicable
Cresophene Liq	Dexamethasone (1 mg / 1 g) + Camphor (649 mg / 1 g) + Parachlorophenol (300 mg / 1 g) + Thymol (50 mg / 1 g)	Liquid	Dental	Septodont	1978-12-31	2012-07-07
Cushings Syndrome Diagnostic	Dexamethasone (0.5 mg/1) + Benzalkonium chloride (0.13 mg/1mL)	Kit	Oral; Topical	Integrated Pharma Solutions Llc	2016-11-02	2017-10-17
DECADRON OFTALMICO	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg)	Solution	Conjunctival; Ophthalmic	TECNOFAR TQ S.A.S	2006-11-10	Not applicable
DERMATREX® CREMA	Dexamethasone (0.04 g) + Gentamicin sulfate (0.1 g) + Ketoconazole (2 g)	Cream	Topical	COASPHARMA S.A.S. (PLANTA PALOQUEMAO)	2006-11-10	Not applicable
DERMOTRIZOL ®	Dexamethasone (0.054 g) + Fusidic acid (2.04 g) + Ketoconazole (2.04 g)	Cream	Topical	COLOMPACK S.A.	2018-05-02	Not applicable
DEXA-GENTAMICIN EYE DROPS	Dexamethasone sodium phosphate (1 mg/ml) + Gentamicin sulfate (5 mg/ml)	Solution	Ophthalmic	PHARMAFORTE SINGAPORE PTE LTD	1998-04-24	Not applicable
DEXA-GENTAMICIN EYE OINTMENT	Dexamethasone (0.3 mg/g) + Gentamicin sulfate (3 mg/g)	Ointment	Ophthalmic	PHARMAFORTE SINGAPORE PTE LTD	1998-05-14	Not applicable
Dexagenta - POS - Augensalbe	Dexamethasone (0.3 mg) + Gentamicin (3 mg)	Ointment	Ophthalmic	Ursapharm Gmb H	1996-11-18	Not applicable
Dexagenta - POS - Augentropfen	Dexamethasone sodium phosphate (1 mg) + Gentamicin (3 mg)	Solution / drops	Ophthalmic	Ursapharm Gmb H	1996-11-29	Not applicable
DEXANETİL % 0,1 + % 0,3 GÖZ DAMLASI, ÇÖZELTİ, 1 ADET	Dexamethasone sodium phosphate (0.1 %) + Netilmicin sulfate (0.3 %)	Solution / drops	Ophthalmic	Deva Holding A.S.	2020-01-21	Not applicable
DEXASONE EYE - EAR DROPS	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (3.5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท โรงงานเภสัชกรรมแอตแลนติค จำกัด	1983-12-15	2020-09-29
Dexlido-M Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Bupivacaine hydrochloride (2.5 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Lidocaine hydrochloride (10 mg/1mL) + Povidone-iodine (10 mg/1mL)	Kit	Epidural; Infiltration; Intramuscular; Intravenous; Topical	Proficient Rx LP	2014-07-25	Not applicable
DEXTACO	Dexamethasone (0.5 mg) + Dexchlorpheniramine maleate (2 mg)	Tablet		Berlico Mulia Farma	2017-05-29	2027-04-25
DEXTAFEN	Dexamethasone (0.5 mg) + Dexchlorpheniramine maleate (2 mg)	Tablet		Otto Pharmaceutical Industries	2017-04-03	2027-03-14
DEXTOPHARM®	Dexamethasone sodium phosphate (1 mg) + Tobramycin sulfate (3 mg)	Solution	Ophthalmic	ARBOFARMA S.A.S.	2014-10-21	2021-04-01
DEXTRACIN EYE/EAR DROPS	Dexamethasone sodium phosphate (0.1 % w/v) + Neomycin sulfate (0.5 % w/v)	Solution	Auricular (otic); Ophthalmic	APEX PHARMA MARKETING PTE. LTD.	1988-10-05	Not applicable
Dioptrol Ointment	Dexamethasone (1 mg / g) + Neomycin sulfate (3.5 mg / g) + Polymyxin B sulfate (10000 unit / g)	Ointment	Ophthalmic	Steri Med Pharma Inc.	1994-12-31	Not applicable
Dioptrol Suspension	Dexamethasone (1 mg / mL) + Neomycin sulfate (3.5 mg / mL) + Polymyxin B sulfate (10000 unit / mL)	Suspension	Ophthalmic	Pharma Stulln Inc.	1994-12-31	Not applicable
DUODECADRON ® SUSPENSIÓN INYECTABLE 1 ML	Dexamethasone sodium phosphate (2 mg) + Dexamethasone acetate (8 mg)	Suspension	Intra-articular; Intralesional; Intramuscular	TECNOFAR TQ S.A.S	2007-02-05	2007-02-05
EYES FLEX® SOLUCIÓN OFTÁLMICA	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	OPHARM LTDA.	2021-07-12	Not applicable
FIXAMICIN DEXACIPRO GOTAS OTICAS	Dexamethasone (1 mg) + Azelaic acid (3 mg)	Suspension	Auricular (otic)	TECNOFAR TQ S.A.S	2009-05-18	Not applicable
FIXAMICIN DOL®	Dexamethasone (1 mg) + Lidocaine hydrochloride (40 mg) + Neomycin sulfate (3.75 mg) + Polymyxin B sulfate (10000 IU)	Solution	Auricular (otic); Topical	TECNOFAR TQ S.A.S	2018-07-11	Not applicable
FLOBACT - D	Dexamethasone (1.152 mg) + Toremifene (3.5 mg)	Suspension	Conjunctival; Ophthalmic	ARBOFARMA S.A.S.	2006-11-10	Not applicable
FUNGIMED®	Dexamethasone sodium phosphate (0.04 g) + Clotrimazole (1 g) + Neomycin sulfate (0.5 g)	Cream	Topical	COLOMPACK S.A.	2011-09-21	2020-01-15
FUSITREX ®CREMA	Dexamethasone (0.04 g) + Fusidic acid (2 g) + Ketoconazole (2 g)	Cream	Topical	LABORATORIOS DEMAC LTDA.	2006-11-10	Not applicable
GATIPHARM - D® (GATIFLOXACINA 0.3% + DEXAMETASONA 0.1% SOLUCIÓN OFTÁLMICA ESTERIL)	Dexamethasone (1 mg) + Gatifloxacin sesquihydrate (3 mg)	Solution	Conjunctival; Ophthalmic	OPHARM LTDA	2015-05-06	2021-10-01
GENTA-DEX EYE DROPS	Dexamethasone sodium phosphate (1 mg) + Gentamicin sulfate (3 mg)	Solution / drops	Ophthalmic	DUOPHARMA (M) SDN. BHD.	2020-09-08	Not applicable
GLYDEXİL PLUS % 0.3 + % 0.1 GÖZ DAMLASI, ÇÖZELTİ, 1 ADET	Dexamethasone sodium phosphate (0.1 %) + Netilmicin sulfate (0.3 %)	Solution / drops	Ophthalmic	World Medicine Ilac San. Ve Tic. a.s.	2020-02-05	Not applicable
Levodexa	Dexamethasone sodium phosphate (0.1 % w/v) + Levofloxacin hemihydrate (0.5 % w/v)	Solution	Ophthalmic	Xediton Pharmaceuticals Inc	Not applicable	Not applicable
Ludaxine	Dexamethasone sodium phosphate (4 mg/1mL) + Bupivacaine hydrochloride (5 mg/1mL)	Injection, solution; Kit	Intra-articular; Intralesional; Intramuscular; Intravenous; Perineural; Soft tissue	It3 Medical Llc	2018-11-01	Not applicable
Mas Care-pak Dexamethasone	Dexamethasone sodium phosphate (10 mg/1mL) + Isopropyl alcohol (0.7 mL/1mL) + Povidone-iodine (10 mg/1mL)	Kit	Topical	Mas Management Group Inc.	2017-11-01	Not applicable
Maxitrol	Dexamethasone (0.1 % w/v) + Neomycin sulfate (3.5 mg / mL) + Polymyxin B sulfate (6000 unit / mL)	Suspension	Ophthalmic	Novartis	1963-12-31	Not applicable
Maxitrol	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	ALCON LABORATORIES, INC.	1964-11-15	Not applicable
Maxitrol	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Harrow Eye, LLC	1964-11-15	Not applicable
Maxitrol	Dexamethasone (0.1 % w/w) + Neomycin sulfate (3.5 mg / g) + Polymyxin B sulfate (6000 unit / g)	Ointment	Ophthalmic	Novartis	1970-12-31	Not applicable
Maxitrol	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	ALCON LABORATORIES, INC.	1972-01-17	2024-05-31
Maxitrol	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Novartis Pharmaceuticals Corporation	1972-01-17	Not applicable
Maxitrol	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Novartis Pharmaceuticals Corporation	1964-11-15	2024-10-31
MAXITROL (OINTMENT)	Dexamethasone (1 mg/1g) + Neomycin sulfate (5 mg/1g) + Polymyxin B sulfate (6000 iu/1g)	Ointment	Ophthalmic	บริษัท โนวาร์ตีส (ประเทศไทย) จำกัด	2017-09-08	Not applicable
MAXITROL STERILE OPHTHALMIC SUSPENSION	Dexamethasone (1.0 mg/ml) + Neomycin sulfate (3500 iu/ml) + Polymyxin B sulfate (6000 iu/ml)	Solution	Ophthalmic	NOVARTIS (SINGAPORE) PTE LTD	1990-02-05	Not applicable
MAXITROL® SUSPENSION OFTALMICA ESTÉRIL	Dexamethasone (1 mg) + Neomycin (3500 IU) + Polymyxin B sulfate (6000 IU)	Suspension	Conjunctival; Ophthalmic	NOVARTIS DE COLOMBIA S.A.	2006-11-10	1900-01-01
MAXITROL® SUSPENSION OFTALMICA ESTÉRIL	Dexamethasone (1 mg) + Neomycin (3500 IU) + Polymyxin B sulfate (6000 IU)	Suspension	Conjunctival; Ophthalmic	NOVARTIS DE COLOMBIA S.A.	2006-11-10	Not applicable
MEODEX®	Dexamethasone (1 mg) + Vincristine (3 mg)	Suspension	Ophthalmic	LABORATORIOS OTICOFF	2007-12-14	Not applicable
Methedex	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Solution / drops	Ophthalmic	Major	1995-09-13	2012-02-28
MIRACORT- F SOLUCION OFTALMICA	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Conjunctival; Ophthalmic	COASPHARMA S.A.S.	2015-03-10	Not applicable
MIXOFTAL ® SUSPENSION OFTALMICA ESTERIL	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6000 IU)	Suspension	Conjunctival; Ophthalmic	TECNOFAR TQ S.A.S	2007-10-25	Not applicable
MOFLAG D	Dexamethasone (1 mg) + Moxifloxacin (5 mg)	Solution	Ophthalmic	LABORATORIOS SYNTHESIS S.A.S	2015-05-27	Not applicable
MOXİDEXA % 0,5 + % 0,1 GÖZ DAMLASI, ÇÖZELTİ, 1 ADET	Dexamethasone (1 mg) + Moxifloxacin (5 mg)	Solution / drops	Ophthalmic	ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.	2016-08-08	Not applicable
Multodrin - Salbe	Dexamethasone (0.1 %) + Diphenhydramine hydrochloride (0.15 %)	Ointment	Topical	Pharmazeutische Fabrik Montavit Gmb H	1966-08-09	Not applicable
Neo-poly-dex	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Butler Animal Health Supply	1995-09-13	Not applicable
Neo-poly-dex	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Butler Animal Health Supply	1994-07-25	Not applicable
Neo/Poly-B/Dex Ophth Oint	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Direct_Rx	2024-01-12	Not applicable
Neodecadron Eye Ear Soln 0.1%	Dexamethasone (1 mg / mL) + Neomycin sulfate (5 mg / mL)	Liquid	Auricular (otic); Ophthalmic	Merck Frosst Canada & Cie, Merck Frosst Canada & Co.	1959-12-31	1997-08-14
NEOMICINA SULFATO 3.5 MG + DEXAMATASONA SODIO FOSFATO 1.3MG + POLIMIXINA B SULFATO 6.600U.I / ML SOLUCION OFTALMICA	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	OPHARM LTDA.	2019-03-26	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Preferred Pharmaceuticals Inc.	2016-11-29	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Rpk Pharmaceuticals, Inc.	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Padagis US LLC	2014-07-03	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Nucare Pharmaceuticals,inc.	2014-07-03	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Advanced Rx Pharmacy of Tennessee, LLC	2023-01-11	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	REMEDYREPACK INC.	2019-07-10	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Proficient Rx LP	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Nucare Pharmaceuticals,inc.	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	A-S Medication Solutions	2014-07-03	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Major	1994-07-25	2013-08-31
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	A-S Medication Solutions	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 mg/1mL)	Suspension	Ophthalmic	Rebel Distributors	1986-11-17	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 U/1g)	Ointment	Ophthalmic	Fera Pharmaceuticals	2011-07-20	2013-06-14
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Direct Rx	2017-03-17	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Physicians Total Care, Inc.	2002-11-11	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Proficient Rx LP	2014-07-03	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	MWI/VetOne	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Rxv	1994-07-25	2016-06-24
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Physicians Total Care, Inc.	2007-12-04	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	A-S Medication Solutions	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	Proficient Rx LP	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	Preferreed Pharmaceuticals Inc.	2012-04-02	2016-11-29
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	Nucare Pharmaceuticals,inc.	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Mwi	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Putney, Inc.	2016-02-29	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Preferred Pharmaceuticals, Inc.	2014-09-02	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	A-S Medication Solutions	1996-02-21	2018-04-30
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Aidarex Pharmaceuticals LLC	2017-11-13	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	A-S Medication Solutions	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Preferred Pharmaceuticals, Inc.	2011-08-30	2019-11-06
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	Direct_Rx	2019-10-09	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Bausch & Lomb Incorporated	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [iU]/1g)	Ointment	Ophthalmic	Sandoz Inc	1996-02-21	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Nucare Pharmaceuticals,inc.	1994-07-25	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Preferred Pharmaceuticals, Inc.	2020-04-01	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 U/1g)	Ointment	Ophthalmic	Preferreed Pharmaceuticals Inc.	2015-05-11	2016-11-29
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Aidarex Pharmaceuticals LLC	2014-07-03	Not applicable
Neomycin and Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension	Ophthalmic	Sandoz Inc.	1996-02-21	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Phoenix Pharmaceutical, Inc.	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1995-09-13	2019-12-31
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Unit Dose Services	1995-09-13	2017-12-31
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	H.J. Harkins Company	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Bausch & Lomb Incorporated	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	medsource pharmaceuticals	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Topical	Directrx	2022-01-18	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Rpk Pharmaceuticals, Inc.	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	MWI/VetOne	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Rxv	1995-09-13	2016-06-24
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Directrx	2015-01-01	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Preferred Pharmaceuticals, Inc.	2013-03-14	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Proficient Rx LP	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1995-09-13	Not applicable
Neomycin Polymyxin B Sulfates and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 [USP'U]/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	1995-09-13	Not applicable
Neomycin Sulfate, Polymyxin B Sulfate and Dexamethasone	Dexamethasone (1 mg/1mL) + Neomycin sulfate (3.5 mg/1mL) + Polymyxin B sulfate (10000 U/1mL)	Suspension	Ophthalmic	STAT RX LLC USA	1984-05-22	Not applicable
NEPOLDEX® SUSPENSIÓN OFTÁLMICA	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6000 IU)	Suspension	Ophthalmic	LABORATORIOS COASPHARMA S.A.S - COASPHARMA S.A.S	2007-09-03	Not applicable
Netildex	Dexamethasone sodium phosphate (0.1 % w/v) + Netilmicin sulfate (0.3 % w/v)	Solution	Ophthalmic	Sifi S.P.A.	Not applicable	Not applicable
NETILDEX	Dexamethasone (1 MG/ML) + Netilmicin (3 MG/ML)	Solution / drops	Ophthalmic	Sifi S.P.A.	2014-07-08	Not applicable
NETILDEX	Dexamethasone (1 MG/ML) + Netilmicin (3 MG/ML)	Gel	Conjunctival	Sifi S.P.A.	2014-07-08	Not applicable
NETILDEX	Dexamethasone (1 MG/ML) + Netilmicin (3 MG/ML)	Solution / drops	Ophthalmic	Sifi S.P.A.	2014-07-08	Not applicable
Netildex	Dexamethasone sodium phosphate (0.1 % w/v) + Netilmicin sulfate (0.3 % w/v)	Solution	Ophthalmic	Sifi S.P.A.	Not applicable	Not applicable
NETILDEX	Dexamethasone (1 MG/ML) + Netilmicin (3 MG/ML)	Gel	Conjunctival	Sifi S.P.A.	2014-07-08	Not applicable
NETILDEX	Dexamethasone (1 MG/ML) + Netilmicin (3 MG/ML)	Solution / drops	Ophthalmic	Sifi S.P.A.	2014-07-08	Not applicable
NETİZON 5 MG+15 MG/5 ML GÖZ DAMLASI, ÇÖZELTİ, 1 ADET	Dexamethasone sodium phosphate (5 mg/5mL) + Netilmicin sulfate (15 mg/5mL)	Solution / drops	Ophthalmic	VEM İLAÇ SAN. VE TİC. A.Ş.	2019-10-01	Not applicable
Neuromaquel Neuroma/Anti-Inflammatory System	Dexamethasone sodium phosphate (4 mg/1mL) + Bupivacaine hydrochloride (5 mg/1mL) + Isopropyl alcohol (0.7 mL/1mL)	Injection, solution; Kit	Epidural; Intracaudal; Intramuscular; Intravenous; Perineural; Topical	It3 Medical Llc	2017-03-01	Not applicable
NORIGRAN®	Dexamethasone sodium phosphate (1 mg) + Gatifloxacin sesquihydrate (3 mg)	Solution	Ophthalmic; Topical	OPHARM LTDA.	2020-05-29	Not applicable
Npd	Dexamethasone (1 mg/1g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (10000 [USP'U]/1g)	Ointment	Ophthalmic	Phoenix Pharmaceutical, Inc.	1994-07-25	Not applicable
OCUBRAX® SUSPENSION OFTALMICA	Dexamethasone (1 mg) + Bosentan (3 mg)	Suspension	Conjunctival; Ophthalmic	OPHARM LTDA.	2008-07-23	Not applicable
OCUTOB - D	Dexamethasone (1 MG/1ML) + Tobramycin (3 MG/1ML)	Liquid	Ophthalmic	ห้างหุ้นส่วนจำกัด ภิญโญฟาร์มาซี	2004-11-16	Not applicable
OCUTRIX SOLUCION OFTALMICA	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	OPHARM LTDA.	2018-12-05	2019-11-13
Odan-trol	Dexamethasone (1 mg / mL) + Neomycin sulfate (3.5 mg / mL) + Polymyxin B sulfate (10000 unit / mL)	Suspension	Ophthalmic	Odan Laboratories Ltd	1992-12-31	Not applicable
OFTALMAX®	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6.6 IU)	Solution	Ophthalmic	OPHARM LTDA.	2020-08-27	Not applicable
OFTAMYCIN-DX %0.3 + %0.1 STERİL GÖZ DAMLASI, ÇÖZELTİ, 5 ML 1 ADET	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution / drops	Ophthalmic	Deva Holding A.S.	2018-01-23	Not applicable
OMEGTAMINE	Dexamethasone (0.5 mg) + Dexchlorpheniramine maleate (2 mg)	Tablet		Mutiara Mukti Farma	2017-10-26	2027-06-10
ONYCOS®	Dexamethasone (0.04 g) + Clotrimazole (1 g) + Neomycin (0.5 g)	Cream	Topical	COLOMPACK S.A.	2017-12-13	Not applicable
OPHTHABRACIN-D UNGUENTO	Dexamethasone (0.1 g) + Tobramycin (0.3 g)	Ointment	Ophthalmic	ARBOFARMA S.A.S.	2018-08-14	2020-03-13
OPHTHABRACIND SOLUCIÓN OFTALMICA	Dexamethasone sodium phosphate (1 mg) + Tobramycin sulfate (3 mg)	Solution	Ophthalmic	ARBOFARMA S.A.S.	2007-03-29	2021-10-01
OQ-CORT®	Dexamethasone (1 mg) + Ciprofloxacin hydrochloride (3 mg)	Suspension	Conjunctival; Ophthalmic	ARBOFARMA S.A.S.	2010-06-28	Not applicable
OTOFAST®	Dexamethasone (1 mg) + Ciprofloxacin hydrochloride (3 mg)	Suspension	Auricular (otic)	ARBOFARMA S.A.S.	2010-06-10	2017-02-22
POLIMIXINA B SULFATO 6.600 UI/ML. NEOMICINA SULFATO 3.5 MG/ML. DEXAMETASONA SODIO FOSFATO 1.3 MG/ML. SOLUCIÓN OFTÁLMICA ESTÉRIL.	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	OPHARM LTDA.	2022-08-08	Not applicable
POLIOFTAL® SOLUCION OFTALMICA	Dexamethasone sodium phosphate (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6000 IU)	Solution	Ophthalmic	SANIGGI S.A.S.	2006-11-10	2016-03-08
PYRADEC	Dexamethasone (0.5 mg) + Dexchlorpheniramine maleate (2 mg)	Tablet		Pyridam Farma Tbk	2017-01-16	2027-01-16
ReadySharp Anesthetics plus Dexamethasone	Dexamethasone sodium phosphate (10 mg/1mL) + Bupivacaine hydrochloride (5 mg/1mL) + Lidocaine hydrochloride (10 mg/1mL)	Kit	Intramuscular; Intravenous	Terrain Pharmaceuticals	2015-12-29	Not applicable
Rheumesser 3 ml - Ampullen	Dexamethasone (3.5 mg/3mL) + Cyanocobalamin (2.5 mg/3mL) + Kebuzone (450 mg/3mL) + Lidocaine (5 mg/3mL) + Salicylamide O-acetic acid (150 mg/3mL)	Injection, solution	Intramuscular	G.L. Pharma Gmb H	1983-08-29	Not applicable
Sandoz Ciprofloxacin / Dexamethasone	Dexamethasone (0.1 % w/v) + Ciprofloxacin hydrochloride (0.3 % w/v)	Suspension	Auricular (otic)	Sandoz Canada Incorporated	2021-01-26	Not applicable
Sandoz Tobramycin / Dexamethasone	Dexamethasone (0.1 % w/v) + Tobramycin (0.3 % w/v)	Suspension	Ophthalmic	Sandoz Canada Incorporated	Not applicable	Not applicable
Sandoz Tobramycin / Dexamethasone	Dexamethasone (0.1 % w/w) + Tobramycin (0.3 % w/w)	Ointment	Ophthalmic	Sandoz Canada Incorporated	Not applicable	Not applicable
SEVETRON® SOLUCION OFTALMICA ESTERIL	Dexamethasone (1.3 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	Laboratorios Incobra S.A.	2021-06-23	2022-09-30
SIPROGUT PLUS %0.3 + %0.1 KULAK DAMLASI, ÇÖZELTİ, 5 ML	Dexamethasone (0.1 %) + Ciprofloxacin hydrochloride (0.3 %)	Solution / drops	Auricular (otic)	BİLİM İLAÇ SAN. VE TİC. A.Ş.	2015-04-15	Not applicable
Sofracort Ear/eye Ointment	Dexamethasone (0.5 mg / g) + Framycetin sulfate (5 mg / g) + Gramicidin D (0.05 mg / g)	Ointment	Auricular (otic); Ophthalmic	Roussel Canada Inc.	1966-12-31	1996-09-09
Sofracort Sterile Ear/eye Ointment	Dexamethasone (0.5 mg / g) + Framycetin sulfate (5 mg / g) + Gramicidin D (0.05 mg / g)	Ointment	Topical	Hoechst Roussel Canada Inc.	1966-12-31	2001-07-20
Sofracort Sterile Ear/eye Ointment	Dexamethasone (0.5 mg / g) + Framycetin sulfate (5 mg / g) + Gramicidin D (0.05 mg / g)	Ointment	Auricular (otic); Ophthalmic	Aventis Pharma Ltd.	1999-10-25	2006-07-28
SOPHIXIN DX OFTENO	Dexamethasone (1 mg) + Ciprofloxacin hydrochloride (3 mg)	Solution	Ophthalmic	LABORATORIOS SOPHIA DE COLOMBIA L.T.D.A.	2017-11-03	Not applicable
SYVIOFTAL® SOLUCIÓN OFTÁLMICA	Dexamethasone sodium phosphate (1 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	OPHARM LTDA.	2018-11-08	2019-12-11
Taro-ciprofloxacin/dexamethasone	Dexamethasone (0.1 % w/v) + Ciprofloxacin hydrochloride (0.3 % w/v)	Suspension	Auricular (otic)	Taro Pharmaceuticals, Inc.	2020-11-23	Not applicable
TOBRACORT 0.3%	Dexamethasone (1 mg) + Tobramycin (3 mg)	Suspension	Ophthalmic	PHARMAYECT S.A.	2006-11-10	2012-02-29
TobraDex	Dexamethasone (1 mg/1g) + Tobramycin (3 mg/1g)	Ointment	Ophthalmic	A S Medication Solutions	1988-10-15	Not applicable
TOBRADEX	Dexamethasone (1 MG/1G) + Tobramycin (3 MG/1G)	Ointment	Ophthalmic	บริษัท โนวาร์ตีส (ประเทศไทย) จำกัด	2018-04-30	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	ALCON LABORATORIES, INC.	1988-09-15	2023-08-31
TobraDex	Dexamethasone (0.1 % w/v) + Tobramycin (0.3 % w/v)	Suspension	Ophthalmic	Novartis	1990-12-31	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	1988-09-15	2017-01-31
TobraDex	Dexamethasone (1 mg/1g) + Tobramycin (3 mg/1g)	Ointment	Ophthalmic	Rebel Distributors	1988-09-28	Not applicable
TobraDex	Dexamethasone (1 mg/1g) + Tobramycin (3 mg/1g)	Ointment	Ophthalmic	Novartis Pharmaceuticals Corporation	1988-10-15	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension	Ophthalmic	A S Medication Solutions	1988-09-15	Not applicable
TOBRADEX	Dexamethasone (1 MG/1ML) + Tobramycin (3 MG/1ML)	Suspension / drops	Ophthalmic	บริษัท โนวาร์ตีส (ประเทศไทย) จำกัด	2017-09-08	Not applicable
TobraDex	Dexamethasone (1 mg/1g) + Tobramycin (3 mg/1g)	Ointment	Ophthalmic	Physicians Total Care, Inc.	1988-10-15	2010-06-30
TobraDex	Dexamethasone (1 mg/1g) + Tobramycin (3 mg/1g)	Ointment	Ophthalmic	ALCON LABORATORIES, INC.	1988-10-15	2022-06-30
TobraDex	Dexamethasone (0.1 % w/w) + Tobramycin (0.3 % w/w)	Ointment	Ophthalmic	Novartis	1990-12-31	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension	Ophthalmic	A S Medication Solutions	1988-09-15	Not applicable
Tobradex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension	Ophthalmic	Stat Rx USA	1988-09-15	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension	Ophthalmic	Rebel Distributors	1988-08-18	Not applicable
TobraDex	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Novartis Pharmaceuticals Corporation	1988-09-15	Not applicable
TOBRADEX ® UNGUENTO OFTÁLMICO ESTERIL	Dexamethasone (0.1 g) + Tobramycin (0.3 g)	Ointment	Conjunctival; Ophthalmic	ALCON-COUVREUR NV	2006-11-10	1900-01-01
TOBRADEX ® UNGUENTO OFTÁLMICO ESTERIL	Dexamethasone (0.1 g) + Tobramycin (0.3 g)	Ointment	Conjunctival; Ophthalmic	ALCON-COUVREUR NV	2006-11-10	Not applicable
TOBRADEX % 0,3 + % 0,1 STERİL GÖZ DAMLASI, SÜSPANSİYON	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Ointment	Ophthalmic	NOVARTİS SAĞLIK GIDA VE TARIM ÜRÜNLERİ SAN. VE TİC. A.Ş.	2017-09-29	2024-01-17
Tobradex Augensalbe	Dexamethasone (1 mg) + Tobramycin (3 mg)	Ointment	Ophthalmic	Novartis Pharma Gmb H	1998-06-19	Not applicable
Tobradex Augentropfen	Dexamethasone (1 mg) + Tobramycin (3 mg)	Solution / drops	Ophthalmic	Novartis Pharma Gmb H	1998-06-20	Not applicable
TOBRADEX OPHTHALMIC OINTMENT	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Ointment	Ophthalmic	NOVARTIS (SINGAPORE) PTE LTD	1990-04-16	Not applicable
Tobradex ST	Dexamethasone (0.5 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	ALCON LABORATORIES, INC.	2010-09-07	2021-06-30
Tobradex ST	Dexamethasone (0.5 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Eyevance Pharmaceuticals, LLC	2021-05-19	Not applicable
TOBRADEX STERILE OPHTHALMIC SUSPENSION	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Solution	Ophthalmic	NOVARTIS (SINGAPORE) PTE LTD	1990-05-21	Not applicable
TOBRADEX SUSPENSION	Dexamethasone (1 mg) + Tobramycin (3 mg)	Suspension	Conjunctival; Ophthalmic	N.V ALCON COUVREUR S.A DE BELGICA	2006-11-10	Not applicable
TOBRAMISONASUSPENSION OFTALMICAESTERIL	Dexamethasone (1 mg) + Tobramycin (3 mg)	Suspension	Ophthalmic	TECNOFAR TQ S.A.S	2006-11-10	2018-06-27
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1999-10-27	2019-12-31
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Advanced Rx Pharmacy of Tennessee, LLC	2023-11-02	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1.0 mg/1mL) + Tobramycin (3.0 mg/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Amneal Pharmaceuticals NY LLC	2021-07-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	bryant ranch prepack	2022-03-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Remedy Repack	2013-06-03	2014-06-03
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension	Ophthalmic	H.J. Harkins Company	2009-01-02	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Padagis US LLC	2022-03-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	REMEDYREPACK INC.	2024-01-24	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Physicians Total Care, Inc.	2011-07-25	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Bausch & Lomb Incorporated	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Preferred Pharmaceuticals Inc.	2016-08-09	2019-04-04
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Sandoz Inc	2009-01-02	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Quality Care Products, LLC	2021-07-08	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	2009-01-02	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Amneal Pharmaceuticals NY LLC	2021-07-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	bryant ranch prepack	2022-03-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Rebel Distributors	1988-08-18	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	2009-01-02	2017-11-21
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Nucare Pharmaceuticals,inc.	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1.0 mg/1mL) + Tobramycin (3.0 mg/1mL)	Suspension / drops	Ophthalmic	A-S Medication Solutions	1999-10-27	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	NuCare Pharmaceuticasl,Inc.	2022-03-17	Not applicable
Tobramycin and dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Advanced Rx Pharmacy of Tennessee, LLC	2023-02-15	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	Amneal Pharmaceuticals NY LLC	2021-07-17	Not applicable
Tobramycin and Dexamethasone	Dexamethasone (1 mg/1mL) + Tobramycin (3 mg/1mL)	Suspension / drops	Ophthalmic	bryant ranch prepack	2022-03-17	Not applicable
TOBRAZON %0.3 + %0.1 GÖZ DAMLASI, SÜSPANSİYON, 1 ADET	Dexamethasone (0.1 %) + Tobramycin (0.3 %)	Suspension / drops	Ophthalmic	VEM İLAÇ SAN. VE TİC. A.Ş.	2020-02-26	Not applicable
TOBROPTIC® COMPUESTO SUSPENSIÓN OFTÁLMICA	Dexamethasone (1 mg) + Tobramycin (3 mg)	Suspension	Conjunctival; Ophthalmic	SANIGGI S.A.S.	2010-08-18	Not applicable
TopiDex	Dexamethasone sodium phosphate (10 mg/1mL) + Isopropyl alcohol (0.7 mL/1mL) + Povidone-iodine (10 mg/1mL)	Kit	Intramuscular; Intravenous; Topical	Topicare Management, Llc	2018-04-16	Not applicable
TOR CREMA DERMATOLOGICA	Dexamethasone sodium phosphate (0.04 g) + Clotrimazole (1 g) + Neomycin sulfate (0.5 g)	Cream	Topical	COLOMPACK S.A.	2007-03-24	Not applicable
TORCREMA PROCTOLOGICA	Dexamethasone sodium phosphate (0.1 g) + Lidocaine (2 g)	Cream	Rectal; Topical	COLOMPACK S.A.	2007-12-01	Not applicable
TQ OFTAMOX D UD®	Dexamethasone (1 mg) + Moxifloxacin (5 mg)	Solution	Conjunctival; Ophthalmic	TECNOFAR TQ S.A.S	2011-06-23	2017-03-28
TQ OFTAMOX® D UD	Dexamethasone (1 mg) + Moxifloxacin (5 mg)	Solution	Ophthalmic	TECNOFAR TQ S.A.S.	2019-10-11	2020-05-29
TQ TOBRAOFTAL D® SUSPENSION OFTALMICA ESTERIL	Dexamethasone (1 mg) + Tobramycin (3 mg)	Suspension	Ophthalmic	TECNOFAR TQ S.A.S	2007-10-09	Not applicable
TREEVER- OFT SOLUCION OFTALMICA	Dexamethasone sodium phosphate (1 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6600 IU)	Solution	Ophthalmic	ARBOFARMA S.A.S.	2017-12-14	2018-11-15
TRICOREX CREMA	Dexamethasone (0.04 %) + Clotrimazole (1 %) + Neomycin sulfate (0.5 %)	Cream	Topical	COASPHARMA S.A.S.	2018-06-22	Not applicable
TRIMAZOL® SUSPENSIÓN OFTALMICA	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6 IU)	Suspension	Ophthalmic	COASPHARMA S.A.S.	2018-04-19	Not applicable
TRINSICON® CREMA TOPICA	Dexamethasone (0.04 g) + Clotrimazole (1 g) + Neomycin (0.5 g)	Cream	Topical	COASPHARMA S.A.S.	2016-05-16	2021-12-02
TRIVISIOL SOLUCION OFTALMICA	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B (6.6 IU)	Solution	Ophthalmic	OPHARM LTDA	2008-12-11	2020-06-23
Uromont - Emulsion	Dexamethasone (0.4 mg) + Lidocaine hydrochloride (20 mg)	Emulsion	Urethral	Pharmazeutische Fabrik Montavit Gmb H	1979-10-10	Not applicable
VIGADEXA	Dexamethasone (1 MG/1ML) + Moxifloxacin (5 MG/1ML)	Solution / drops	Ophthalmic	บริษัท โนวาร์ตีส (ประเทศไทย) จำกัด	2017-11-07	Not applicable
VISODEX OFT®	Dexamethasone (1 mg) + Naphazoline hydrochloride (0.12 mg)	Solution	Ophthalmic	Laboratorios Incobra S.A.	2021-08-27	Not applicable
VITATRIOL (NEOMICINA 3.5 MG + POLIMIXINA B SULFATO 6000 U.I. + DEXAMETASONA 1 MG)/1ML	Dexamethasone (1 mg) + Neomycin sulfate (3.5 mg) + Polymyxin B sulfate (6000 IU)	Suspension	Conjunctival; Ophthalmic	VITALIS S.A. C.I. PLANTA 8	2008-10-01	2018-06-15
VITATRIOL® UNGÜENTO OFTALMICO	Dexamethasone (1 g) + Dexamethasone (0.1 g) + Neomycin sulfate (0.35 g) + Polymyxin B (600000 IU)	Ointment	Ophthalmic	ARBOFARMA S.A.S.	2013-05-16	Not applicable
VITATRIOL® UNGÜENTO OFTALMICO	Dexamethasone (1 g) + Dexamethasone (0.1 g) + Neomycin sulfate (0.35 g) + Polymyxin B (600000 IU)	Ointment	Ophthalmic	ARBOFARMA S.A.S.	2013-05-16	Not applicable
WASSERTROL® SUSPENSION OFTALMICA	Dexamethasone (1 mg) + Neomycin (3.5 mg) + Polymyxin B sulfate (6000 IU)	Suspension	Conjunctival; Ophthalmic	TECNOFAR TQ S.A.S	2006-11-10	Not applicable
WASSERTROL® UNGUENTO OFTALMICO	Dexamethasone (0.1 g) + Neomycin (0.35 g) + Polymyxin B sulfate (600000 IU)	Ointment	Conjunctival; Ophthalmic	TECNOFAR TQ S.A.S	2007-01-29	Not applicable
คาเด๊กซิน-เอ็น	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท ไทยนครพัฒนา จำกัด	1986-02-11	Not applicable
ซีดี - อ๊อฟ ยาหยอดตา	Dexamethasone sodium phosphate (1 MG/1ML) + Chloramphenicol (5 MG/1ML) + Tetrahydrozoline hydrochloride (0.25 MG/1ML)	Liquid	Ophthalmic	บริษัท แสงไทยกำปะนี จำกัด	2000-03-14	Not applicable
ทรานคาล	Dexamethasone (0.5 MG) + Cyanocobalamin (100 MCG) + Indomethacin (25 MG) + Magnesium trisilicate (100 MG) + Pyridoxine (25 MG) + Thiamine (50 MG)	Capsule		บริษัท พอนด์ เคมีคอล จำกัด	2017-11-07	2020-09-01
นิวเด็กซ์	Dexamethasone (5 MG/1G) + Neomycin (5 MG/1G)	Cream	Topical	บริษัท เอเชี่ยนยูเนี่ยนแล็บบอราตอรี่ จำกัด จำกัด	1988-01-13	Not applicable
นีโอเด๊กซ์ ครีม	Dexamethasone (0.05 G/100G) + Neomycin (0.33 G/100G)	Cream	Topical	บริษัท โอสถ อินเตอร์ แลบบอราทอรีส์ จำกัด จำกัด	1988-07-14	Not applicable
ยาหยอดตา หู ออฟซ่าร์เด็กซ์	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท ไทย พี ดี เคมีคอล จำกัด จำกัด	1988-11-13	Not applicable
อายเด็กซ์	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท สยามเภสัช จำกัด	1985-10-23	Not applicable
อาร์คีเด็กซ์	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic)	บริษัท ที.พี.ดรัก แลบบอราทอรี่ส์ (1969) จำกัด	1998-03-05	Not applicable
เด๊ก - อ๊อฟ แคลร์	Dexamethasone sodium phosphate (4 MG/4ML) + Neomycin sulfate (14 MG/4ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท ยูเมด้า จำกัด	2005-09-03	2020-08-23
เด๊ก ซอฟ ยาหยอดตา-หู	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท แสงไทยกำปะนี จำกัด	1984-11-04	Not applicable
เด็กซาซิน ยาหยอดตาและหู	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (3.5 MG/1ML)	Solution / drops	Auricular (otic); Ophthalmic	บริษัท เอ.เอ็น.บี.ลาบอราตอรี่ (อำนวยเภสัช) จำกัด จำกัด	2017-05-04	2020-08-17
เด๊กซิน ครีม	Dexamethasone (0.05 G/100G) + Neomycin (0.33 G/100G)	Cream	Topical	บริษัท ฟาร์สเป็ค จำกัด จำกัด	1998-08-10	Not applicable
เด๊กซ์ไซลิน	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท เยนเนอร์ราลดรั๊กส์เฮ้าส์ จำกัด	1987-04-23	Not applicable
เวสอ็อฟ (ยาหยอดตา - หู)	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Auricular (otic); Ophthalmic	บริษัท เวสโก ฟาร์มาซูติคอล จำกัด	2005-08-27	Not applicable
โรต้าเด็กซ์	Dexamethasone sodium phosphate (1 MG/1ML) + Neomycin sulfate (5 MG/1ML)	Liquid	Ophthalmic	บริษัท โรต้าลาบอเร็ทตอรี่ส์ จำกัด จำกัด	2011-07-28	Not applicable

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Dex-Moxi	Dexamethasone sodium phosphate (1 mg/1mL) + Moxifloxacin hydrochloride monohydrate (5 mg/1mL)	Injection, solution	Ophthalmic	Imprimis Njof, Llc	2018-01-05	Not applicable
Dex-Moxi PF	Dexamethasone sodium phosphate (1 mg/1mL) + Moxifloxacin hydrochloride monohydrate (5 mg/1mL)	Injection, solution	Intraocular	ImprimisRx NJ	2018-01-01	Not applicable
Dex-Moxi-Ketor	Dexamethasone sodium phosphate (1 mg/1mL) + Ketorolac tromethamine (0.4 mg/1mL) + Moxifloxacin hydrochloride monohydrate (0.5 mg/1mL)	Injection, solution	Ophthalmic	Imprimis Njof, Llc	2018-01-05	Not applicable
Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5%	Dexamethasone sodium phosphate (0.1 g/100g) + Finasteride (0.1 g/100g) + Minoxidil (5 g/100g)	Solution	Topical	Sincerus Florida, LLC	2019-05-09	Not applicable
Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% / Tretinoin 0.025%	Dexamethasone sodium phosphate (0.1 g/100g) + Finasteride (0.1 g/100g) + Minoxidil (5 g/100g) + Tretinoin (0.025 g/100g)	Solution	Topical	Sincerus Florida	2019-05-09	Not applicable
Dexlido Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Lidocaine hydrochloride (10 mg/1mL) + Povidone-iodine (10 mg/1mL)	Kit	Infiltration; Intramuscular; Intravenous; Topical	Asclemed Usa, Inc.	2014-07-25	Not applicable
Dexlido-M Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Bupivacaine hydrochloride (2.5 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Lidocaine hydrochloride (10 mg/1mL) + Povidone-iodine (10 mg/1mL)	Kit	Epidural; Infiltration; Intramuscular; Intravenous; Topical	Asclemed Usa, Inc.	2014-07-25	Not applicable
DexMoxiKetor PF	Dexamethasone sodium phosphate (1 mg/1mL) + Ketorolac tromethamine (0.4 mg/1mL) + Moxifloxacin hydrochloride monohydrate (0.5 mg/1mL)	Injection, solution	Intraocular	ImprimisRx NJ	2018-01-01	Not applicable
Dexopin	Dexamethasone sodium phosphate (10 mg/1mL) + Povidone-iodine (10 mg/1mL) + Ropivacaine hydrochloride (5 mg/1mL)	Kit	Topical	Asclemed Usa, Inc.	2019-06-10	Not applicable
Dmt Suik	Dexamethasone sodium phosphate (10 mg/1mL)	Injection, solution	Intramuscular; Intravenous	Asclemed Usa, Inc.	2003-05-29	Not applicable
DoubleDex Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Povidone-iodine (10 mg/1mL)	Kit	Intramuscular; Intravenous; Topical	Advanced Rx Pharmacy of Tennessee, LLC	2023-05-12	Not applicable
DoubleDex Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Povidone-iodine (10 mg/1mL)	Kit	Intramuscular; Intravenous; Topical	Asclemed Usa, Inc.	2014-07-25	Not applicable
Gati-Dex	Dexamethasone sodium phosphate (1 mg/1mL) + Gatifloxacin sesquihydrate (5 mg/1mL)	Solution / drops	Ophthalmic	Imprimis Njof, Llc	2018-01-05	2019-02-01
Mardex 25 Kit	Dexamethasone sodium phosphate (10 mg/1mL) + Bupivacaine hydrochloride (2.5 mg/1mL) + Isopropyl alcohol (70 mL/100mL) + Povidone-iodine (10 mg/1mL)	Kit	Epidural; Infiltration; Intramuscular; Intravenous; Topical	Asclemed Usa, Inc.	2014-08-21	Not applicable
NETILDEX GOZ DAMLASI %0,1 DEKSAMETAZON + %0,3 NETILMISIN 0,3 ML × 20 ADET	Dexamethasone (0.1 %) + Netilmicin sulfate (0.3 %)	Solution / drops	Ophthalmic	TEKA TEKNİK CİHAZLAR SAN.VE TİC. A.Ş.	2013-01-29	2022-04-11
NETILDEX GOZ DAMLASI %0,1 DEKSAMETAZON + %0,3 NETILMISIN 5 ML	Dexamethasone (1 mg) + Netilmicin (3 mg)	Solution / drops	Ophthalmic	TEKA TEKNİK CİHAZLAR SAN.VE TİC. A.Ş.	2013-01-29	2022-04-11
Ropidex	Dexamethasone sodium phosphate (10 mg/1mL) + Povidone-iodine (10 mg/1mL) + Ropivacaine hydrochloride (5 mg/1mL)	Kit	Epidural; Infiltration; Intramuscular; Intravenous; Perineural; Topical	Asclemed Usa, Inc.	2019-06-10	Not applicable

Chemical Identifiers

UNII: 7S5I7G3JQL
CAS number: 50-02-2
InChI Key: UREBDLICKHMUKA-CXSFZGCWSA-N
InChI: InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
IUPAC Name: (1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
SMILES: [H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C

References

Synthesis Reference

Fried, J.; US. Patent 2,852.51 1; September 16, 1958; assigned to Olin Mathieson Chemical Corporation. Muller, G., Bardoneschi, R. and Jolly, J.; U.S. Patent 3,007,923; November 7, 1961; assigned to Les Laboratories Francais de Chimiotherapie, France.

General References

Tomlinson ES, Maggs JL, Park BK, Back DJ: Dexamethasone metabolism in vitro: species differences. J Steroid Biochem Mol Biol. 1997 Jul;62(4):345-52. doi: 10.1016/s0960-0760(97)00038-1. [Article]
Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E: Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S94-8. doi: 10.4103/0976-500X.120975. [Article]
Yasir M, Sonthalia S: Corticosteroid Adverse Effects . [Article]
Czock D, Keller F, Rasche FM, Haussler U: Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003. [Article]
Loew D, Schuster O, Graul EH: Dose-dependent pharmacokinetics of dexamethasone. Eur J Clin Pharmacol. 1986;30(2):225-30. doi: 10.1007/bf00614309. [Article]
Spoorenberg SM, Deneer VH, Grutters JC, Pulles AE, Voorn GP, Rijkers GT, Bos WJ, van de Garde EM: Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol. 2014 Jul;78(1):78-83. doi: 10.1111/bcp.12295. [Article]
Diederich S, Hanke B, Oelkers W, Bahr V: Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction. J Clin Endocrinol Metab. 1997 May;82(5):1598-602. [Article]
Diederich S, Hanke B, Burkhardt P, Muller M, Schoneshofer M, Bahr V, Oelkers W: Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man. Steroids. 1998 May-Jun;63(5-6):271-7. doi: 10.1016/s0039-128x(98)00039-7. [Article]
BUNIM JJ, BLACK RL, LUTWAK L, PETERSON RE, WHEDON GD: Studies on dexamethasone, a new synthetic steroid, in rheurheumatoid arthritis: a preliminary report; adrenal cortical, metabolic and early clinical effects. Arthritis Rheum. 1958 Aug;1(4):313-31. doi: 10.1002/art.1780010404. [Article]
Cummings DM, Larijani GE, Conner DP, Ferguson RK, Rocci ML Jr: Characterization of dexamethasone binding in normal and uremic human serum. DICP. 1990 Mar;24(3):229-31. doi: 10.1177/106002809002400301. [Article]
FDA Approved Drug Products: Decadron Dexamethasone Oral Tablet (Discontinued) [Link]
FDA Approved Drug Products: Ciprodex Dexamethasone and Ciprofloxacin Otic Suspension [Link]
FDA Approved Drug Products: Dexamethasone Injection [Link]
FDA Approved Drug Products: Dextenza Dexamethasone Ophthalmic Insert [Link]
FDA Approved Drug Products: Dexycu Dexamethasone Intraocular Suspension [Link]
FDA Approved Drug Products: Hemady Dexamethasone Oral Tablets [Link]
FDA Approved Drug Products: Maxidex Dexamethasone Ophthalmic Suspension [Link]
FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Suspension [Link]
FDA Approved Drug Products: Ozurdex Dexamethasone Intravitreal Implant [Link]
FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Ointment [Link]
FDA Approved Drug Products: Tobradex Tobramycin and Dexamethasone Ophthlamic Suspension [Link]
RECOVERY trial news release: dexamethasone [Link]

External Links

Human Metabolome Database: HMDB0015364
KEGG Drug: D00292
KEGG Compound: C15643
PubChem Compound: 5743
PubChem Substance: 46508930
ChemSpider: 5541
BindingDB: 18207
RxNav: 3264
ChEBI: 41879
ChEMBL: CHEMBL384467
ZINC: ZINC000003875332
Therapeutic Targets Database: DAP000007
PharmGKB: PA449247
Guide to Pharmacology: GtP Drug Page
PDBe Ligand: DEX
RxList: RxList Drug Page
Drugs.com: Drugs.com Drug Page
PDRhealth: PDRhealth Drug Page
Wikipedia: Dexamethasone

PDB Entries

1m2z / 1p93 / 3mne / 3mno / 3mnp / 4uda / 4udc / 6nwk / 6xk0 / 7krj …

show 8 more

FDA label

Download (96 KB)

MSDS

Download (74.8 KB)

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
4	Active Not Recruiting	Basic Science	Critical Limb Ischemia (CLI) / Peripheral Arterial Disease (PAD) / Vascular Diseases	1
4	Active Not Recruiting	Other	ACL Injuries	1
4	Active Not Recruiting	Prevention	Dysphagia	1
4	Active Not Recruiting	Prevention	Postoperative pain	1
4	Active Not Recruiting	Supportive Care	Chemotherapy-Induced Nausea and Vomiting	1
4	Active Not Recruiting	Supportive Care	Shivering	1
4	Active Not Recruiting	Treatment	Anesthesia therapy	1
4	Active Not Recruiting	Treatment	Anterior Cruciate Ligament Injury	1
4	Active Not Recruiting	Treatment	Aqueous Dexamethasone / Inflammatory Cytokine Response / Pharmacokinetics	1
4	Active Not Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Corticosteroids	1
4	Active Not Recruiting	Treatment	Diabetic Macular Edema (DME)	1
4	Active Not Recruiting	Treatment	Inflammatory Responses	1
4	Active Not Recruiting	Treatment	Metastatic Prostate Cancer	1
4	Active Not Recruiting	Treatment	Multiple Myeloma (MM)	2
4	Active Not Recruiting	Treatment	Pain, Radiating	1
4	Active Not Recruiting	Treatment	Pterygium of Both Eyes	1
4	Active Not Recruiting	Treatment	Relapsed/Refractory Multiple Myeloma (RRMM)	1
4	Active Not Recruiting	Treatment	Spinal Canal Stenosis / Spinal Stenosis of Lumbar Region	1
4	Active Not Recruiting	Treatment	Tinnitus	1
4	Completed	Not Available	Pain	1
4	Completed	Not Available	Postoperative pain	1
4	Completed	Basic Science	Acute Pain / Analgesia / Upper Extremity Injuries	1
4	Completed	Basic Science	Cataracts	1
4	Completed	Basic Science	Insulin Secretion	1
4	Completed	Basic Science	Ovarian Cancer	1
4	Completed	Basic Science	Premature Births	1
4	Completed	Diagnostic	Allergic Conjunctivitis (AC)	1
4	Completed	Health Services Research	Bronchiolitis	1
4	Completed	Other	Lung Cancer	1
4	Completed	Other	Pain / Shoulder Arthroscopy	1
4	Completed	Other	Systemic Inflammatory Response Syndrome (SIRS)	1
4	Completed	Prevention	Acute Leukemic Patients in Children	1
4	Completed	Prevention	Arthrosis, Unspecified, Ankle and Foot	1
4	Completed	Prevention	Bone Fractures / Morphine Adverse Reaction / Post Operative Nausea and Vomiting (PONV) / Pruritus / Satisfaction, Personal	1
4	Completed	Prevention	Chemotherapy-Induced Nausea and Vomiting	1
4	Completed	Prevention	Children / Postoperative pain	1
4	Completed	Prevention	Chronic Obstructive Pulmonary Disease (COPD)	2
4	Completed	Prevention	Cystoid Macular Edema Following Cataract Surgery	1
4	Completed	Prevention	Disk, Herniated / Radiculopathy, Cervical / Spondylosis, Cervical	1
4	Completed	Prevention	Dry Eye Syndrome (DES)	1
4	Completed	Prevention	Edema	1
4	Completed	Prevention	Edema / Pain / Surgical Site Infections / Trismus	1
4	Completed	Prevention	Endophthalmitis Postoperative	1
4	Completed	Prevention	Foot and Ankle Procedures	1
4	Completed	Prevention	Hypospadias / Postoperative pain	1
4	Completed	Prevention	Hypotension	2
4	Completed	Prevention	Keloids Scars	1
4	Completed	Prevention	Laparoscopic Sleeve Gastrectomy (LSG) / Post Operative Nausea and Vomiting (PONV)	1
4	Completed	Prevention	Migraine	2
4	Completed	Prevention	Nausea and vomiting	1
4	Completed	Prevention	Nausea / Neoplasm / Vomiting	1
4	Completed	Prevention	Nausea / Post Operative Nausea and Vomiting (PONV)	1
4	Completed	Prevention	Nausea / Vomiting	2
4	Completed	Prevention	Ototoxicity From Cisplatin Chemotherapy	1
4	Completed	Prevention	Pain Measurement	1
4	Completed	Prevention	Pain / Sore Throat	1
4	Completed	Prevention	Pancreatico-duodenectomy	1
4	Completed	Prevention	POCD - Postoperative Cognitive Dysfunction	1
4	Completed	Prevention	Post Operative Nausea and Vomiting (PONV)	10
4	Completed	Prevention	Post Operative Nausea and Vomiting (PONV) / Postoperative pain	1
4	Completed	Prevention	Post-Craniotomy Headache / Postoperative pain	1
4	Completed	Prevention	Post-operative Pain Management	1
4	Completed	Prevention	Postoperative Complications	1
4	Completed	Prevention	Postoperative pain	1
4	Completed	Prevention	Postoperative pain / Surgical Wounds	1
4	Completed	Prevention	Preterm Delivery	1
4	Completed	Prevention	Shivering	2
4	Completed	Prevention	Sore Throat	1
4	Completed	Prevention	Swelling	1
4	Completed	Prevention	Vomiting	1
4	Completed	Supportive Care	Acute Pain / Analgesia / Upper Extremity Injuries	1
4	Completed	Supportive Care	Anesthesia Intubation Complications / Anesthesia therapy / Anesthetics Adverse Reaction	1
4	Completed	Supportive Care	Ankle Surgery / Foot Surgery	1
4	Completed	Supportive Care	Cancer / Tumor	1
4	Completed	Supportive Care	Caudal epidural block therapy	1
4	Completed	Supportive Care	Collagen Crosslinking / Keratoconus, Unstable / Postoperative pain	1
4	Completed	Supportive Care	Fracture, Ankle	1
4	Completed	Supportive Care	Irreversible Pulpitis (Toothache)	1
4	Completed	Supportive Care	Lip, Cleft	1
4	Completed	Supportive Care	Obstructive Sleep Apnea (OSA)	1
4	Completed	Supportive Care	Pain Management	1
4	Completed	Supportive Care	Post Operative Nausea and Vomiting (PONV)	1
4	Completed	Supportive Care	Postoperative pain	1
4	Completed	Supportive Care	Shoulder Injury	1
4	Completed	Supportive Care	Third Molar Surgery	1
4	Completed	Treatment	Abdominal Surgeries / Patient Controlled Analgesia / Postoperative Analgesia / Postoperative pain	1
4	Completed	Treatment	Acute Lymphoblastic Leukemia (ALL)	4
4	Completed	Treatment	Acute Pain	1
4	Completed	Treatment	Acute Pain / Analgesia / Hip Arthropathy / Postoperative pain	1
4	Completed	Treatment	Acute Pain / Chronic Pain	1
4	Completed	Treatment	Acute Respiratory Distress Syndrome (ARDS)	1
4	Completed	Treatment	Acute Respiratory Distress Syndrome (ARDS) / Coronavirus Disease 2019 (COVID‑19)	1
4	Completed	Treatment	Age - Related Macular Degeneration (AMD)	1
4	Completed	Treatment	Ambulatory Surgical Procedures / Brachial Plexus Blockade / Postoperative pain / Shoulder Joint Disorder	1
4	Completed	Treatment	Anaesthetics Gases, Xenon / Anaesthetics Volatile, Sevoflurane / Depth of Anaesthesia / Nausea, Postoperative / Vomiting, Postoperative	1
4	Completed	Treatment	Analgesia	1
4	Completed	Treatment	Analgesia / Brachial Plexus Blockade / Dexamethasone / Intravenous Drug Usage / Shouldersurgery / Time	1
4	Completed	Treatment	Anaplastic Large Cell Lymphoma / Burkitt Lymphoma / Burkitt's Leukemia / Lymphoblastic Lymphoma / Mediastinal Neoplasms	1
4	Completed	Treatment	Ankle Disease / Cerebral Palsy (CP) / Foot Deformities / Foot Diseases	1
4	Completed	Treatment	Anterior chamber inflammation / Corneal defects / Corneal Edema / Corneal Transplant / Eye Pain / Intraocular Pressure (IOP) / Penetrating Keratoplasty	1
4	Completed	Treatment	Anterior Cruciate Ligament Reconstruction / Saphenous Nerve Block	1
4	Completed	Treatment	Arthritis / Impingement Syndrome, Shoulder	1
4	Completed	Treatment	Arthroplasties, Replacement, Knee	1
4	Completed	Treatment	Asthma / Asthma Acute	1
4	Completed	Treatment	Asthma / Reactive Airways Disease (RAD)	1
4	Completed	Treatment	Atrial Fibrillation / Surgery, Cardiac	1
4	Completed	Treatment	Atypical Facial Pain or Atypical Odontalgia / Typical Facial Pain	1
4	Completed	Treatment	Back Pain Lower Back / Stenosis, Spinal	1
4	Completed	Treatment	Bilateral Conjunctivitis (Disorder)	1
4	Completed	Treatment	Blepharokeratoconjunctivitis	1
4	Completed	Treatment	Breast Cancer / Dexamethasone / Glucocorticoid Treatment / Mastectomy / Post Operative Nausea and Vomiting (PONV) / Postoperative Complications / Postoperative pain / Steroid therapy / Systemic Inflammatory Response Syndrome (SIRS)	1
4	Completed	Treatment	Cancer	1
4	Completed	Treatment	Cataract Surgery	1
4	Completed	Treatment	Cataracts	5
4	Completed	Treatment	Cataracts / Cystoid Macular Edema Following Cataract Surgery / Diabetic Macular Edema (DME) / Macular Edema, Cystoid / Vision Disorders	1
4	Completed	Treatment	Cataracts / Ocular Hypertension, Primary Open-angle Glaucoma (POAG)	1
4	Completed	Treatment	Cataracts / Pseudo Exfoliation Syndrome	1
4	Completed	Treatment	Catastrophizing, Pain / Chronic Pain / Opioids Use / Osteoarthritis in the Hip Joint / Perioperative/Postoperative Complications / Post Operative Nausea and Vomiting (PONV) / Postoperative pain / Surgery	1
4	Completed	Treatment	Catastrophizing, Pain / Chronic Pain / Opioids Use / Osteoarthritis of the Knee / Perioperative/Postoperative Complications / Post Operative Nausea and Vomiting (PONV) / Postoperative pain / Surgery	1
4	Completed	Treatment	Childhood Asthma	1
4	Completed	Treatment	Chronic Migraine / Headache	1
4	Completed	Treatment	Colorectal Cancer / Crohn's Disease (CD) / Digestive System Diseases / Gastrointestinal Diseases / Gastrointestinal Tract Cancer / Inflammatory Bowel Diseases (IBD) / Intestinal Diseases / Neuropathic Pain / Pain / Postoperative pain	1
4	Completed	Treatment	Constipation / Narcotics Use / Nausea / Pain	1
4	Completed	Treatment	Coronary Artery Disease (CAD) / Inflammatory Responses	1
4	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19)	2
4	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19) / Corticosteroids	1
4	Completed	Treatment	Croup	1
4	Completed	Treatment	Depressive Symptomatology	1
4	Completed	Treatment	Dexamethasone / Knee Pain Chronic / Total Knee Arthroplasty (TKA)	1
4	Completed	Treatment	Diabetic Macular Edema (DME)	6
4	Completed	Treatment	Diabetic Macular Edema (DME) / Diabetic Retinopathy (DR)	1
4	Completed	Treatment	Diabetic Macular Edema (DME) / Epiretinal Membranes	1
4	Completed	Treatment	Disorder of Shoulder / Postoperative pain	1
4	Completed	Treatment	Dry Eye Syndrome (DES)	2
4	Completed	Treatment	Dry Eye Syndrome (DES) / Keratoconjunctivitis Sicca (KCS)	1
4	Completed	Treatment	Dry Eyes	2
4	Completed	Treatment	Epithelial Defect After Phototherapeutic Keratectomy	1
4	Completed	Treatment	Evaporative Dry Eye / Meibomian Gland Dysfunction (Disorder)	1
4	Completed	Treatment	Graves' Disease	1
4	Completed	Treatment	Hip Dysplasia / Postoperative Complications	1
4	Completed	Treatment	Immune Thrombocytopenia (ITP)	2
4	Completed	Treatment	Impacted Mandibular Third Molar Extraction	1
4	Completed	Treatment	Impacted Third Molar Tooth	1
4	Completed	Treatment	Incomplete Reversal of Neuromuscular Block	1
4	Completed	Treatment	Inflammation	1
4	Completed	Treatment	Inflammatory Responses / Intestinal Obstruction and Ileus / Pathophysiology / Perforated Viscus / Sepsis	1
4	Completed	Treatment	Instability of Lumbar Spine / Lumbar Spine Disc Herniation / Spinal Stenosis of Lumbar Region / Spondylolisthesis, Lumbar Region	1
4	Completed	Treatment	Intraocular Pressure (IOP)	1
4	Completed	Treatment	Knee Arthropathy	1
4	Completed	Treatment	Laparoscopy / Post Operative Nausea and Vomiting (PONV)	1
4	Completed	Treatment	Leukemia, Lymphocytic, Acute, Adult	6
4	Completed	Treatment	Local Anaesthesia therapy	3
4	Completed	Treatment	Lower Limb Injuries / Postoperative pain	1
4	Completed	Treatment	Lung Cancer	1
4	Completed	Treatment	Lymphoblastic Lymphoma	1
4	Completed	Treatment	Macular Edema Caused by Retinal Vein Occlusion	1
4	Completed	Treatment	Macular Edema / Retinal Vein Occlusion	3
4	Completed	Treatment	Macular Edema / Uveitis	1
4	Completed	Treatment	Migraine	1
4	Completed	Treatment	Modified Radical Mastectomy	1
4	Completed	Treatment	Multiple Myeloma (MM)	1
4	Completed	Treatment	Nasal Surgery	1
4	Completed	Treatment	Nausea / Vomiting	2
4	Completed	Treatment	Nerve Block / Pain / Total Knee Arthroplasty (TKA)	1
4	Completed	Treatment	Nerve Block / Postoperative pain	1
4	Completed	Treatment	Nerve Block / Shouldersurgery	1
4	Completed	Treatment	Ocular Hypertension / Open Angle Glaucoma (OAG)	1
4	Completed	Treatment	Ocular Inflammation	1
4	Completed	Treatment	Open Angle Glaucoma (OAG)	1
4	Completed	Treatment	Ophthalmopathy , Lacrimal System	1
4	Completed	Treatment	Opioid Use, Unspecified	1
4	Completed	Treatment	Opioids Use / Postoperative pain	1
4	Completed	Treatment	Osteoarthritis (OA)	1
4	Completed	Treatment	Osteoarthritis in the Hip Joint	1
4	Completed	Treatment	Osteoarthritis of the Knee	2
4	Completed	Treatment	Osteoarthritis of the Knee / Perioperative/Postoperative Complications / Post Operative Nausea and Vomiting (PONV) / Postoperative pain / Surgery	1
4	Completed	Treatment	Osteoarthritis of the Shoulder / Pain Management / Postoperative pain / Total Shoulder Arthroplasty	1
4	Completed	Treatment	Pain	1
4	Completed	Treatment	Pain / Peripheral Nerve Blocks	1
4	Completed	Treatment	Pain / Postoperative	1
4	Completed	Treatment	Pain / Pterygium	1
4	Completed	Treatment	Pain / Shoulder Arthroscopy	1
4	Completed	Treatment	Pain / Tonsillitis	1
4	Completed	Treatment	Pediatric Post-tonsillectomy Pain	1
4	Completed	Treatment	Perioperative Pain	1
4	Completed	Treatment	Peripheral Arterial Disease (PAD)	1
4	Completed	Treatment	Post Operative Nausea and Vomiting (PONV)	1
4	Completed	Treatment	Post procedural infection	1
4	Completed	Treatment	Post Traumatic Stress Disorder (PTSD)	1
4	Completed	Treatment	Posterior Uveitis / Uveitis, Intermediate	1
4	Completed	Treatment	Postoperative Analgesia / Postoperative Complications	1
4	Completed	Treatment	Postoperative Complications	1
4	Completed	Treatment	Postoperative pain	7
4	Completed	Treatment	Postoperative pain / Rotator Cuff Tears	1
4	Completed	Treatment	Postoperative pain / Urethral Strictures	1
4	Completed	Treatment	Postoperative Sore Throat, Cough, Hoarseness	1
4	Completed	Treatment	Prostate Cancer	1
4	Completed	Treatment	Pterygium	1
4	Completed	Treatment	Radiculopathy, Cervical	1
4	Completed	Treatment	Recession, Gingival	1
4	Completed	Treatment	Recurrent Pterygium of Eye / Steroid Induced Glaucoma	1
4	Completed	Treatment	Relapsed/Refractory Multiple Myeloma (RRMM)	1
4	Completed	Treatment	Retinal Vein Occlusion	1
4	Completed	Treatment	Rotator Cuff Tears / Shoulder Pain	1
4	Completed	Treatment	Rupture of Anterior Cruciate Ligament	1
4	Completed	Treatment	Shoulder Pain	1
4	Completed	Treatment	Sjögren's Syndrome (SS)	1
4	Completed	Treatment	Stage I Breast Cancer / Syndrome Pain	1
4	Completed	Treatment	Stiffness Following Total Knee Arthroplasty	1
4	Completed	Treatment	Temporomandibular Disorders (TMD)	1
4	Completed	Treatment	Total Knee Arthroplasty (TKA)	1
4	Completed	Treatment	Trigger Finger Disorder	1
4	Completed	Treatment	Vernal Keratoconjunctivitis	1
4	Completed	Treatment	Video-assisted Thoracoscopic Surgery (VATS)	1
4	Completed	Treatment	Viral Bronchiolitis	1
4	Completed	Treatment	Vital Pulp Therapy	1
4	Completed	Treatment	Vitreoretinal Surgery	1
4	Enrolling by Invitation	Prevention	Ocular Inflammation / Postoperative Inflammatory Response / Postoperative pain / Vitreoretinal Surgery	1
4	Enrolling by Invitation	Treatment	ACL / Postoperative pain	1
4	Enrolling by Invitation	Treatment	Cataracts	1
4	Enrolling by Invitation	Treatment	Orthopedic Surgery	1
4	Not Yet Recruiting	Prevention	Abdominal Aortic Aneurysm (AAA) / Dexamethasone / Endovascular Aneurysm Repair / Postimplantation syndrome	1
4	Not Yet Recruiting	Prevention	Breast Cancer	1
4	Not Yet Recruiting	Prevention	C08.381.840.500.475 / C08.381.840.500.737	1
4	Not Yet Recruiting	Prevention	Caesarean Sections / Spinal Anesthesia therapy	1
4	Not Yet Recruiting	Prevention	Complications; Cesarean Section / Post Operative Nausea and Vomiting (PONV) / Spinal Epidrual	1
4	Not Yet Recruiting	Supportive Care	Ocular Disease Requiring Surgery	1
4	Not Yet Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / Lymphoblastic Lymphoma / Mixed Phenotype Acute Leukemia (MPAL)	1
4	Not Yet Recruiting	Treatment	Adolescent Idiopathic Scoliosis (AIS) / Neuromuscular Scoliosis	1
4	Not Yet Recruiting	Treatment	Ankle Disease / Ankle Injuries and Disorders / Foot Diseases / Injuries, Foot	1
4	Not Yet Recruiting	Treatment	Ankle Injuries and Disorders / Foot Injuries and Disorders	1
4	Not Yet Recruiting	Treatment	Bronchiectasis With Acute Exacerbation	1
4	Not Yet Recruiting	Treatment	Cancer	1
4	Not Yet Recruiting	Treatment	Cataracts	2
4	Not Yet Recruiting	Treatment	Clinically Significant Macular Edema Due to Diabetes Mellitus	1
4	Not Yet Recruiting	Treatment	Congenital Adrenal Hyperplasia (CAH)	1
4	Not Yet Recruiting	Treatment	Dexamethasone / Dexmedetomidine / Lobectomy / Ropivacaine	1
4	Not Yet Recruiting	Treatment	Dexamethasone / Urologic Endoscopic Surgery	1
4	Not Yet Recruiting	Treatment	Diabetic Cataract / Macula Edema	1
4	Not Yet Recruiting	Treatment	Disc Degeneration / Disc Disease / Fusion of Spine / Spinal Stenosis of Lumbar Region / Surgery	1
4	Not Yet Recruiting	Treatment	Erector Spinae Plane Block / Spine Diseases / Spine Fusion / Stenosis, Spinal	1
4	Not Yet Recruiting	Treatment	Fuchs' Endothelial Dystrophy / Intraocular Pressure (IOP) / Pseudophakic Bullous Keratopathy	1
4	Not Yet Recruiting	Treatment	Glaucoma Following Surgery	1
4	Not Yet Recruiting	Treatment	Hip Arthropathy / Hip Pain Chronic / Osteoarthritis in the Hip Joint	1
4	Not Yet Recruiting	Treatment	Osteoarthritis of the Knee	1
4	Not Yet Recruiting	Treatment	Postoperative pain	2
4	Not Yet Recruiting	Treatment	Spine Fusion	1
4	Not Yet Recruiting	Treatment	Steroid Ophthalmic Insert	1
4	Recruiting	Other	ACL / Anterior Cruciate Ligament Injury	1
4	Recruiting	Other	Acute Pain / Opioids Use	1
4	Recruiting	Other	Allogeneic Granulocyte Donation	1
4	Recruiting	Other	Diabetic Macular Edema (DME)	1
4	Recruiting	Other	Genicular Nerve Block / Opioids Use / Total Knee Replacement Surgery	1
4	Recruiting	Prevention	Analgesia	1
4	Recruiting	Prevention	Asthma / Inflammation	1
4	Recruiting	Prevention	Chemotherapy-Induced Nausea and Vomiting	1
4	Recruiting	Prevention	Deficiency, Vitamin D / Hoarseness / Hypocalcemia / Hypoparathyroidism Postprocedural / Nausea, Postoperative / Postoperative Complications / Postoperative pain	1
4	Recruiting	Prevention	Post Operative Nausea and Vomiting (PONV)	1
4	Recruiting	Prevention	Total Knee Arthroplasty (TKA)	1
4	Recruiting	Supportive Care	Analgesia / Osteoarthritis of the Knee / Postoperative pain	1
4	Recruiting	Supportive Care	Analgesic Effects	1
4	Recruiting	Supportive Care	Chemotherapy-Induced Nausea and Vomiting	1
4	Recruiting	Supportive Care	Complications; Arthroplasty / Osteoarthritis of the Knee / Postoperative pain	1
4	Recruiting	Supportive Care	Complications; Cesarean Section / Postoperative Pain Following Cesarean Section	1
4	Recruiting	Supportive Care	Dexamethasone / Epidural Block / Overall Survivals / Pancreatic Cancer / Surgery	1
4	Recruiting	Supportive Care	Fusion of Spine, Cervical Region	1
4	Recruiting	Supportive Care	Pain Management	1
4	Recruiting	Supportive Care	Tonsillitis	1
4	Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL)	1
4	Recruiting	Treatment	Acute Respiratory Distress Syndrome (ARDS)	1
4	Recruiting	Treatment	Adolescent Idiopathic Scoliosis (AIS)	1
4	Recruiting	Treatment	Age Related Cataracts	1
4	Recruiting	Treatment	Ankle Disease / Foot Diseases / Injuries, Ankle / Injuries, Foot	1
4	Recruiting	Treatment	Anterior chamber inflammation / CME - Cystoid Macular Edema / Corneal defects / Corneal Edema / Corneal Staining / Eye Pain / Visual Outcomes	1
4	Recruiting	Treatment	Arthroplasty, Replacement, Shoulder	1
4	Recruiting	Treatment	B-Cell Non-Hodgkin Lymphoma (NHL) / Burkitt Lymphoma / Diffuse Large B-Cell Lymphoma (DLBCL) / Primary Central Nervous System Lymphoma / Primary Mediastinal Lymphoma	1
4	Recruiting	Treatment	Back Pain Lower Back / Back Pain With Radiation / Radiculopathy, Lumbosacral Region	1
4	Recruiting	Treatment	Carpal Tunnel Syndrome (CTS)	1
4	Recruiting	Treatment	Cataract Surgery	1
4	Recruiting	Treatment	Cataracts	2
4	Recruiting	Treatment	Cataracts / Diabetic Macular Edema (DME)	1
4	Recruiting	Treatment	Children, Only / Glucocorticoid Treatment / Immune Thrombocytopenia (ITP)	1
4	Recruiting	Treatment	Chronic Lymphocytic Thyroiditis / Graves' Disease	1
4	Recruiting	Treatment	Chronic Obstructive Pulmonary Disease (COPD) / Heart Failure	1
4	Recruiting	Treatment	Chronic Pain	1
4	Recruiting	Treatment	Chronic Pain Post-Proceduraal / Post Operative Nausea and Vomiting (PONV) / Postoperative pain	1
4	Recruiting	Treatment	Congenital Adrenal Hyperplasia (CAH)	1
4	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Hypoxemic Acute Respiratory Failure	1
4	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Loss of smell	1
4	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Pandemic, COVID-19	1
4	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Post Operative Nausea and Vomiting (PONV)	1
4	Recruiting	Treatment	Cytokine Storm / Hemophagocytic Lymphohistiocytosis	1
4	Recruiting	Treatment	Descemet Membrane Endothelial Keratoplasty (DMEK) / Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)	1
4	Recruiting	Treatment	Dexamethasone Intravitreal Implant / Diabetic Macular Edema (DME) / Intraoperative Optical Coherence Tomography / Pars Plana Vitrectomy	1
4	Recruiting	Treatment	Dexamethasone / Spinal Anesthesia therapy	1
4	Recruiting	Treatment	Disease Bowel	1
4	Recruiting	Treatment	Dry Eye Syndrome (DES)	1
4	Recruiting	Treatment	Dry Eyes	1
4	Recruiting	Treatment	Epstein Barr Virus Infections	1
4	Recruiting	Treatment	Fabry's Disease	1
4	Recruiting	Treatment	Fracture of Neck of Femur (Hip)	1
4	Recruiting	Treatment	Hand Disease / Hand Injuries and Disorders / Injury, Hand / Wrist Disease / Wrist Injury	1
4	Recruiting	Treatment	Hand Injuries and Disorders / Wrist Disease	1
4	Recruiting	Treatment	Headache / Occipital Nerve Block	1
4	Recruiting	Treatment	Hemophagocytic Syndrome (HPS) / NK/T-cell Lymphoma	1
4	Recruiting	Treatment	Immune Thrombocytopenia (ITP)	1
4	Recruiting	Treatment	Immune Thrombocytopenia Purpura	1
4	Recruiting	Treatment	Liver Cancer	1
4	Recruiting	Treatment	Lumbar Spine Disc Herniation	1
4	Recruiting	Treatment	Macular Pucker / Retinal Edema / Vitrectomy therapy	1
4	Recruiting	Treatment	Multiple Myeloma (MM)	2
4	Recruiting	Treatment	Nasal Septum; Deviation	1
4	Recruiting	Treatment	Osteoarthritis (OA) / Shoulder Impingement / Tendinopathy	1
4	Recruiting	Treatment	Panuveitis / Posterior Uveitis / Uveitis, Intermediate	1
4	Recruiting	Treatment	Post-Traumatic Headaches	1
4	Recruiting	Treatment	Postoperative Analgesia	1
4	Recruiting	Treatment	Postoperative pain	3
4	Recruiting	Treatment	Postoperative Pain, Acute	1
4	Recruiting	Treatment	Primary Central Nervous System Lymphoma	1
4	Recruiting	Treatment	Prostatic Hyperplasia	1
4	Recruiting	Treatment	Radius Fracture Distal	1
4	Recruiting	Treatment	Robotic Lung Surgery	1
4	Recruiting	Treatment	Sacro-Iliac Spondylosis / Sacroiliac Joint Dysfunction	1
4	Recruiting	Treatment	Scoliosis Idiopathic / Scoliosis; Adolescence	1
4	Recruiting	Treatment	Shoulder Arthropathy / Shoulder Pain	1
4	Recruiting	Treatment	Sudden Sensorineural Hearing Loss (SSNHL)	1
4	Recruiting	Treatment	Total Knee Replacement Surgery	1
4	Terminated	Other	Kidney Stones / Surgery	1
4	Terminated	Other	Post Operative Nausea and Vomiting (PONV) / Postoperative pain / Tonsillar Bleeding	1
4	Terminated	Prevention	Anesthesia, Pediatrics, Surgery	1
4	Terminated	Prevention	Delirium / Dexamethasone / Flubiprofen Axetil / Non-Small Cell Lung Carcinoma / Surgical Complications	1
4	Terminated	Prevention	Delirium / POCD - Postoperative Cognitive Dysfunction	1
4	Terminated	Prevention	Neuritis / Radioiodine ablation of thyroid tissue therapy	1
4	Terminated	Prevention	Post Operative Nausea and Vomiting (PONV) / Postoperative pain	1
4	Terminated	Supportive Care	Dexamethasone / Flubiprofen Axetil / Long-Term Effects Secondary to Cancer Therapy in Adults / Non-Small Cell Lung Carcinoma / Surgery	1
4	Terminated	Supportive Care	Head And Neck Cancer / Lung Cancer / Oncologic Complications / Pancreatic Cancer / Poor Nutrition / Quality of Life (QOL)	1
4	Terminated	Supportive Care	Postoperative pain	1
4	Terminated	Supportive Care	Retinal Detachment	1
4	Terminated	Treatment	Abdominal Pain / Nausea	1
4	Terminated	Treatment	Acute Pain / Local Anaesthesia therapy / Osteoarthritis of the Knee / Regional Anesthesia therapy	1
4	Terminated	Treatment	Acute Respiratory Distress Syndrome Caused by COVID-19 / Coronavirus Disease 2019 (COVID‑19)	1
4	Terminated	Treatment	Analgesia Duration	1
4	Terminated	Treatment	Anesthesia therapy / Opioids Use	1
4	Terminated	Treatment	Arthroplasties, Replacement, Knee / Postoperative pain	1
4	Terminated	Treatment	Asthma / Croup	1
4	Terminated	Treatment	Asthma / Status Asthmaticus / Wheezing	1
4	Terminated	Treatment	Calcific Tendinitis	1
4	Terminated	Treatment	Cataracts	1
4	Terminated	Treatment	Cataracts / Glaucoma	1
4	Terminated	Treatment	Community Acquired Pneumonia (CAP)	1
4	Terminated	Treatment	Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus	2
4	Terminated	Treatment	Diabetic Macular Edema (DME)	1
4	Terminated	Treatment	Diabetic Macular Edema (DME) / Neovascular Age-Related Macular Degeneration (nAMD) / Retinal Vein Occlusion	1
4	Terminated	Treatment	Dry Eye Syndrome (DES)	1
4	Terminated	Treatment	Dry Eyes	1
4	Terminated	Treatment	Duration of Pain Relief	1
4	Terminated	Treatment	Elbow Fractures	1
4	Terminated	Treatment	HELLP Syndrome	1
4	Terminated	Treatment	Hematoma, Subdural, Chronic	1
4	Terminated	Treatment	Hip Fracture	1
4	Terminated	Treatment	Inflammation / Osteoarthritis (OA) / Postoperative pain	1
4	Terminated	Treatment	Kidney Diseases / Postoperative Complications	1
4	Terminated	Treatment	Myofascial Pain Syndrome	1
4	Terminated	Treatment	Nausea / Postoperative pain	1
4	Terminated	Treatment	Pain	1
4	Terminated	Treatment	Pericarditis Acute	1
4	Terminated	Treatment	Postoperative pain	4
4	Terminated	Treatment	Sacro-Iliac Spondylosis	1
4	Terminated	Treatment	Surgery	1
4	Terminated	Treatment	Trigger Finger	1
4	Terminated	Treatment	Trigger Finger Disorder	1
4	Terminated	Treatment	Tumor	1
4	Terminated	Treatment	Viral Bronchiolitis	1
4	Unknown Status	Other	Hand Injury Wrist / Peripheral Nerve Block Prolongation	1
4	Unknown Status	Other	Preference, Patient	1
4	Unknown Status	Other	Tonsillectomy	1
4	Unknown Status	Prevention	Hyaline Membrane Disease (HMD) / Necrotizing Enterocolitis of Newborn	1
4	Unknown Status	Prevention	POCD - Postoperative Cognitive Dysfunction	1
4	Unknown Status	Prevention	Post Operative Nausea and Vomiting (PONV)	2
4	Unknown Status	Prevention	Postoperative pain	1
4	Unknown Status	Supportive Care	Impacted Third Molar Tooth	1
4	Unknown Status	Treatment	Acute Lymphoblastic Leukemia (ALL)	2
4	Unknown Status	Treatment	Acute Lymphoblastic Leukemia (ALL) / Non-Hodgkin's Lymphoma (NHL)	1
4	Unknown Status	Treatment	Acute Pain	1
4	Unknown Status	Treatment	Adductor Canal Block / Sciatic Nerve Block / Total Knee Arthroplasty (TKA)	1
4	Unknown Status	Treatment	Arthritis	1
4	Unknown Status	Treatment	Arthritis of the Knee Joint / Nausea, Postoperative / Postoperative pain	1
4	Unknown Status	Treatment	Branch Retinal Vein Occlusion With Macular Edema	1
4	Unknown Status	Treatment	Breast Pain / Effect of Drugs / Local Anaesthesia therapy	1
4	Unknown Status	Treatment	Cancer / Nausea / Vomiting	1
4	Unknown Status	Treatment	Cataract Surgery / Dry Eye Syndrome (DES) / Ocular Surface Disease	1
4	Unknown Status	Treatment	Central Retinal Vein Occlusion (CRVO) / Macular Edema	1
4	Unknown Status	Treatment	Chronic Pain	1
4	Unknown Status	Treatment	Chronic Sinusitis	1
4	Unknown Status	Treatment	Dexamethasone Effect on Induction of Labor	1
4	Unknown Status	Treatment	Dexamethasone / Supraclavicular Brachial Plexus Block	1
4	Unknown Status	Treatment	Diabetes Mellitus / Macular Edema / Retinal Exudates and Deposits	1
4	Unknown Status	Treatment	Diabetic Macular Edema (DME)	1
4	Unknown Status	Treatment	Diabetic Macular Edema (DME) / Diabetic Retinopathy (DR) / Retinal Ischemia	1
4	Unknown Status	Treatment	Diabetic Retinopathy (DR)	1
4	Unknown Status	Treatment	Extranodal NK/T-cell Lymphoma, Nasal Type	1
4	Unknown Status	Treatment	Fracture of Neck of Femur (Hip)	1
4	Unknown Status	Treatment	Glaucoma	1
4	Unknown Status	Treatment	Grade of Post-Operative Cystoid Macular Edema / Patient Outcomes / Postoperative Inflammatory Response / Preference, Patient / Rate of Post-Operative Cystoid Macular Edema	1
4	Unknown Status	Treatment	Immune Thrombocytopenia (ITP)	1
4	Unknown Status	Treatment	Infertility	1
4	Unknown Status	Treatment	Inflammation / Intraocular Pressure (IOP)	1
4	Unknown Status	Treatment	Localized Primary Osteoarthritis of Both Hips (Diagnosis) / Osteoarthritis in the Hip Joint	1
4	Unknown Status	Treatment	Mantle Cell Lymphoma (MCL)	1
4	Unknown Status	Treatment	Medical Induction of Labor Affecting Fetus	1
4	Unknown Status	Treatment	Modified Radical Mastectomy	1
4	Unknown Status	Treatment	Multiple Myeloma (MM)	3
4	Unknown Status	Treatment	Osteoarthritis of the Knee	1
4	Unknown Status	Treatment	Peripheral T-Cell Lymphoma (PTCL)	1
4	Unknown Status	Treatment	Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)	1
4	Unknown Status	Treatment	Post Minimally Invasive Thorascopic Surgical Pain	1
4	Unknown Status	Treatment	Post Operative Nausea and Vomiting (PONV)	2
4	Unknown Status	Treatment	Post Surgical Ocular Inflammation / Post-Surgical Ocular Pain	1
4	Unknown Status	Treatment	Postherpetic Neuralgia	1
4	Unknown Status	Treatment	Postoperative pain	4
4	Unknown Status	Treatment	Refractive Surgery	1
4	Unknown Status	Treatment	Total Knee Replacement Surgery	1
4	Unknown Status	Treatment	Tuberculous Meningitis	1
4	Unknown Status	Treatment	Viral Encephalitis	1
4	Unknown Status	Treatment	Vomiting	2
4	Withdrawn	Not Available	Adrenal Insufficiency	1
4	Withdrawn	Prevention	Premature Births	1
4	Withdrawn	Supportive Care	Diabetes Mellitus	1
4	Withdrawn	Supportive Care	Retinal Detachment	1
4	Withdrawn	Treatment	Analgesia / Analgesics, Opioids / Morphine / Peripheral Nervous System Agents	1
4	Withdrawn	Treatment	Antibody Mediated Rejection / End Stage Renal Disease (ESRD)	1
4	Withdrawn	Treatment	Bronchiolitis Acute	1
4	Withdrawn	Treatment	Corneal Endothelial Decompensation / Dexamethasone Adverse Reaction / Diabetes Mellitus / Endothelial Cell Loss, Corneal	1
4	Withdrawn	Treatment	Graft-versus-host Disease (GVHD)	1
4	Withdrawn	Treatment	Headache	1
4	Withdrawn	Treatment	Immune Thrombocytopenia (ITP)	1
4	Withdrawn	Treatment	Multiple Myeloma (MM)	1
4	Withdrawn	Treatment	Neuromuscular Blockade	1
4	Withdrawn	Treatment	Newly Diagnosed Multiple Myeloma	1
4	Withdrawn	Treatment	Ocular Rosacea	1
4	Withdrawn	Treatment	Osteoarthritis (OA) / Postoperative pain	1
4	Withdrawn	Treatment	Otitis Media (OM) / Otorrhoea	1
4	Withdrawn	Treatment	Otitis Media With Effusion in Children / Otorrhoea	1
4	Withdrawn	Treatment	Pain / Total Knee Arthroplasty (TKA)	1
4	Withdrawn	Treatment	Post-operative Pain Management	1
4	Withdrawn	Treatment	Postoperative pain	1
4	Withdrawn	Treatment	Radiculopathy, Cervical	1
4	Withdrawn	Treatment	Spinal Stenosis of Lumbar Region	1
4	Withdrawn	Treatment	Surgery, Oral	1
3	Active Not Recruiting	Supportive Care	Reproductive neoplasms female malignant and unspecified	1
3	Active Not Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / Acute Undifferentiated Leukemia (AUL) / T-cell Childhood Acute Lymphoblastic Leukemia	1
3	Active Not Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / Adult B Lymphoblastic Lymphoma / Ann Arbor Stage I B Lymphoblastic Lymphoma / Ann Arbor Stage II B Lymphoblastic Lymphoma / B-cell Childhood Acute Lymphoblastic Leukemia / Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 / Childhood B Lymphoblastic Lymphoma / Down Syndrome (DS) / Hypodiploid B Acute Lymphoblastic Leukemia / Philadelphia Chromosome Positive (Ph+)	1
3	Active Not Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative	1
3	Active Not Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / Lymphoblastic Lymphoma	1
3	Active Not Recruiting	Treatment	Acute Lymphoblastic Leukemia, Pediatric	1
3	Active Not Recruiting	Treatment	Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA	1
3	Active Not Recruiting	Treatment	Amyloidosis	1
3	Active Not Recruiting	Treatment	Ann Arbor Stage II Adult Lymphoblastic Lymphoma / Ann Arbor Stage II Childhood Lymphoblastic Lymphoma / Ann Arbor Stage III Adult Lymphoblastic Lymphoma / Ann Arbor Stage III Childhood Lymphoblastic Lymphoma / Ann Arbor Stage IV Adult Lymphoblastic Lymphoma / Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma / T-cell Acute Lymphoblastic Leukemia / T-cell Childhood Acute Lymphoblastic Leukemia	1
3	Active Not Recruiting	Treatment	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like / B-cell Acute Lymphoblastic Leukemia / Central Nervous System Leukemia / Testicular Leukemia	1
3	Active Not Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19)	1
3	Active Not Recruiting	Treatment	Drug Induced Liver Injury / Tuberculosis (TB) / Tuberculous Meningitis	1
3	Active Not Recruiting	Treatment	DS Stage I Multiple Myeloma / DS Stage II Multiple Myeloma / DS Stage III Multiple Myeloma	2
3	Active Not Recruiting	Treatment	Extranodal NK/T-cell Lymphoma, Nasal Type	1
3	Active Not Recruiting	Treatment	Immune Thrombocytopenia (ITP)	1
3	Active Not Recruiting	Treatment	Lymphoblastic Lymphoma	1
3	Active Not Recruiting	Treatment	Multiple Myeloma (MM)	32
3	Active Not Recruiting	Treatment	Multiple Myeloma (MM) / New Diagnosis Tumor	1
3	Active Not Recruiting	Treatment	Multiple Myeloma (MM) / Recurrent or Refractory	1
3	Active Not Recruiting	Treatment	Neuroblastoma (NB) / Opsoclonus Myoclonus Syndrome	1
3	Active Not Recruiting	Treatment	Newly Diagnosed Multiple Myeloma	2
3	Active Not Recruiting	Treatment	Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)	1
3	Active Not Recruiting	Treatment	Plasmacytoma	1
3	Active Not Recruiting	Treatment	Primary Amyloidosis	2
3	Active Not Recruiting	Treatment	Primary Progressive Multiple Sclerosis (PPMS) / Relapsing Multiple Sclerosis (RMS)	1
3	Active Not Recruiting	Treatment	Recurrent B Acute Lymphoblastic Leukemia	1
3	Active Not Recruiting	Treatment	Refractory Multiple Myeloma / Relapsed Multiple Myeloma	1
3	Active Not Recruiting	Treatment	Relapsed Multiple Myeloma	1
3	Active Not Recruiting	Treatment	Relapsed/Refractory Multiple Myeloma (RRMM)	1
3	Active Not Recruiting	Treatment	Solitary Osseous Plasmacytoma	1
3	Active Not Recruiting	Treatment	T-cell Acute Lymphoblastic Leukemia / T-cell Lymphoblastic Lymphoma	1
3	Active Not Recruiting	Treatment	Uterine Fibroids (Leiomyomas)	1
3	Active Not Recruiting	Treatment	Waldenström's Macroglobulinemia (WM)	1
3	Completed	Not Available	Pneumonia	1
3	Completed	Diagnostic	Development	1
3	Completed	Diagnostic	Polycystic Ovarian Syndrome (PCOS)	1
3	Completed	Prevention	Analgesia / Analgesics, Opioids / Anesthesia therapy / Dexmedetomidine / Gabapentin / General Anesthesia / Lidocaine / Narcotics / Obstructive Sleep Apnea of Child / Oximetry, Pulse / Pathologic Processes / Physiologic Effects of Drugs / Postoperative Complications / Respiratory Depression / S-ketamine / Sleep Disordered Breathing (SDB) / Tonsillectomy	1
3	Completed	Prevention	Antiemetics / Cervical Cancer / Chemotherapy-Induced Nausea and Vomiting / Nasopharyngeal Cancer / Radiation-Induced Nausea and Vomiting	1
3	Completed	Prevention	C.Surgical Procedure; Gastrointestinal	1
3	Completed	Prevention	Cataracts	1
3	Completed	Prevention	Cataracts / Diabetes Mellitus / Macular Edema, Cystoid	1
3	Completed	Prevention	Chemotherapy-Induced Nausea and Vomiting	14
3	Completed	Prevention	Chemotherapy-Induced Nausea and Vomiting / Neoplasms, Gastrointestinal	1
3	Completed	Prevention	Complications; Cesarean Section	1
3	Completed	Prevention	Corneal Edema	1
3	Completed	Prevention	Diabetic Macular Edema (DME)	1
3	Completed	Prevention	Drug hypersensitivity reaction	1
3	Completed	Prevention	Dysphagia	1
3	Completed	Prevention	Dysphasia	1
3	Completed	Prevention	Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection / Urinary Tract Infection	1
3	Completed	Prevention	Hernia, Femoral / Inguinal Hernias	1
3	Completed	Prevention	Lung Disorder / Respiratory Distress Syndrome	1
3	Completed	Prevention	Nausea, Postoperative / Postoperative pain / Vomiting, Postoperative	1
3	Completed	Prevention	Nausea / Pediatric Cancer / Vomiting	1
3	Completed	Prevention	Neoplasm	1
3	Completed	Prevention	Pelvic Organ Prolapse (POP) / Post Operative Nausea and Vomiting (PONV)	1
3	Completed	Prevention	Post Operative Nausea and Vomiting (PONV) / Postoperative Fatigue / Postoperative pain	1
3	Completed	Prevention	Postoperative pain	1
3	Completed	Prevention	Postoperative Wound Infection / Surgery, Colon	1
3	Completed	Prevention	Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy	1
3	Completed	Prevention	Renal Failure, Chronic Renal Failure	1
3	Completed	Prevention	Respiratory; Disorder, Functional, Impaired	1
3	Completed	Prevention	Thyroid Gland Diseases / Thyroidectomy	1
3	Completed	Prevention	Vomiting	1
3	Completed	Prevention	Vomiting, Postoperative	1
3	Completed	Supportive Care	Anemia / Fatigue / Prostate Cancer	1
3	Completed	Supportive Care	Brachial Plexus Blockade	1
3	Completed	Supportive Care	Cancer	1
3	Completed	Supportive Care	Chemotherapy-Induced Nausea and Vomiting	2
3	Completed	Supportive Care	Chemotherapy-Induced Nausea and Vomiting / Colorectal Cancer	1
3	Completed	Supportive Care	Chemotherapy-Induced Nausea and Vomiting / Unspecified Adult Solid Tumor, Protocol Specific	1
3	Completed	Supportive Care	Hematopoietic/Lymphoid Cancer / Nausea and vomiting / Unspecified Adult Solid Tumor, Protocol Specific	1
3	Completed	Supportive Care	Laparoscopic Cholecystectomy	1
3	Completed	Supportive Care	Malignant Neoplasm	1
3	Completed	Supportive Care	Malignant Neoplasms of Male Genital Organs	1
3	Completed	Supportive Care	Nausea	1
3	Completed	Supportive Care	Nausea and vomiting / Unspecified Adult Solid Tumor, Protocol Specific	3
3	Completed	Supportive Care	Nausea / Neoplasms of the Female Genitalia / Vomiting	1
3	Completed	Supportive Care	Oral Surgical Procedures	1
3	Completed	Treatment	Abdominal wall neoplasm / Fallopian Tube Neoplasms / Ovarian Neoplasms	1
3	Completed	Treatment	Active, Symptomatic Blepharitis	1
3	Completed	Treatment	Acute Lymphoblastic Leukemia (ALL)	7
3	Completed	Treatment	Acute Lymphoblastic Leukemia (ALL) / B-cell Adult Acute Lymphoblastic Leukemia (ALL) / B-cell Childhood Acute Lymphoblastic Leukemia	2
3	Completed	Treatment	Acute Lymphoblastic Leukemia (ALL) / B-cell Childhood Acute Lymphoblastic Leukemia	1
3	Completed	Treatment	Acute Myeloid Leukemia	1
3	Completed	Treatment	Acute Otitis Externa	3
3	Completed	Treatment	Allergic Conjunctivitis (AC)	1
3	Completed	Treatment	Amyloidosis	1
3	Completed	Treatment	Analgesia / Carcinoma of Unknown Primary / Head And Neck Cancer / Oropharyngeal Cancer / Postoperative pain / Surgery	1
3	Completed	Treatment	Anesthesia therapy / Forearm Injuries / Postoperative pain	1
3	Completed	Treatment	Anesthesia, Conduction	1
3	Completed	Treatment	Anesthesia, Conduction / Axillary Brachial Plexus Block / Dexamethasone / Ropivacaine	1
3	Completed	Treatment	Anterior Uveitis (AU)	2
3	Completed	Treatment	Asthma	2
3	Completed	Treatment	B-cell Childhood Acute Lymphoblastic Leukemia / Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia / L1 Childhood Acute Lymphoblastic Leukemia / L2 Childhood Acute Lymphoblastic Leukemia	1
3	Completed	Treatment	Bleeding / Coronavirus Disease 2019 (COVID‑19) / Thrombosis Embolism	1
3	Completed	Treatment	Blepharitis	2
3	Completed	Treatment	Blepharitis / Conjunctivitis / Keratitis	2
3	Completed	Treatment	Blepharoconjunctivitis	1
3	Completed	Treatment	Bone Metastases	1
3	Completed	Treatment	Brachial Plexus Blockade / Postoperative pain	1
3	Completed	Treatment	Breast Cancer	1
3	Completed	Treatment	Bronchiolitis	1
3	Completed	Treatment	Cancer / Nausea / Vomiting	1
3	Completed	Treatment	Carcinoma / Non Small Cell Lung	1
3	Completed	Treatment	Cardiopulmonary Bypass / Heart Defects,Congenital / Surgery, Cardiac	1
3	Completed	Treatment	Cataract Surgery / Cataracts	1
3	Completed	Treatment	Cataracts	4
3	Completed	Treatment	Cataracts / Inflammation	1
3	Completed	Treatment	Central Retinal Vein Occlusion (CRVO) / Macular Edema / Visual Impairment	1
3	Completed	Treatment	Chemotherapy-Induced Nausea and Vomiting	4
3	Completed	Treatment	Chemotherapy-Induced Nausea and Vomiting / Nausea / Vomiting	1
3	Completed	Treatment	Childhood Acute Erythroleukemia (M6) / Childhood Acute Megakaryocytic Leukemia (M7) / Childhood Acute Monoblastic Leukemia (M5a) / Childhood Acute Monocytic Leukemia (M5b) / Childhood Acute Myeloblastic Leukemia With Maturation (M2) / Childhood Acute Myeloblastic Leukemia Without Maturation (M1) / Childhood Acute Myelomonocytic Leukemia (M4) / Childhood Myelodysplastic Syndromes / Chronic Myelomonocytic Leukemia / Primary Myelodysplastic Syndromes (MDS) / Refractory Anemia / Refractory Anemia With Excess Blasts in Transformation / Refractory Anemia With Excess of Blasts (RAEB) / Refractory Anemia With Ringed Sideroblasts / Secondary Myelodysplastic Syndromes / Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies	1
3	Completed	Treatment	Childhood Acute Lymphoblastic Leukemia in Remission / Recurrent Childhood Acute Lymphoblastic Leukemia	1
3	Completed	Treatment	Childhood Favorable Prognosis Hodgkin Lymphoma / Childhood Lymphocyte Depletion Hodgkin Lymphoma / Childhood Mixed Cellularity Hodgkin Lymphoma / Childhood Nodular Sclerosis Hodgkin Lymphoma / Stage I Childhood Hodgkin Lymphoma / Stage II Childhood Hodgkin Lymphoma	1
3	Completed	Treatment	Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma / Childhood Mixed Cellularity Classical Hodgkin Lymphoma / Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma / Childhood Nodular Sclerosis Classical Hodgkin Lymphoma / Stage I Childhood Hodgkin Lymphoma / Stage II Childhood Hodgkin Lymphoma / Stage III Childhood Hodgkin Lymphoma / Stage IV Childhood Hodgkin Lymphoma	1
3	Completed	Treatment	Chronic Allergic Conjunctivitis	2
3	Completed	Treatment	Chronic Lung Disease of Prematurity	1
3	Completed	Treatment	Chronic Lung Disease of Prematurity / Infants, Premature / Low Birth Weight Infants / Newborn, Infant / Small for Gestational Age Infants	1
3	Completed	Treatment	Chronic Renal Failure With Uremic Nephropathy	1
3	Completed	Treatment	Colles' Fracture / Forearm Wound / Fracture Forearm / Hand Fractures / Hand Wound / Wrist Wound	1
3	Completed	Treatment	Colorectal Cancer / Metastatic Cancer	1
3	Completed	Treatment	Congenital Adrenal Hyperplasia (CAH)	1
3	Completed	Treatment	Conjunctivitis, Viral	1
3	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19)	5
3	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19) / Hypoxia	1
3	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus	1
3	Completed	Treatment	Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) / Viral Pneumonia Human Coronavirus	1
3	Completed	Treatment	Dexamethasone / Pregnancy	1
3	Completed	Treatment	Diabetic Macular Edema (DME)	3
3	Completed	Treatment	Diffuse Large B-Cell Lymphoma (DLBCL)	1
3	Completed	Treatment	Drug Induced Liver Injury / Human Immunodeficiency Virus (HIV) Infections / IRIS / Tuberculosis (TB) / Tuberculous Meningitis	1
3	Completed	Treatment	Drug/Agent Toxicity by Tissue/Organ / Leukemias	1
3	Completed	Treatment	Dry Eyes	1
3	Completed	Treatment	Effects of Chemotherapy / Multiple Myeloma (MM)	1
3	Completed	Treatment	Focal Lipoid Glomerulosclerosis / Nephrosis	1
3	Completed	Treatment	Focal Segmental Glomerulosclerosis (FSGS)	1
3	Completed	Treatment	Glaucoma	1
3	Completed	Treatment	Graft-versus-host Disease (GVHD) / Oral Manifestations	1
3	Completed	Treatment	Headache / Intranasal Ketamine	1
3	Completed	Treatment	Hemophagocytic Lymphohistiocytosis	1
3	Completed	Treatment	Hip Disease	1
3	Completed	Treatment	Human Immunodeficiency Virus (HIV) Infections / Non-Hodgkin's Lymphoma (NHL)	1
3	Completed	Treatment	Immune Thrombocytopenia (ITP)	5
3	Completed	Treatment	Immune Thrombocytopenia (ITP) / Purpura	1
3	Completed	Treatment	Infection / Neutropenia	1
3	Completed	Treatment	Inflammation and Pain Associated With Cataract Surgery	2
3	Completed	Treatment	Inflammatory Macular Edema	1
3	Completed	Treatment	Injuries Related Work / Lateral Epicondylitis	1
3	Completed	Treatment	Injuries:Knee Injuries	1
3	Completed	Treatment	Interaction Between Antiemetic Drugs and Paracetamol	1
3	Completed	Treatment	Kidney Failure / Multiple Myeloma and Plasma Cell Neoplasm	1
3	Completed	Treatment	Leukemias	13
3	Completed	Treatment	Leukemias / Lymphoma	2
3	Completed	Treatment	Leukemias / Myelodysplastic Syndrome	1
3	Completed	Treatment	Light Chain Deposition Disease / Primary Amyloidosis	1
3	Completed	Treatment	Lung Cancer / Metastatic Cancer	1
3	Completed	Treatment	Lymphoma	6
3	Completed	Treatment	Lymphoma / Multiple Myeloma (MM)	1
3	Completed	Treatment	M Protein / Multiple Myeloma (MM) / Myeloma Proteins	1
3	Completed	Treatment	Macular Edema	3
3	Completed	Treatment	Macular Edema / Retinal Vein Occlusion	3
3	Completed	Treatment	Macular Edema / Uveitis	2
3	Completed	Treatment	Major Non-cardiac Surgeries	1
3	Completed	Treatment	Menière's Disease	2
3	Completed	Treatment	Migraine	2
3	Completed	Treatment	Multiple Myeloma (MM)	38
3	Completed	Treatment	Multiple Myeloma (MM) / Plasma Cell Neoplasms	1
3	Completed	Treatment	Multiple Myeloma and Plasma Cell Neoplasm	6
3	Completed	Treatment	Multiple Myeloma de Novo Treatment	1
3	Completed	Treatment	Nausea, Postoperative / Opioids Use / Postoperative pain	1
3	Completed	Treatment	Neoplasms of the Prostate	1
3	Completed	Treatment	Neurocysticercosis	1
3	Completed	Treatment	Non Neoplastic Condition	1
3	Completed	Treatment	Non-Small Cell Lung Carcinoma	3
3	Completed	Treatment	Ocular Inflammation Associated With Blepharaconjunctivitis	1
3	Completed	Treatment	Osteoarthritis of the Knee	1
3	Completed	Treatment	Ovarian Cancer	1
3	Completed	Treatment	Pain	1
3	Completed	Treatment	Patients Undergoing a Lumbar Slipped Disc Surgery	1
3	Completed	Treatment	Perennial Allergic Rhinitis (PAR)	1
3	Completed	Treatment	Post Operative Nausea and Vomiting (PONV)	1
3	Completed	Treatment	Post Surgical Ocular Inflammation and Pain	1
3	Completed	Treatment	Post Surgical Ocular Inflammation / Post-Surgical Ocular Pain	2
3	Completed	Treatment	Post-operative Pain Management	1
3	Completed	Treatment	Postoperative pain	3
3	Completed	Treatment	Primary Amyloidosis	1
3	Completed	Treatment	Prostate Cancer	3
3	Completed	Treatment	Refractory Multiple Myeloma / Relapsed Multiple Myeloma	2
3	Completed	Treatment	Relapsed Multiple Myeloma	1
3	Completed	Treatment	Relapsed/Refractory Multiple Myeloma (RRMM)	5
3	Completed	Treatment	Respiratory Distress Syndrome	1
3	Completed	Treatment	Rotator Cuff Tears / Shoulder Bursitis	1
3	Completed	Treatment	Sciatica	1
3	Completed	Treatment	Small Cell Lung Cancer (SCLC)	1
3	Completed	Treatment	Soft Tissue Sarcoma	1
3	Enrolling by Invitation	Prevention	Antiemetics / Pediatric / Post Operative Nausea and Vomiting (PONV) / Surgery, Laparoscopic / Therapeutic Uses	1
3	Enrolling by Invitation	Prevention	Postoperative pain	1
3	Enrolling by Invitation	Treatment	Postoperative pain / Radius Fracture Distal	1
3	Not Yet Recruiting	Prevention	Chemotherapy-Induced Nausea and Vomiting / Highly emetogenic cancer chemotherapy (MEC)	1
3	Not Yet Recruiting	Prevention	Hepatocellular Carcinoma	1
3	Not Yet Recruiting	Prevention	Ovarian Hyper Stimulation Syndrome (OHSS)	1
3	Not Yet Recruiting	Supportive Care	Amyloidosis, Immunoglobulin Light-chain	1
3	Not Yet Recruiting	Supportive Care	Analgesia / Nausea, Postoperative / Opioids Use / Postoperative pain / Vomiting, Postoperative	1
3	Not Yet Recruiting	Treatment	Ataxia-Telangiectasia (A-T)	1
3	Not Yet Recruiting	Treatment	CAEBV	1
3	Not Yet Recruiting	Treatment	Cataracts	1
3	Not Yet Recruiting	Treatment	Chemotherapy-Induced Nausea and Vomiting	1
3	Not Yet Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19)	1
3	Not Yet Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Dexamethasone	1
3	Not Yet Recruiting	Treatment	Etp All	1
3	Not Yet Recruiting	Treatment	Hospital-Acquired Pneumonia	1
3	Not Yet Recruiting	Treatment	Mastoiditis; Acute	1
3	Not Yet Recruiting	Treatment	Multiple Myeloma (MM)	3
3	Not Yet Recruiting	Treatment	Newly Diagnosed Multiple Myeloma	1
3	Not Yet Recruiting	Treatment	Non-Small Cell Lung Cancer (NSCLC)	1
3	Not Yet Recruiting	Treatment	Primary Amyloidosis	1
3	Not Yet Recruiting	Treatment	Prophylaxis of Rheumatic fever / Sydenham Chorea	1
3	Not Yet Recruiting	Treatment	Spinal Disorders	1
3	Recruiting	Diagnostic	Respiratory Failure	1
3	Recruiting	Prevention	Acute Pain / Chronic Pain / Spine Erector / Surgery, Cardiac	1
3	Recruiting	Prevention	Acute Respiratory Distress Syndrome (ARDS) / Coronavirus Disease 2019 (COVID‑19) / Viral Pneumonia	1
3	Recruiting	Prevention	Acute Tubulo-Interstitial Nephritis / Dexamethasone / Hypertension in Children / Kidney Scarring / Renal Failure, Chronic Renal Failure / Urinary Tract Infection / Urinary Tract Infections in Children	1
3	Recruiting	Prevention	Analgesia / Analgesics, Opioids / Anesthesia therapy / Dexmedetomidine / General Anesthesia / Lidocaine / Opioid Free Anesthesia / Postoperative paralytic ileus / S-ketamine / Surgery, Colorectal / Surgery, Laparoscopic	1
3	Recruiting	Prevention	Cataracts / Eye Diseases / Lens Diseases / Macular Edema / Macular Edema, Cystoid / Retinal Diseases	1
3	Recruiting	Prevention	Drug hypersensitivity reaction	1
3	Recruiting	Prevention	Laparoscopic Cholecystectomy / Post Operative Nausea and Vomiting (PONV)	1
3	Recruiting	Prevention	Post Operative Nausea and Vomiting (PONV)	1
3	Recruiting	Supportive Care	Breast Carcinoma	1
3	Recruiting	Supportive Care	Pediatric Cancer	1
3	Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL)	1
3	Recruiting	Treatment	Acute Lymphoblastic Leukemia (ALL) / B-cell Acute Lymphoblastic Leukemia / Mixed Phenotype Acute Leukemia (MPAL) / T-cell Acute Lymphoblastic Leukemia	1
3	Recruiting	Treatment	Acute Lymphoblastic Leukemia, Pediatric	1
3	Recruiting	Treatment	Adult Hodgkin Lymphoma	1
3	Recruiting	Treatment	Amount of Postoperative Opioid Use in Milligrams / Nausea, Postoperative / Pain	1
3	Recruiting	Treatment	Anaesthesia / Back pain / Local Anaesthesia therapy / Nerve Block / Postoperative pain / Spine Fusion / Surgery	1
3	Recruiting	Treatment	Aneurysmal Subarachnoid Hemorrhage (A-sah)	1
3	Recruiting	Treatment	Atrioventricular Block / Fetal AVB	1
3	Recruiting	Treatment	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	1
3	Recruiting	Treatment	B-cell Acute Lymphoblastic Leukemia / Central Nervous System Leukemia / Cognitive Side Effects of Cancer Therapy / Necrosis of Bone / Neurotoxicity Syndromes / Pain / Testicular Leukemia / Therapy-Related Toxicity / Untreated Adult Acute Lymphoblastic Leukemia / Untreated Childhood Acute Lymphoblastic Leukemia	1
3	Recruiting	Treatment	B-cell Acute Lymphoblastic Leukemia / Central Nervous System Leukemia / Lymphoblastic B-Cell Lymphoma / Mixed Phenotype Acute Leukemia (MPAL) / Testicular Leukemia	1
3	Recruiting	Treatment	B-cell Acute Lymphoblastic Leukemia / Down Syndrome (DS) / Lymphoblastic B-Cell Lymphoma	1
3	Recruiting	Treatment	B-Cell Non-Hodgkin Lymphoma (NHL)	1
3	Recruiting	Treatment	Bendamustine / Multiple Myeloma (MM)	1
3	Recruiting	Treatment	Bronchiolitis	1
3	Recruiting	Treatment	Cataracts / Ocular Inflammation / Postoperative pain	1
3	Recruiting	Treatment	Chemotherapy-Induced Nausea and Vomiting	2
3	Recruiting	Treatment	Childhood Lymphoblastic Lymphoma	1
3	Recruiting	Treatment	Classical Hodgkin's Lymphoma	1
3	Recruiting	Treatment	Community-acquired Pneumonia, Influenza, COVID-19 / Coronavirus Disease 2019 (COVID‑19)	1
3	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus / Viral Pneumonia	1
3	Recruiting	Treatment	Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS)	1
3	Recruiting	Treatment	Diabetic Macular Edema (DME)	1
3	Recruiting	Treatment	Diabetic Retinopathy (DR)	1
3	Recruiting	Treatment	Disorders of the Eye Following Cataract Surgery	1
3	Recruiting	Treatment	Dysphagia / Dysphonia	1
3	Recruiting	Treatment	Edema of the cerebrum / Traumatic Brain Injury (TBI)	1
3	Recruiting	Treatment	Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer	1
3	Recruiting	Treatment	Extranodal NK/T-cell Lymphoma, Nasal Type	1
3	Recruiting	Treatment	Immune Thrombocytopenia (ITP)	1
3	Recruiting	Treatment	Mature B-cell Non-Hodgkin Lymphoma	1
3	Recruiting	Treatment	Metastatic Castration-Resistant Prostate Cancer (mCRPC) / Neoplasms of the Prostate	1
3	Recruiting	Treatment	Metastatic Colorectal Cancer (CRC)	1
3	Recruiting	Treatment	Metastatic Prostate Cancer	1
3	Recruiting	Treatment	Multiple Myeloma (MM)	20
3	Recruiting	Treatment	Multiple Myeloma (MM) / RISS Stage I Plasma Cell Myeloma / RISS Stage II Plasma Cell Myeloma	1
3	Recruiting	Treatment	Obstructive Sleep Apnea (OSA)	1
3	Recruiting	Treatment	Ocular Inflammation / Ocular Prostheses	1
3	Recruiting	Treatment	Out-of-hospital Cardiac Arrest (OHCA) / Postcardiac Arrest Syndrome	1
3	Recruiting	Treatment	Pediatric Solid Tumor, Unspecified, Protocol Specific	1
3	Recruiting	Treatment	Perioperative Optimization	1
3	Recruiting	Treatment	Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia	1
3	Recruiting	Treatment	Postoperative pain	1
3	Recruiting	Treatment	Primary Immune Thrombocytopenia (ITP)	1
3	Recruiting	Treatment	Recurrent Plasma Cell Myeloma	1
3	Recruiting	Treatment	Relapsed or Refractory Acute Myeloid Leukemia (AML)	1
3	Recruiting	Treatment	Relapsed Refractory Multiple Myeloma (RRMM)	1
3	Recruiting	Treatment	Relapsed/Refractory Multiple Myeloma (RRMM)	5
3	Recruiting	Treatment	Smoldering Multiple Myeloma (SMM)	1
3	Recruiting	Treatment	T-cell Lymphoblastic Lymphoma	1
3	Suspended	Treatment	B-cell Acute Lymphoblastic Leukemia	1
3	Terminated	Basic Science	Newly Diagnosed, Previously Untreated Multiple Myeloma	1
3	Terminated	Health Services Research	Follicular Lymphoma ( FL)	1
3	Terminated	Other	Asthma	1
3	Terminated	Prevention	Chemotherapy-Induced Nausea and Vomiting	1
3	Terminated	Supportive Care	Headache / Vomiting	1
3	Terminated	Supportive Care	Malignant Neoplasm	1
3	Terminated	Treatment	Acute Fungal Otitis Externa	1
3	Terminated	Treatment	Acute Lymphoblastic Leukemia (ALL)	1
3	Terminated	Treatment	Acute Otitis Externa	1
3	Terminated	Treatment	Acute Respiratory Distress Syndrome (ARDS) / Coronavirus Disease 2019 (COVID‑19)	2
3	Terminated	Treatment	Acute Respiratory Distress Syndrome (ARDS) / Coronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus / Viral Pneumonia	1
3	Terminated	Treatment	Adenotonsillectomy / Analgesia / Surgery	1
3	Terminated	Treatment	Chronic Lung Disease of Prematurity / Infants, Premature / Low Birth Weight Infants / Newborn, Infant / Respiratory Distress Syndrome / Small for Gestational Age Infants	1
3	Terminated	Treatment	Cirrhosis of the Liver	1
3	Terminated	Treatment	Coronavirus Disease 2019 (COVID‑19) / Covid 19 Infection	1
3	Terminated	Treatment	Crohn's Disease (CD)	1
3	Terminated	Treatment	De Quervain's Tenosynovitis / Inflammatory Diseases / Lateral Epicondylitis / Tenosynovitis / Trigger Finger	1
3	Terminated	Treatment	Dysphagia After Anterior Cervical Decompression and Fusion of the Spine	1
3	Terminated	Treatment	Immune Thrombocytopenia (ITP)	1
3	Terminated	Treatment	Lymphoma	2
3	Terminated	Treatment	Menière's Disease	3
3	Terminated	Treatment	Metastatic Non-squamous Non Small Cell Lung Cancer	1
3	Terminated	Treatment	Multiple Myeloma (MM)	12
3	Terminated	Treatment	Neoplasms of the Prostate	1
3	Terminated	Treatment	Non-Hodgkin's Lymphoma (NHL)	1
3	Terminated	Treatment	Otitis Externa	1
3	Terminated	Treatment	Otitis Media in Patients With Tympanostomy Tubes	1
3	Terminated	Treatment	Prostate Cancer	1
3	Terminated	Treatment	Relapsed Multiple Myeloma / Relapsed/Refractory Multiple Myeloma (RRMM)	1
3	Terminated	Treatment	Relapsed or Refractory Systemic Light Chain Amyloidosis	1
3	Terminated	Treatment	Sickle Cell Anemia	1
3	Terminated	Treatment	Small Cell Lung Cancer (SCLC)	1
3	Terminated	Treatment	Stage 3 Multiple Myeloma (MM) / Stage I Multiple Myeloma / Stage II Multiple Myeloma	1
3	Terminated	Treatment	Vomiting	2
3	Unknown Status	Prevention	Anesthesia therapy / Post Operative Nausea and Vomiting (PONV) / Strabismus	1
3	Unknown Status	Prevention	Nausea / Vomiting	1
3	Unknown Status	Prevention	Pain	1
3	Unknown Status	Supportive Care	Cancer	1
3	Unknown Status	Supportive Care	Chemotherapy-Induced Nausea and Vomiting	2
3	Unknown Status	Treatment	Acute Bacterial Conjunctivitis	1
3	Unknown Status	Treatment	Acute Lymphoblastic Leukemia (ALL)	1
3	Unknown Status	Treatment	Acute Respiratory Distress Syndrome (ARDS) / Coronavirus Disease 2019 (COVID‑19)	1
3	Unknown Status	Treatment	Acute / Bacterial Conjunctivitis	1
3	Unknown Status	Treatment	Allergic Reaction / Dermatitis	1
3	Unknown Status	Treatment	Arthropathy of Knee	1
3	Unknown Status	Treatment	Bacterial Vaginosis (BV) / Fungal Vaginal Infections	1
3	Unknown Status	Treatment	Bladder Cancer / Transitional Cell Carcinoma / Ureteral Cancer	1
3	Unknown Status	Treatment	Chorioretinitis	1
3	Unknown Status	Treatment	Extramedullary Plasmacytoma	1
3	Unknown Status	Treatment	Extranodal NK/T-cell Lymphoma, Nasal Type / Non-Hodgkin's Lymphoma, Relapsed / T-Cell Non-Hodgkin Lymphoma	1
3	Unknown Status	Treatment	HELLP Syndrome	1
3	Unknown Status	Treatment	Hemophagocytic Lymphohistiocytosis	2
3	Unknown Status	Treatment	Hepatocellular Carcinoma

Dexamethasone

Identification

Structure for Dexamethasone (DB01234)

Pharmacology

Interactions

Products

Categories

Chemical Identifiers

References

Clinical Trials